data_2rqz_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2rqz _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.798 0.332 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.9 t -99.88 84.83 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.992 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.1 mm -102.71 -66.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 t -109.02 56.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 56.93 90.88 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.836 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.424 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 17.8 Cg_endo -60.62 -32.45 93.35 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.486 2.124 . . . . 0.0 112.287 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.1 m -60.61 154.59 20.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.728 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -123.17 32.24 5.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.214 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -150.0 20.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.596 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 t0 70.66 43.62 0.73 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.106 0.479 . . . . 0.0 110.381 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.66 164.92 13.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.255 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.3 m -89.99 130.85 36.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.75 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.5 t -97.61 132.23 43.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.918 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mt -121.07 -170.47 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.5 146.51 25.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -179.16 6.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -89.9 99.41 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.7 21.54 50.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.674 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -148.01 -179.39 6.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.869 0.366 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 39.2 p90 -104.63 157.51 17.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.039 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.13 88.02 2.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.93 108.33 19.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.1 mt -90.97 96.09 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.073 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 m -70.95 175.29 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.09 171.6 7.28 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.909 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.02 101.4 1.49 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.501 2.134 . . . . 0.0 112.353 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.19 26.64 6.53 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -104.15 -175.48 2.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 0.0 110.863 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -146.12 178.57 8.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.21 165.9 32.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.522 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.01 -43.57 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.836 0.35 . . . . 0.0 111.117 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 1.9 m-85 -101.04 28.51 5.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 83.8 m 52.86 80.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.952 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -152.41 -44.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.093 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.825 0.345 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.79 79.57 2.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 mm -102.51 -67.13 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.293 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 t -108.85 54.56 0.65 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.93 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 53.69 93.06 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.002 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.427 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 18.1 Cg_endo -60.45 -32.49 93.85 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.487 2.124 . . . . 0.0 112.219 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.3 m -64.78 162.53 15.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.79 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.59 -29.71 7.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.448 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -90.04 12.07 18.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.709 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 74.12 56.35 0.09 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.198 0.523 . . . . 0.0 110.546 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.0 169.72 10.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.172 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.3 m -89.95 145.57 25.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.4 t -105.39 135.53 46.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 tp -127.3 141.0 51.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.81 155.89 16.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -137.87 -77.3 0.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.0 110.983 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.1 mt -146.69 -46.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.162 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -161.23 28.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.47 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -141.85 160.04 41.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 110.858 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -96.51 147.38 23.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.981 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.09 118.33 20.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -105.99 114.37 28.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.3 mt -89.98 105.25 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.948 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 t -86.4 166.36 15.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.078 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.09 172.51 0.71 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.935 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.89 109.59 2.75 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.618 2.212 . . . . 0.0 112.387 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.48 24.05 10.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.485 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -100.54 -176.07 3.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 0.0 110.838 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.93 -176.99 5.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.9 173.07 34.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.526 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.01 -51.36 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 111.083 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 18.0 m-85 -98.42 30.04 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.789 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.7 t 57.55 70.09 0.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -154.82 26.16 0.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.978 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.0 mm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.095 179.955 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.711 0.291 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.5 t -89.92 84.25 6.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mm -107.73 -66.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.126 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -109.4 55.6 0.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.795 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 58.42 88.62 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.77 -38.78 46.8 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.47 2.113 . . . . 0.0 112.229 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.401 ' CB ' ' HB2' ' A' ' 14' ' ' ALA . 8.8 m -57.47 151.0 17.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.648 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -118.71 29.67 7.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.506 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -150.06 17.48 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t0 71.15 60.17 0.18 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.14 0.495 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 10' ' ' CYS . . . -105.43 166.83 10.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.251 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.2 m -90.02 132.06 35.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.739 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.4 t -102.83 127.58 49.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.89 -171.83 2.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -141.64 164.34 30.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.49 -50.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.3 mt -144.8 -66.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.181 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.12 26.44 0.9 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.528 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -128.0 170.73 12.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.744 0.307 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CE2' ' CE1' ' A' ' 35' ' ' TYR . 48.0 p90 -98.43 137.26 37.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.029 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.36 146.22 41.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.78 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.2 t -141.45 115.98 9.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.716 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.7 mt -89.88 114.24 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.03 169.84 14.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.006 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.403 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -74.54 172.51 8.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.721 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 73.3 Cg_endo -75.36 81.61 2.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.475 2.116 . . . . 0.0 112.354 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.94 38.47 0.75 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.464 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -107.44 -176.1 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -149.11 177.84 9.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.86 170.79 41.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.95 -48.52 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.085 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CE1' ' CE2' ' A' ' 23' ' ' PHE . 2.3 m-85 -98.33 30.0 3.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.8 m 53.14 93.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -170.42 -39.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.857 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.9 mm . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.076 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.887 0.375 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.5 t -138.57 87.7 2.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.954 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.1 mm -116.29 -67.29 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.214 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 t -108.45 55.26 0.64 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 53.71 87.06 0.15 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.944 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.88 -26.64 75.15 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.549 2.166 . . . . 0.0 112.347 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.5 m -59.99 171.5 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.806 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -136.07 28.88 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -149.54 19.69 0.93 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.455 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.63 43.19 0.47 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.092 0.472 . . . . 0.0 110.544 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.98 170.62 10.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.125 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.9 m -99.95 153.67 18.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.015 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.8 t -103.94 127.45 51.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tp -121.04 81.49 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.75 127.54 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.884 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -108.28 -52.35 2.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.08 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -140.99 -75.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.343 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.82 -19.32 1.16 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.142 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.91 179.61 5.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 111.034 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.501 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 54.3 p90 -110.49 133.45 53.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -116.56 112.29 21.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.802 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 m -89.99 120.74 31.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.935 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.2 mt -89.91 98.64 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.32 163.86 23.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.132 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.75 172.02 0.93 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.74 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.08 72.88 5.13 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.484 2.123 . . . . 0.0 112.334 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.57 40.08 0.31 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.486 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -108.67 -175.75 2.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.747 0.308 . . . . 0.0 110.89 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -148.16 173.96 12.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.53 166.82 24.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.58 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.8 t -89.93 -47.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.501 ' CE1' ' CE1' ' A' ' 23' ' ' PHE . 2.4 m-85 -101.69 28.57 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.6 m 55.53 92.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.922 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -169.49 -41.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.961 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 27.2 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.093 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.851 0.358 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.31 79.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 mm -108.09 -65.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.191 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 t -108.3 54.44 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 53.95 89.08 0.11 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.099 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.93 -39.09 43.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.436 2.091 . . . . 0.0 112.336 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 17.1 m -58.11 155.21 11.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.803 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -122.15 27.5 7.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.409 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -149.77 17.06 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t70 72.19 59.92 0.14 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.107 0.48 . . . . 0.0 110.447 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . . . -101.57 165.26 11.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.218 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.4 m -89.96 136.46 33.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.745 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -103.23 139.8 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.4 137.18 33.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.05 130.39 45.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -113.66 -78.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.978 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.2 mm -113.6 -66.7 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -158.04 27.77 0.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.409 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -127.66 176.38 7.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -105.51 123.47 47.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.014 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.6 118.09 35.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.5 t -110.06 114.07 27.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.994 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.7 mt -89.94 100.17 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.972 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.6 t -81.12 165.69 21.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.043 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.419 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -60.56 170.73 1.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.837 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.76 111.48 3.13 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.663 2.242 . . . . 0.0 112.357 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.42 26.53 9.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.532 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 28' ' ' MET . 7.4 m-85 -102.83 -175.86 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.784 0.326 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -145.99 178.86 7.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.93 166.46 38.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.554 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -90.04 -41.49 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.038 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -100.75 29.79 4.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.4 t 49.24 85.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.053 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -158.8 -43.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.774 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.711 0.291 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.0 t -89.84 86.89 6.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 111.024 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.6 mm -110.87 -66.11 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 t -107.44 55.88 0.64 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 58.52 96.33 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 16.3 Cg_endo -58.34 -46.85 22.27 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.421 2.081 . . . . 0.0 112.124 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.2 m -60.34 160.71 8.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.809 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 2.7 mm-40 -123.99 36.83 4.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.038 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -148.66 17.7 1.02 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.606 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t0 70.04 50.32 0.45 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.118 0.485 . . . . 0.0 110.298 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.11 175.44 5.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.281 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.4 m -89.99 156.53 18.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.741 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 t -131.0 130.91 43.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.96 152.16 34.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -82.07 128.07 33.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.969 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -140.5 163.86 31.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.78 132.88 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.36 -56.01 4.93 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.516 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -124.99 163.59 22.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.339 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.48 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 9.3 p90 -90.88 157.33 17.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.03 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.03 127.02 48.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.763 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -132.28 112.75 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.5 mt -89.94 96.94 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 28.1 p -89.38 -174.32 4.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -58.13 165.69 2.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.98 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -85.4 99.07 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.842 2.362 . . . . 0.0 112.604 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.61 32.65 1.56 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.636 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 28' ' ' MET . 3.4 m-30 -99.82 -177.76 3.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.816 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.99 -175.02 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.173 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.26 -169.15 32.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.587 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.88 -52.12 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 0.0 110.872 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.48 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 2.0 m-85 -99.06 28.3 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.638 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.1 m 54.52 32.75 17.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.605 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -102.47 30.07 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.037 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.8 mm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.188 179.98 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 69.0 m -90.0 106.15 18.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.8 mm -122.45 -68.42 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.479 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 t -109.25 51.53 0.74 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.091 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 46.55 87.74 0.11 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.464 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 11.8 Cg_endo -56.54 -34.46 95.22 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.451 2.1 . . . . 0.0 112.192 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -58.2 173.62 0.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.85 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.98 29.29 2.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.232 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -149.01 19.76 0.98 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.54 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.05 63.83 0.3 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.245 0.545 . . . . 0.0 110.139 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.17 171.65 7.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.313 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.1 m -89.92 145.42 25.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.928 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.48 124.94 50.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.48 153.68 32.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.62 92.26 3.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -121.05 -57.32 1.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.806 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.0 mt -98.3 160.37 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.939 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.81 -26.03 7.72 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.745 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -89.89 -176.23 4.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.911 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -89.86 131.0 36.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -116.03 90.37 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.2 t -94.93 129.93 41.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.0 mt -89.93 121.17 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.024 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.81 172.61 9.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.017 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.44 171.27 11.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.816 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.34 68.86 5.95 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.532 2.154 . . . . 0.0 112.338 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.97 41.85 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.469 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -108.98 -174.69 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.811 0.338 . . . . 0.0 110.821 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 -163.61 1.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.42 171.47 26.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.563 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.95 -36.63 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.871 0.367 . . . . 0.0 111.165 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.2 m-85 -111.94 31.15 6.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 90.1 m 51.77 78.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -155.88 27.39 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.9 mm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.187 179.948 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.0 t -124.36 79.4 1.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.443 HD11 HG21 ' A' ' 6' ' ' ILE . 21.0 mm -101.8 -66.06 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.264 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 t -106.39 56.71 0.66 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.946 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 57.22 95.78 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 28.4 Cg_endo -63.72 -36.87 49.51 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.425 2.083 . . . . 0.0 112.399 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.6 m -59.26 163.42 3.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.93 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.49 -27.47 7.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.525 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -90.01 11.57 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.768 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t0 72.59 66.38 0.12 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.029 0.442 . . . . 0.0 110.325 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.67 -175.92 2.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.374 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.8 m -96.49 161.68 13.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.2 t -130.97 137.04 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.07 3.41 7.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.463 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 59.24 161.3 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.92 0.39 . . . . 0.0 110.835 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.75 -178.28 6.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 pt -89.88 89.98 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.06 -28.39 15.91 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.494 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -127.56 174.87 8.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.432 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 24.9 p90 -90.01 148.1 23.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -123.79 81.55 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 t -93.98 128.38 40.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.4 mt -92.84 116.06 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.074 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 t -86.25 163.17 17.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.829 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.4 169.84 0.22 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.053 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.53 102.42 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.637 2.225 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.9 34.21 5.26 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.556 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -108.5 -175.49 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -149.4 174.45 12.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.58 173.64 21.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.427 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.0 t -90.09 -49.5 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 111.06 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.432 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 1.7 m-85 -105.36 34.33 3.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.868 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.2 t 49.18 94.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.988 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -169.94 -39.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.2 mm . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.071 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.761 0.315 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 47.7 t -114.84 85.32 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.025 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.7 mm -111.04 -66.11 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.7 t -107.99 55.8 0.64 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 57.83 91.08 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.421 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 23.7 Cg_endo -62.39 -29.45 79.35 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.554 2.169 . . . . 0.0 112.373 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.4 m -62.69 163.58 8.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.731 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.65 -30.53 6.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.535 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -90.91 13.41 16.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.831 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 t0 73.76 56.4 0.1 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.082 0.468 . . . . 0.0 110.548 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.7 175.79 6.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.185 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.8 m -89.94 139.56 30.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.1 t -123.44 108.26 12.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.9 mt -99.94 154.37 18.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.22 89.75 3.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -130.42 -46.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.0 mt -98.24 160.42 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.057 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.51 -25.99 14.55 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.679 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -100.18 177.1 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.772 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -89.99 147.74 23.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.23 99.62 6.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.5 t -97.38 111.1 23.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.2 mt -89.95 101.9 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.923 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.05 173.24 12.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.989 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.47 171.01 0.43 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.973 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.25 95.18 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.642 2.228 . . . . 0.0 112.509 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.47 46.41 1.68 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.607 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -114.87 -174.49 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.34 -167.52 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.16 168.25 40.3 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.01 -43.96 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.795 0.331 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.5 m-85 -108.27 35.2 3.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.855 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.8 t 54.85 89.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.831 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -171.97 -39.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 mm . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.125 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.747 0.308 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.13 77.43 1.31 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.912 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.1 mm -102.93 -67.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.2 t -110.82 55.59 0.65 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 57.56 91.96 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.96 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 33.9 Cg_endo -64.94 -38.62 28.35 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.489 2.126 . . . . 0.0 112.207 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.7 m -57.92 134.18 56.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.721 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 20.4 mm-40 -97.58 34.49 1.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.342 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -149.37 13.83 0.86 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 70.53 55.86 0.27 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.136 0.493 . . . . 0.0 110.435 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.46 -179.7 4.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.267 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.8 m -98.58 157.28 16.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -129.81 140.62 50.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.969 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.64 88.12 2.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.767 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.55 85.67 2.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.98 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -32.79 6.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.763 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -117.34 163.45 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.835 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -46.95 -28.51 3.97 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.729 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -90.92 168.96 11.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.759 0.314 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -90.6 138.25 31.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.98 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -126.38 88.25 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.838 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.36 127.05 36.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.467 HD12 HG21 ' A' ' 26' ' ' ILE . 31.2 mt -89.96 116.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.4 m -71.66 178.02 3.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.048 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.57 169.56 15.2 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.77 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -73.23 64.41 4.34 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.499 2.133 . . . . 0.0 112.295 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.47 41.61 0.22 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.54 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -114.56 -175.14 2.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.82 0.343 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -150.15 -177.94 6.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.81 -175.55 25.41 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.592 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.91 -54.8 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.393 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 4.3 m-85 -98.22 29.6 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.795 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.2 m 54.46 30.39 12.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.016 0.436 . . . . 0.0 110.435 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.416 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 4.1 pt-20 -99.34 23.29 9.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.254 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.131 -179.959 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.733 0.301 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.49 97.15 7.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.995 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 6' ' ' ILE . 24.3 mm -109.92 -69.16 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 t -114.37 54.9 0.75 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.772 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 56.01 88.61 0.12 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.027 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.01 -37.24 78.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.54 2.16 . . . . 0.0 112.349 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 m -58.83 171.39 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.77 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -130.43 30.59 4.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.051 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -145.32 16.28 1.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.593 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 t0 69.37 48.11 0.66 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.158 0.504 . . . . 0.0 110.103 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.9 174.34 7.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.511 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.3 m -89.9 162.11 15.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.4 t -135.84 156.09 49.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.03 -47.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t0 56.05 103.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.043 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -133.38 -46.57 0.83 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 mm -95.41 174.02 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.784 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.97 -27.36 4.96 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.657 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -96.26 172.39 7.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.337 . . . . 0.0 110.823 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.491 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 52.8 p90 -92.19 133.0 36.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.07 93.16 4.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.1 t -104.51 120.03 40.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.946 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.4 mt -89.94 126.04 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.017 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.7 p -113.14 -174.87 2.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.03 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.452 ' CB ' ' CE1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.58 163.14 2.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.6 100.16 0.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.815 2.343 . . . . 0.0 112.522 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.9 23.64 3.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.798 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.452 ' CE1' ' CB ' ' A' ' 28' ' ' MET . 3.2 m-85 -94.8 179.71 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.748 0.309 . . . . 0.0 110.82 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -150.22 -177.31 5.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.46 -174.3 23.71 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.632 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 t -89.84 -32.27 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 110.794 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.491 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 5.8 m-85 -121.11 26.73 8.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.682 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m 53.85 32.88 15.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.726 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.64 31.47 2.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.028 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.118 -179.993 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.92 0.39 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.0 t -142.46 102.91 4.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.963 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.458 HD13 HG23 ' A' ' 6' ' ' ILE . 22.6 mm -121.99 -66.9 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t -110.42 55.41 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.963 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 57.09 94.49 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 26.5 Cg_endo -62.99 -38.22 48.16 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.358 2.039 . . . . 0.0 112.257 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 m -58.1 143.85 42.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.744 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -107.43 30.19 6.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.343 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -147.0 15.26 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 t70 71.09 60.4 0.18 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.123 0.487 . . . . 0.0 110.508 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -110.26 177.42 4.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.205 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.0 m -89.9 161.53 15.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.82 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.1 t -141.27 74.93 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.7 86.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.756 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.16 118.42 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.972 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -149.97 -47.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.9 mm -92.14 161.52 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.953 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.12 -26.86 6.57 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.726 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -95.19 165.82 12.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 110.797 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -89.97 130.22 36.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -119.4 95.0 4.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.949 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -94.2 128.31 40.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.782 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.9 122.12 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.018 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.1 m -82.92 174.7 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.022 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.417 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -79.08 171.51 12.32 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.615 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 61.2 Cg_endo -72.4 80.16 1.69 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.391 2.061 . . . . 0.0 112.342 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.38 57.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.466 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -118.32 -174.28 2.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -142.22 -176.81 4.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.55 172.93 46.02 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.97 -49.08 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.1 m-85 -98.15 27.49 4.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.3 97.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -168.89 -38.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.826 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 38' ' ' ILE . 21.7 mm . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.097 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 . . . . . 0 CA--C 1.527 0.058 0 CA-C-O 120.804 0.335 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.85 93.76 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.972 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.4 mm -128.19 -65.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.166 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.1 t -99.35 53.32 0.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 52.74 89.61 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.14 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.88 -58.43 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.431 2.087 . . . . 0.0 112.213 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 m -50.1 132.21 23.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -96.28 30.94 2.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.543 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -149.21 12.8 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.5 t0 69.48 66.28 0.26 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.193 0.52 . . . . 0.0 110.351 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.92 179.19 4.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.32 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.6 m -90.0 140.13 29.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.692 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.1 t -134.42 92.44 2.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.825 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -71.35 124.08 23.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.953 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.17 112.32 3.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.29 161.09 23.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.5 mt -91.3 92.0 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.23 -76.93 0.26 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.545 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -123.44 179.14 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.878 0.371 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -97.31 129.85 44.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.978 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -107.71 87.47 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.17 114.86 27.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.972 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.6 mt -89.94 122.67 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.998 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 164.9 19.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.067 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.03 171.39 1.55 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.809 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.37 79.69 3.1 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.553 2.169 . . . . 0.0 112.462 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.47 37.78 0.71 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.449 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -109.35 -175.16 2.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -144.78 -178.15 5.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.03 169.75 46.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.02 -47.93 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -99.74 27.98 5.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.9 m 54.1 100.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.972 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -174.54 -38.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.95 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.464 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.81 0.338 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -137.49 77.46 1.64 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.802 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.0 mm -108.98 -66.46 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.212 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.36 55.86 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 56.08 88.76 0.12 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.438 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 30.6 Cg_endo -64.61 -39.3 27.99 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.512 2.142 . . . . 0.0 112.277 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.412 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 4.3 m -70.05 150.84 46.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.74 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 20.3 mm-40 -118.46 27.94 8.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.34 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -146.83 15.14 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 72.11 50.26 0.22 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.135 0.493 . . . . 0.0 110.562 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 10' ' ' CYS . . . -90.13 172.73 8.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.179 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.1 m -97.57 132.5 43.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.797 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 t -99.47 131.59 45.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.21 142.95 47.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.85 117.7 34.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -102.87 -77.88 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.8 mp -141.52 -66.47 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.186 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -140.11 28.38 2.49 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -141.36 171.31 14.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.41 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 52.1 p90 -102.58 136.75 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.987 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -117.05 92.78 3.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -89.98 119.74 30.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.3 mt -89.92 113.64 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.5 m -74.75 174.06 9.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.141 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.42 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -70.53 172.72 5.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.565 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 64.2 Cg_endo -73.1 66.78 4.2 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.343 2.028 . . . . 0.0 112.32 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.77 41.03 0.25 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.526 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' A' ' 28' ' ' MET . 4.3 m-85 -113.8 -176.47 2.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -150.22 -177.95 6.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.14 -175.92 28.84 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.626 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 t -89.97 -54.09 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 10.3 m-85 -96.97 26.18 4.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.792 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 m 51.66 32.6 9.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.957 0.408 . . . . 0.0 110.586 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 1.9 pt-20 -99.06 29.85 3.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.109 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.8 mm . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.973 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.824 0.345 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.71 85.6 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.837 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.5 mm -94.89 -69.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.226 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t -116.05 55.17 0.8 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 55.16 91.3 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.48 -27.72 46.41 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.483 2.122 . . . . 0.0 112.381 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.405 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 14.2 m -55.43 135.69 50.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -102.2 32.52 3.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.192 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -146.43 14.14 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 t0 68.53 43.85 1.32 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.199 0.524 . . . . 0.0 110.218 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.405 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -89.95 178.82 6.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.411 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.0 m -99.25 145.51 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.808 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.3 t -106.67 137.6 44.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.712 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.18 118.53 18.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -69.7 122.87 20.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.89 -76.57 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.9 mt -145.28 -46.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.167 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.64 -38.16 0.06 OUTLIER Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.844 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -89.79 178.63 6.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.388 . . . . 0.0 111.004 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -100.17 153.84 18.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.053 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -132.36 112.66 12.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.795 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -90.01 109.94 20.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 26' ' ' ILE . 31.0 mt -99.44 90.88 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.827 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 p -97.32 -176.37 3.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.068 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.424 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -51.38 168.51 0.26 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.105 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.07 138.73 10.35 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.697 2.264 . . . . 0.0 112.448 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.82 24.06 62.97 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.714 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.424 ' CE1' ' HB3' ' A' ' 28' ' ' MET . 2.6 m-85 -90.38 -176.37 4.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.726 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -150.09 -178.47 6.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.124 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.12 176.0 30.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.522 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.2 t -89.88 -48.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.996 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -100.38 28.91 4.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.799 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.2 m 58.85 51.95 6.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.875 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -113.86 -33.43 5.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.823 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.7 mm . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.06 -179.996 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.759 0.314 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.6 t -100.11 83.28 2.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.053 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 1.7 mp -102.09 -75.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.808 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -107.97 55.91 0.64 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.809 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 59.15 90.26 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.31 -38.31 81.93 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.581 2.187 . . . . 0.0 112.313 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 m -57.13 168.21 0.74 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.823 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -127.99 27.26 5.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.285 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -146.13 17.19 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.518 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 69.71 52.65 0.42 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.305 0.574 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.53 176.55 5.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.256 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.0 m -90.03 149.85 22.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.816 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.0 t -125.89 139.15 53.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.34 126.16 43.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -65.02 137.54 57.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -149.48 163.54 37.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.991 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.36 90.21 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.176 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.41 -82.19 0.23 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.518 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -113.31 178.02 4.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.85 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.472 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 54.8 p90 -89.96 142.33 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.999 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -109.39 96.77 6.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -106.29 119.16 38.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.8 mt -90.06 116.57 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.4 m -73.56 178.48 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.045 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.449 ' CB ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -75.66 170.79 14.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.45 72.6 4.86 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.526 2.151 . . . . 0.0 112.475 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.37 38.78 0.47 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.621 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.449 ' CD1' ' CB ' ' A' ' 28' ' ' MET . 4.9 m-85 -112.16 -175.95 2.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -150.04 179.23 8.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.8 -177.7 29.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.03 -50.54 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.472 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 6.3 m-85 -98.21 28.69 3.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.2 m 54.12 30.73 12.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.968 0.413 . . . . 0.0 110.753 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -100.56 -23.66 14.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.212 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 mm . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.08 -179.942 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.583 0.23 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.3 m -89.91 73.84 7.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.425 HG22 HD12 ' A' ' 6' ' ' ILE . 23.3 mm -101.59 -67.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.226 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.64 53.57 0.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.016 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 49.44 91.72 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.29 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.96 -39.36 41.05 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.519 2.146 . . . . 0.0 112.221 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 m -49.5 151.37 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -114.08 32.07 6.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.31 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -149.6 17.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t0 69.98 57.91 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.197 0.522 . . . . 0.0 110.482 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.1 -175.6 2.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.251 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.4 m -105.57 160.62 15.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.054 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.01 148.41 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.781 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.98 159.68 41.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -113.29 158.66 20.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.86 -77.03 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.93 -67.43 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.089 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.32 26.96 1.39 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.399 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.33 -178.98 5.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 0.0 110.968 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -106.53 137.26 44.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -124.93 94.95 4.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.644 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.94 130.54 36.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.1 mt -89.91 122.87 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.987 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -84.36 -176.1 6.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.048 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.412 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -84.75 172.1 9.65 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.611 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.9 Cg_endo -74.17 75.46 3.29 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.403 2.069 . . . . 0.0 112.356 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.98 38.57 0.56 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.557 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -112.95 -176.21 2.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -150.1 -177.26 5.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.36 174.03 41.84 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.491 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 t -89.96 -53.4 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.82 0.343 . . . . 0.0 110.954 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -97.81 25.62 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.815 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.17 100.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.934 0.397 . . . . 0.0 111.068 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -173.84 -33.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.976 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.1 mm . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.979 -179.941 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.812 0.339 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -106.72 90.24 3.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.833 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.455 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 1.6 mp -106.14 -77.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.941 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.9 53.97 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 53.4 86.3 0.17 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.169 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 17.4 Cg_endo -58.9 -37.39 93.88 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.529 2.152 . . . . 0.0 112.249 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.97 177.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.925 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -134.95 28.14 3.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.251 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -146.36 15.75 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.716 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 70.23 49.68 0.45 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.085 0.469 . . . . 0.0 110.209 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.97 175.1 7.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.203 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.7 m -90.04 154.22 19.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -112.9 131.07 55.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.743 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 112.58 6.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -80.57 151.05 29.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -118.75 -80.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 mt -129.2 -68.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.28 -37.45 0.6 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.546 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.87 172.48 8.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -97.64 162.87 13.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.014 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -147.74 96.46 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.817 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.8 t -90.08 131.06 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.028 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.9 mt -91.88 118.52 37.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.001 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -100.2 161.39 13.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.976 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.67 171.69 0.99 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.835 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.73 127.22 7.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.656 2.237 . . . . 0.0 112.424 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.96 31.24 39.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.51 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -106.68 -174.88 2.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.816 0.341 . . . . 0.0 110.885 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -147.09 -176.98 5.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.59 164.92 38.32 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.456 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 t -89.94 -30.19 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 111.042 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.7 m-85 -118.12 35.98 4.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.3 t 49.84 84.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -157.31 -42.62 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.461 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.681 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.78 0.324 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.12 71.11 1.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.843 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 1.7 mp -99.67 -77.74 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.046 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 t -93.37 55.49 2.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.076 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 53.06 92.93 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.999 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.67 -46.17 9.62 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.504 2.136 . . . . 0.0 112.243 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 9.6 m -59.88 161.45 6.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.621 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.87 28.96 4.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.188 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -149.18 18.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.511 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t70 71.83 50.43 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.17 0.509 . . . . 0.0 110.465 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . . . -90.17 171.62 9.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.174 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.9 m -94.93 136.65 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.8 t -113.46 118.81 35.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.95 132.84 53.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -60.56 122.28 14.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -165.81 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pt -94.23 23.81 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.633 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.93 -37.78 0.87 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.675 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -100.06 177.33 5.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 110.894 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 44.3 p90 -102.14 146.63 27.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.02 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -116.76 92.01 3.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.002 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.96 113.53 25.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.813 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.0 mt -89.92 119.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.989 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.7 172.8 8.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.048 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.415 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -72.51 172.36 7.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.791 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.47 62.56 7.05 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.499 2.133 . . . . 0.0 112.254 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.57 43.11 0.1 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.467 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' A' ' 28' ' ' MET . 2.6 m-85 -109.93 -175.37 2.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -144.37 175.71 9.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.55 166.25 37.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.16 -33.82 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 0.0 111.159 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 17.4 m-85 -113.54 33.29 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.8 m 49.82 88.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -162.62 -43.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 38' ' ' ILE . 26.9 mm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.071 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.834 0.349 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 21.1 t -143.81 80.17 1.65 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.904 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 1.6 mp -114.81 -76.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.69 55.34 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 53.44 90.05 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.066 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.6 -37.52 87.79 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.674 2.25 . . . . 0.0 112.323 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.1 m -59.45 169.6 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.905 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -131.26 26.75 4.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -149.88 18.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.563 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t0 70.61 48.95 0.42 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.126 0.488 . . . . 0.0 110.275 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.92 168.7 11.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.238 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 97.2 m -89.89 133.93 34.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.6 t -104.15 143.33 33.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.908 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.45 132.98 25.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -126.81 129.87 49.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -124.88 -62.15 1.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.6 mt -93.87 -67.73 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.108 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.12 33.29 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.494 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -135.1 158.01 45.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.494 ' CE2' ' CE1' ' A' ' 35' ' ' TYR . 51.1 p90 -95.05 123.23 38.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -105.21 102.6 12.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -90.03 128.39 36.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.069 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.2 mt -106.87 106.7 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.808 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.07 161.24 18.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.113 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.67 172.78 0.48 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.941 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.05 119.32 4.64 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.536 2.157 . . . . 0.0 112.306 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.12 20.59 35.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.441 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -100.56 -177.04 3.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 110.734 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.07 -177.02 5.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.4 169.16 31.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.38 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.06 -36.05 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 111.145 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' TYR . . . . . 0.494 ' CE1' ' CE2' ' A' ' 23' ' ' PHE . 3.8 m-85 -111.1 26.27 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.988 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 37.8 t 51.66 92.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -162.29 -37.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.998 -179.837 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.795 0.331 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t 63.24 145.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.058 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 67.8 m-20 -114.73 -177.0 3.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -111.51 -34.09 6.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.9 t -99.88 84.83 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.992 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.1 mm -102.71 -66.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 t -109.02 56.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 56.93 90.88 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.836 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.424 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 17.8 Cg_endo -60.62 -32.45 93.35 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.486 2.124 . . . . 0.0 112.287 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.1 m -60.61 154.59 20.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.728 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -123.17 32.24 5.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.214 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -150.0 20.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.596 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 t0 70.66 43.62 0.73 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.106 0.479 . . . . 0.0 110.381 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -92.66 164.92 13.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.255 -179.666 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.3 m -89.99 130.85 36.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.75 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.5 t -97.61 132.23 43.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.918 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 2.9 mt -121.07 -170.47 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.5 146.51 25.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -179.16 6.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -89.9 99.41 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.7 21.54 50.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.674 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -148.01 -179.39 6.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.869 0.366 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 39.2 p90 -104.63 157.51 17.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.039 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.13 88.02 2.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.93 108.33 19.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.1 mt -90.97 96.09 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.073 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 m -70.95 175.29 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -70.09 171.6 7.28 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.909 179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.02 101.4 1.49 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.501 2.134 . . . . 0.0 112.353 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.19 26.64 6.53 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -104.15 -175.48 2.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 0.0 110.863 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -146.12 178.57 8.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.21 165.9 32.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.522 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.01 -43.57 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.836 0.35 . . . . 0.0 111.117 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 1.9 m-85 -101.04 28.51 5.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 83.8 m 52.86 80.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.952 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -152.41 -44.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.093 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.879 0.371 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -136.36 76.85 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.066 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -115.56 -37.25 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.967 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.04 -36.28 15.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.88 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.79 79.57 2.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 mm -102.51 -67.13 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.293 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 t -108.85 54.56 0.65 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.93 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.3 t-20 53.69 93.06 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.002 179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.427 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 18.1 Cg_endo -60.45 -32.49 93.85 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.487 2.124 . . . . 0.0 112.219 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 10.3 m -64.78 162.53 15.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.79 -179.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.59 -29.71 7.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.448 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -90.04 12.07 18.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.709 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 74.12 56.35 0.09 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.198 0.523 . . . . 0.0 110.546 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.0 169.72 10.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.172 -179.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.3 m -89.95 145.57 25.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.4 t -105.39 135.53 46.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 tp -127.3 141.0 51.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.81 155.89 16.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -137.87 -77.3 0.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.0 110.983 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.1 mt -146.69 -46.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.162 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -161.23 28.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.47 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -141.85 160.04 41.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 110.858 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -96.51 147.38 23.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.981 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.09 118.33 20.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 50.9 t -105.99 114.37 28.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 33.3 mt -89.98 105.25 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.948 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 t -86.4 166.36 15.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.078 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.09 172.51 0.71 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.935 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.89 109.59 2.75 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.618 2.212 . . . . 0.0 112.387 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.48 24.05 10.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.485 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -100.54 -176.07 3.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 0.0 110.838 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.93 -176.99 5.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.9 173.07 34.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.526 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.01 -51.36 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 111.083 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.427 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 18.0 m-85 -98.42 30.04 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.789 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.7 t 57.55 70.09 0.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -154.82 26.16 0.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.978 -179.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.0 mm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.095 179.955 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.82 0.343 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.08 143.36 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.03 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -95.47 151.19 19.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.0 -24.71 10.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.5 t -89.92 84.25 6.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mm -107.73 -66.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.126 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -109.4 55.6 0.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.795 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 58.42 88.62 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.77 -38.78 46.8 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.47 2.113 . . . . 0.0 112.229 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.401 ' CB ' ' HB2' ' A' ' 14' ' ' ALA . 8.8 m -57.47 151.0 17.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.648 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -118.71 29.67 7.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.506 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -150.06 17.48 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t0 71.15 60.17 0.18 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.14 0.495 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.401 ' HB2' ' CB ' ' A' ' 10' ' ' CYS . . . -105.43 166.83 10.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.251 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 65.2 m -90.02 132.06 35.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.739 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.4 t -102.83 127.58 49.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -129.89 -171.83 2.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -141.64 164.34 30.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.49 -50.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.3 mt -144.8 -66.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.181 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.12 26.44 0.9 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.528 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -128.0 170.73 12.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.744 0.307 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CE2' ' CE1' ' A' ' 35' ' ' TYR . 48.0 p90 -98.43 137.26 37.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.029 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -115.36 146.22 41.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.78 179.957 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.2 t -141.45 115.98 9.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.716 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.7 mt -89.88 114.24 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 -179.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.03 169.84 14.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.006 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.403 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -74.54 172.51 8.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.721 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.403 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 73.3 Cg_endo -75.36 81.61 2.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.475 2.116 . . . . 0.0 112.354 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.94 38.47 0.75 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.464 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -107.44 -176.1 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -149.11 177.84 9.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.86 170.79 41.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.95 -48.52 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.085 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CE1' ' CE2' ' A' ' 23' ' ' PHE . 2.3 m-85 -98.33 30.0 3.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.8 m 53.14 93.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -170.42 -39.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.857 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.9 mm . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.076 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.792 0.329 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.63 143.15 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.041 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -130.07 -46.12 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -139.56 -67.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.5 t -138.57 87.7 2.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.954 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.1 mm -116.29 -67.29 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.214 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 t -108.45 55.26 0.64 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 53.71 87.06 0.15 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.944 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.88 -26.64 75.15 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.549 2.166 . . . . 0.0 112.347 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 12.5 m -59.99 171.5 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.806 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -136.07 28.88 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -149.54 19.69 0.93 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.455 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.63 43.19 0.47 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.092 0.472 . . . . 0.0 110.544 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.98 170.62 10.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.125 -179.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.9 m -99.95 153.67 18.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.015 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.8 t -103.94 127.45 51.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.5 tp -121.04 81.49 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.75 127.54 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.884 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -108.28 -52.35 2.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.08 -179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.2 mp -140.99 -75.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.343 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.82 -19.32 1.16 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.142 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.91 179.61 5.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 111.034 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.501 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 54.3 p90 -110.49 133.45 53.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -116.56 112.29 21.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.802 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 m -89.99 120.74 31.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.935 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 34.2 mt -89.91 98.64 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.839 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.32 163.86 23.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.132 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.75 172.02 0.93 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.74 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -76.08 72.88 5.13 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.484 2.123 . . . . 0.0 112.334 179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.57 40.08 0.31 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.486 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -108.67 -175.75 2.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.747 0.308 . . . . 0.0 110.89 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -148.16 173.96 12.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.53 166.82 24.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.58 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.8 t -89.93 -47.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.501 ' CE1' ' CE1' ' A' ' 23' ' ' PHE . 2.4 m-85 -101.69 28.57 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.6 m 55.53 92.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.922 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -169.49 -41.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.961 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 27.2 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.093 -179.992 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.754 0.312 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.72 129.54 66.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.074 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -107.26 118.82 37.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.02 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.95 -79.27 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.874 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.31 79.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 mm -108.09 -65.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.191 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 t -108.3 54.44 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 53.95 89.08 0.11 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.099 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.93 -39.09 43.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.436 2.091 . . . . 0.0 112.336 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.404 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 17.1 m -58.11 155.21 11.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.803 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -122.15 27.5 7.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.409 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -149.77 17.06 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t70 72.19 59.92 0.14 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.107 0.48 . . . . 0.0 110.447 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.404 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . . . -101.57 165.26 11.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.218 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.4 m -89.96 136.46 33.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.745 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -103.23 139.8 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.4 137.18 33.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.05 130.39 45.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -113.66 -78.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.978 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.2 mm -113.6 -66.7 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -158.04 27.77 0.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.409 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -127.66 176.38 7.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -105.51 123.47 47.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.014 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.6 118.09 35.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.5 t -110.06 114.07 27.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.994 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 30.7 mt -89.94 100.17 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.972 179.672 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.6 t -81.12 165.69 21.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.043 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.419 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -60.56 170.73 1.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.837 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.76 111.48 3.13 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.663 2.242 . . . . 0.0 112.357 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.42 26.53 9.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.532 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.419 ' CD1' ' HB3' ' A' ' 28' ' ' MET . 7.4 m-85 -102.83 -175.86 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.784 0.326 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -145.99 178.86 7.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.93 166.46 38.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.554 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -90.04 -41.49 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.038 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -100.75 29.79 4.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.4 t 49.24 85.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.053 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -158.8 -43.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.46 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.774 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.839 0.352 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.54 95.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -93.27 143.09 26.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -110.3 -23.8 11.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.0 t -89.84 86.89 6.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 111.024 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.6 mm -110.87 -66.11 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 t -107.44 55.88 0.64 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 51.1 t-20 58.52 96.33 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.431 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 16.3 Cg_endo -58.34 -46.85 22.27 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.421 2.081 . . . . 0.0 112.124 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 13.2 m -60.34 160.71 8.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.809 179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.425 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 2.7 mm-40 -123.99 36.83 4.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.038 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -148.66 17.7 1.02 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.606 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t0 70.04 50.32 0.45 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.118 0.485 . . . . 0.0 110.298 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -101.11 175.44 5.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.281 -179.491 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.4 m -89.99 156.53 18.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.741 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 t -131.0 130.91 43.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -115.96 152.16 34.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -82.07 128.07 33.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.969 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -140.5 163.86 31.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.78 132.88 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.36 -56.01 4.93 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.516 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -124.99 163.59 22.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.339 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.48 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 9.3 p90 -90.88 157.33 17.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.03 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.03 127.02 48.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.763 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -132.28 112.75 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.5 mt -89.94 96.94 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 28.1 p -89.38 -174.32 4.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.823 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.422 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -58.13 165.69 2.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.98 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -85.4 99.07 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.842 2.362 . . . . 0.0 112.604 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.61 32.65 1.56 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.636 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.422 ' CZ ' ' HB2' ' A' ' 28' ' ' MET . 3.4 m-30 -99.82 -177.76 3.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.816 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.99 -175.02 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.173 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.26 -169.15 32.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.587 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.88 -52.12 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 0.0 110.872 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.48 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 2.0 m-85 -99.06 28.3 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.638 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.1 m 54.52 32.75 17.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.605 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.425 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 0.1 OUTLIER -102.47 30.07 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.037 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.8 mm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.188 179.98 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.802 0.334 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.8 m -132.99 150.26 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -113.22 -66.55 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.952 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -150.05 -54.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.941 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 69.0 m -90.0 106.15 18.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.8 mm -122.45 -68.42 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.479 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 t -109.25 51.53 0.74 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.091 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.4 t-20 46.55 87.74 0.11 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.464 179.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.425 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 11.8 Cg_endo -56.54 -34.46 95.22 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.451 2.1 . . . . 0.0 112.192 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.8 m -58.2 173.62 0.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.85 179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.98 29.29 2.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.232 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -149.01 19.76 0.98 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.54 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.05 63.83 0.3 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.245 0.545 . . . . 0.0 110.139 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.17 171.65 7.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.313 -179.352 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.1 m -89.92 145.42 25.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.928 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.48 124.94 50.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -117.48 153.68 32.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.62 92.26 3.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -121.05 -57.32 1.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.806 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 4.0 mt -98.3 160.37 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.939 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.81 -26.03 7.72 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.745 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -89.89 -176.23 4.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.911 179.854 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -89.86 131.0 36.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -116.03 90.37 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.2 t -94.93 129.93 41.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.0 mt -89.93 121.17 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.024 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.81 172.61 9.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.017 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.44 171.27 11.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.816 179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -75.34 68.86 5.95 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.532 2.154 . . . . 0.0 112.338 179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.97 41.85 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.469 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -108.98 -174.69 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.811 0.338 . . . . 0.0 110.821 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 -163.61 1.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.42 171.47 26.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.563 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.95 -36.63 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.871 0.367 . . . . 0.0 111.165 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.425 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.2 m-85 -111.94 31.15 6.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 90.1 m 51.77 78.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -155.88 27.39 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 22.9 mm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.187 179.948 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.715 0.293 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.7 m -145.09 164.33 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.1 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 60.33 170.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.57 -78.15 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.0 t -124.36 79.4 1.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.443 HD11 HG21 ' A' ' 6' ' ' ILE . 21.0 mm -101.8 -66.06 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.264 179.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 t -106.39 56.71 0.66 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.946 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 57.22 95.78 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.422 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 28.4 Cg_endo -63.72 -36.87 49.51 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.425 2.083 . . . . 0.0 112.399 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 16.6 m -59.26 163.42 3.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.93 -179.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.49 -27.47 7.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.525 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -90.01 11.57 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.768 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t0 72.59 66.38 0.12 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.029 0.442 . . . . 0.0 110.325 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -106.67 -175.92 2.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.374 -179.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 86.8 m -96.49 161.68 13.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 8.2 t -130.97 137.04 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -126.07 3.41 7.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.463 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 59.24 161.3 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.92 0.39 . . . . 0.0 110.835 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.75 -178.28 6.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 pt -89.88 89.98 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.06 -28.39 15.91 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.494 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -127.56 174.87 8.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.432 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 24.9 p90 -90.01 148.1 23.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -123.79 81.55 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 t -93.98 128.38 40.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.4 mt -92.84 116.06 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.074 179.961 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 t -86.25 163.17 17.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.829 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.4 169.84 0.22 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.053 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.53 102.42 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.637 2.225 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.9 34.21 5.26 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.556 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -108.5 -175.49 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -149.4 174.45 12.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.58 173.64 21.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.427 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.0 t -90.09 -49.5 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 111.06 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.432 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 1.7 m-85 -105.36 34.33 3.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.868 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.2 t 49.18 94.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.988 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -169.94 -39.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.2 mm . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.071 -179.948 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.6 t0 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.772 0.32 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.9 m -143.34 95.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -176.62 141.49 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.844 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -109.3 31.26 5.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 47.7 t -114.84 85.32 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.025 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.7 mm -111.04 -66.11 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.7 t -107.99 55.8 0.64 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 57.83 91.08 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.421 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 23.7 Cg_endo -62.39 -29.45 79.35 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.554 2.169 . . . . 0.0 112.373 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.4 m -62.69 163.58 8.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.731 -179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.65 -30.53 6.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.535 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -90.91 13.41 16.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.831 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 t0 73.76 56.4 0.1 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.082 0.468 . . . . 0.0 110.548 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -93.7 175.79 6.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.185 -179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.8 m -89.94 139.56 30.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.1 t -123.44 108.26 12.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 29.9 mt -99.94 154.37 18.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.22 89.75 3.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -130.42 -46.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 22.0 mt -98.24 160.42 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.057 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -51.51 -25.99 14.55 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.679 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -100.18 177.1 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.772 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -89.99 147.74 23.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.23 99.62 6.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 49.5 t -97.38 111.1 23.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 20.2 mt -89.95 101.9 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.923 179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.05 173.24 12.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.989 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.47 171.01 0.43 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.973 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.25 95.18 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.642 2.228 . . . . 0.0 112.509 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.47 46.41 1.68 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.607 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -114.87 -174.49 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.34 -167.52 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.16 168.25 40.3 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.01 -43.96 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.795 0.331 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.5 m-85 -108.27 35.2 3.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.855 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.8 t 54.85 89.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.831 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -171.97 -39.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 mm . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.125 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.7 p30 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.0 m -80.42 141.43 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.144 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -161.92 77.43 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -128.73 -81.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.13 77.43 1.31 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.912 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.1 mm -102.93 -67.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.2 t -110.82 55.59 0.65 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 57.56 91.96 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.96 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.42 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 33.9 Cg_endo -64.94 -38.62 28.35 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.489 2.126 . . . . 0.0 112.207 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 11.7 m -57.92 134.18 56.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.721 179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.416 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 20.4 mm-40 -97.58 34.49 1.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.342 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -149.37 13.83 0.86 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 70.53 55.86 0.27 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.136 0.493 . . . . 0.0 110.435 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -99.46 -179.7 4.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.267 -179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.8 m -98.58 157.28 16.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -129.81 140.62 50.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.969 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -130.64 88.12 2.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.767 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.55 85.67 2.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.98 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -110.64 -32.79 6.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.763 179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.6 mp -117.34 163.45 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.835 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -46.95 -28.51 3.97 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.729 -179.908 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -90.92 168.96 11.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.759 0.314 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -90.6 138.25 31.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.98 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -126.38 88.25 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.838 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.36 127.05 36.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.467 HD12 HG21 ' A' ' 26' ' ' ILE . 31.2 mt -89.96 116.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.4 m -71.66 178.02 3.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.048 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.57 169.56 15.2 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.77 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -73.23 64.41 4.34 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.499 2.133 . . . . 0.0 112.295 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.47 41.61 0.22 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.54 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -114.56 -175.14 2.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.82 0.343 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -150.15 -177.94 6.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.81 -175.55 25.41 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.592 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.91 -54.8 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.393 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.42 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 4.3 m-85 -98.22 29.6 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.795 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.2 m 54.46 30.39 12.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.016 0.436 . . . . 0.0 110.435 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.416 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 4.1 pt-20 -99.34 23.29 9.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.254 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 18.5 mm . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.131 -179.959 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.811 0.339 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 m -101.88 134.15 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.17 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -79.1 106.42 11.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.787 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -110.71 -33.09 6.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.49 97.15 7.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.995 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.413 HD11 HG21 ' A' ' 6' ' ' ILE . 24.3 mm -109.92 -69.16 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 t -114.37 54.9 0.75 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.772 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 56.01 88.61 0.12 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.027 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.01 -37.24 78.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.54 2.16 . . . . 0.0 112.349 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 7.8 m -58.83 171.39 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.77 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -130.43 30.59 4.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.051 -179.737 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -145.32 16.28 1.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.593 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 t0 69.37 48.11 0.66 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.158 0.504 . . . . 0.0 110.103 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.9 174.34 7.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.511 -179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.3 m -89.9 162.11 15.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.897 179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.4 t -135.84 156.09 49.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.834 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -138.03 -47.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.943 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t0 56.05 103.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.043 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.8 mt-30 -133.38 -46.57 0.83 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.9 mm -95.41 174.02 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.784 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -47.97 -27.36 4.96 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.657 -179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -96.26 172.39 7.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.337 . . . . 0.0 110.823 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.491 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 52.8 p90 -92.19 133.0 36.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.07 93.16 4.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 44.1 t -104.51 120.03 40.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.946 -179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.4 mt -89.94 126.04 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.017 179.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.7 p -113.14 -174.87 2.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.03 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.452 ' CB ' ' CE1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.58 163.14 2.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.6 100.16 0.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.815 2.343 . . . . 0.0 112.522 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.9 23.64 3.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.798 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.452 ' CE1' ' CB ' ' A' ' 28' ' ' MET . 3.2 m-85 -94.8 179.71 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.748 0.309 . . . . 0.0 110.82 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -150.22 -177.31 5.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.46 -174.3 23.71 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.632 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 t -89.84 -32.27 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 110.794 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.491 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 5.8 m-85 -121.11 26.73 8.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.682 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m 53.85 32.88 15.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.726 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -97.64 31.47 2.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.028 -179.749 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.6 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.118 -179.993 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.78 0.324 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t 62.06 83.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.163 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -129.17 49.84 2.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.93 -74.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.0 t -142.46 102.91 4.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.963 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.458 HD13 HG23 ' A' ' 6' ' ' ILE . 22.6 mm -121.99 -66.9 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t -110.42 55.41 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.963 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 57.09 94.49 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.417 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 26.5 Cg_endo -62.99 -38.22 48.16 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.358 2.039 . . . . 0.0 112.257 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 6.4 m -58.1 143.85 42.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.744 -179.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.7 mm-40 -107.43 30.19 6.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.343 -179.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -147.0 15.26 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 t70 71.09 60.4 0.18 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.123 0.487 . . . . 0.0 110.508 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -110.26 177.42 4.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.205 -179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 51.0 m -89.9 161.53 15.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.82 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.1 t -141.27 74.93 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -62.7 86.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.756 180.0 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.16 118.42 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.972 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -149.97 -47.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 21.9 mm -92.14 161.52 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.953 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -49.12 -26.86 6.57 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.726 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -95.19 165.82 12.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 110.797 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -89.97 130.22 36.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -119.4 95.0 4.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.949 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -94.2 128.31 40.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.782 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.9 122.12 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.018 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.1 m -82.92 174.7 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.022 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.417 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -79.08 171.51 12.32 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.615 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.417 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 61.2 Cg_endo -72.4 80.16 1.69 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.391 2.061 . . . . 0.0 112.342 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.38 57.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.466 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -118.32 -174.28 2.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -142.22 -176.81 4.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.55 172.93 46.02 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.97 -49.08 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.417 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.1 m-85 -98.15 27.49 4.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.3 97.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -168.89 -38.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.826 -179.798 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.409 HD11 HG23 ' A' ' 38' ' ' ILE . 21.7 mm . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.097 179.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.8 t0 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.807 0.337 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 31.6 m -90.94 146.49 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.078 179.979 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 19.1 t-20 -170.95 -66.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.018 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -132.72 -43.07 0.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.156 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.85 93.76 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.972 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.4 mm -128.19 -65.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.166 179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.1 t -99.35 53.32 0.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 52.74 89.61 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.14 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.88 -58.43 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.431 2.087 . . . . 0.0 112.213 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 5.7 m -50.1 132.21 23.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.895 179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -96.28 30.94 2.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.543 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -149.21 12.8 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.5 t0 69.48 66.28 0.26 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.193 0.52 . . . . 0.0 110.351 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -109.92 179.19 4.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.32 -179.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.6 m -90.0 140.13 29.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.692 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.1 t -134.42 92.44 2.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.825 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -71.35 124.08 23.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.953 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.17 112.32 3.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.29 161.09 23.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.5 mt -91.3 92.0 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.23 -76.93 0.26 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.545 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -123.44 179.14 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.878 0.371 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -97.31 129.85 44.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.978 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -107.71 87.47 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.17 114.86 27.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.972 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 27.6 mt -89.94 122.67 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.998 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 164.9 19.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.067 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.03 171.39 1.55 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.809 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.37 79.69 3.1 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.553 2.169 . . . . 0.0 112.462 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.47 37.78 0.71 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.449 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -109.35 -175.16 2.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -144.78 -178.15 5.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.03 169.75 46.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.02 -47.93 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -99.74 27.98 5.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.9 m 54.1 100.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.972 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -174.54 -38.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.95 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.464 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.804 0.335 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t 64.1 112.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.069 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.9 138.28 35.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.09 -78.62 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.816 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -137.49 77.46 1.64 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.802 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.0 mm -108.98 -66.46 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.212 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.36 55.86 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 56.08 88.76 0.12 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.438 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 30.6 Cg_endo -64.61 -39.3 27.99 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.512 2.142 . . . . 0.0 112.277 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.412 ' HB3' ' HB1' ' A' ' 14' ' ' ALA . 4.3 m -70.05 150.84 46.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.74 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.407 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 20.3 mm-40 -118.46 27.94 8.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.34 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -146.83 15.14 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 72.11 50.26 0.22 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.135 0.493 . . . . 0.0 110.562 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.412 ' HB1' ' HB3' ' A' ' 10' ' ' CYS . . . -90.13 172.73 8.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.179 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 61.1 m -97.57 132.5 43.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.797 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 t -99.47 131.59 45.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -119.21 142.95 47.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -99.85 117.7 34.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.6 mt-30 -102.87 -77.88 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.8 mp -141.52 -66.47 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.186 179.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -140.11 28.38 2.49 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -141.36 171.31 14.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.41 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 52.1 p90 -102.58 136.75 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.987 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -117.05 92.78 3.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 52.0 t -89.98 119.74 30.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 26.3 mt -89.92 113.64 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.5 m -74.75 174.06 9.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.141 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.42 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -70.53 172.72 5.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.565 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 64.2 Cg_endo -73.1 66.78 4.2 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.343 2.028 . . . . 0.0 112.32 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.77 41.03 0.25 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.526 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' A' ' 28' ' ' MET . 4.3 m-85 -113.8 -176.47 2.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -150.22 -177.95 6.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.14 -175.92 28.84 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.626 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 t -89.97 -54.09 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.438 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 10.3 m-85 -96.97 26.18 4.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.792 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 m 51.66 32.6 9.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.957 0.408 . . . . 0.0 110.586 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 1.9 pt-20 -99.06 29.85 3.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.109 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.8 mm . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.973 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.861 0.362 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -107.49 155.18 8.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.076 -179.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 12.1 m-20 -160.4 95.92 1.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.855 -179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.75 -80.27 0.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.71 85.6 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.837 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.5 mm -94.89 -69.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.226 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t -116.05 55.17 0.8 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 55.16 91.3 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.48 -27.72 46.41 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.483 2.122 . . . . 0.0 112.381 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.405 ' CB ' ' HB3' ' A' ' 14' ' ' ALA . 14.2 m -55.43 135.69 50.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -102.2 32.52 3.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.192 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -146.43 14.14 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 t0 68.53 43.85 1.32 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.199 0.524 . . . . 0.0 110.218 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.405 ' HB3' ' CB ' ' A' ' 10' ' ' CYS . . . -89.95 178.82 6.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.411 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.0 m -99.25 145.51 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.808 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.3 t -106.67 137.6 44.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.712 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.18 118.53 18.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -69.7 122.87 20.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.89 -76.57 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.9 mt -145.28 -46.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.167 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.64 -38.16 0.06 OUTLIER Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.844 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -89.79 178.63 6.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.388 . . . . 0.0 111.004 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -100.17 153.84 18.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.053 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -132.36 112.66 12.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.795 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -90.01 109.94 20.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . 0.425 HD11 HG22 ' A' ' 26' ' ' ILE . 31.0 mt -99.44 90.88 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.827 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 p -97.32 -176.37 3.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.068 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.424 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -51.38 168.51 0.26 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.105 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 86.9 Cg_endo -82.07 138.73 10.35 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.697 2.264 . . . . 0.0 112.448 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.82 24.06 62.97 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.714 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.424 ' CE1' ' HB3' ' A' ' 28' ' ' MET . 2.6 m-85 -90.38 -176.37 4.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.726 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -150.09 -178.47 6.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.124 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.12 176.0 30.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.522 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.2 t -89.88 -48.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.996 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -100.38 28.91 4.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.799 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.2 m 58.85 51.95 6.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.875 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -113.86 -33.43 5.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.823 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 28.7 mm . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.06 -179.996 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.795 0.331 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.5 m -95.38 147.37 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.182 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -76.8 133.31 39.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -126.38 -79.67 0.6 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.946 -179.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 12.6 t -100.11 83.28 2.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.053 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.45 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 1.7 mp -102.09 -75.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.808 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -107.97 55.91 0.64 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.809 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 59.15 90.26 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.31 -38.31 81.93 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.581 2.187 . . . . 0.0 112.313 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 4.6 m -57.13 168.21 0.74 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.823 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.6 mm-40 -127.99 27.26 5.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.285 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -146.13 17.19 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.518 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 69.71 52.65 0.42 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.305 0.574 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -97.53 176.55 5.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.256 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.0 m -90.03 149.85 22.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.816 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.0 t -125.89 139.15 53.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -126.34 126.16 43.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.871 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -65.02 137.54 57.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -149.48 163.54 37.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.991 -179.955 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.6 mp -90.36 90.21 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.176 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.41 -82.19 0.23 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.518 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -113.31 178.02 4.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.85 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.472 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 54.8 p90 -89.96 142.33 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.999 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -109.39 96.77 6.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -106.29 119.16 38.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.8 mt -90.06 116.57 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.4 m -73.56 178.48 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.045 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.449 ' CB ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -75.66 170.79 14.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.45 72.6 4.86 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.526 2.151 . . . . 0.0 112.475 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.37 38.78 0.47 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.621 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.449 ' CD1' ' CB ' ' A' ' 28' ' ' MET . 4.9 m-85 -112.16 -175.95 2.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -150.04 179.23 8.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.8 -177.7 29.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.03 -50.54 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.472 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 6.3 m-85 -98.21 28.69 3.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.2 m 54.12 30.73 12.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.968 0.413 . . . . 0.0 110.753 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 15.1 pt-20 -100.56 -23.66 14.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.212 -179.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 mm . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.08 -179.942 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.8 t -78.57 88.87 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -122.32 146.22 47.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -115.9 -9.41 11.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.435 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.3 m -89.91 73.84 7.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.425 HG22 HD12 ' A' ' 6' ' ' ILE . 23.3 mm -101.59 -67.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.226 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.64 53.57 0.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.016 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 49.44 91.72 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.29 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.96 -39.36 41.05 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.519 2.146 . . . . 0.0 112.221 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.9 m -49.5 151.37 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 -179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.3 mm-40 -114.08 32.07 6.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.31 -179.438 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -149.6 17.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t0 69.98 57.91 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.197 0.522 . . . . 0.0 110.482 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -108.1 -175.6 2.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.251 -179.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 89.4 m -105.57 160.62 15.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.054 -179.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.01 148.41 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.781 179.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -142.98 159.68 41.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -113.29 158.66 20.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.86 -77.03 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.93 -67.43 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.089 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.32 26.96 1.39 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.399 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.33 -178.98 5.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 0.0 110.968 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -106.53 137.26 44.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -124.93 94.95 4.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.644 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.94 130.54 36.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 29.1 mt -89.91 122.87 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.987 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -84.36 -176.1 6.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.048 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.412 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -84.75 172.1 9.65 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.611 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.9 Cg_endo -74.17 75.46 3.29 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.403 2.069 . . . . 0.0 112.356 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.98 38.57 0.56 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.557 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -112.95 -176.21 2.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -150.1 -177.26 5.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.36 174.03 41.84 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.491 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 t -89.96 -53.4 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.82 0.343 . . . . 0.0 110.954 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -97.81 25.62 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.815 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.17 100.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.934 0.397 . . . . 0.0 111.068 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -173.84 -33.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.976 -179.818 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.1 mm . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.979 -179.941 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.761 0.315 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.8 m -64.62 93.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.077 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -121.7 82.96 2.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.38 -79.42 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.997 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 1.2 m -106.72 90.24 3.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.833 179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.455 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 1.6 mp -106.14 -77.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.941 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.9 53.97 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 53.4 86.3 0.17 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.169 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 17.4 Cg_endo -58.9 -37.39 93.88 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.529 2.152 . . . . 0.0 112.249 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 1.3 m -56.97 177.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.925 -179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -134.95 28.14 3.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.251 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -146.36 15.75 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.716 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 70.23 49.68 0.45 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.085 0.469 . . . . 0.0 110.209 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.97 175.1 7.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.203 -179.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.7 m -90.04 154.22 19.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -112.9 131.07 55.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.743 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 112.58 6.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -80.57 151.05 29.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -118.75 -80.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 mt -129.2 -68.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.28 -37.45 0.6 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.546 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.87 172.48 8.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -97.64 162.87 13.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.014 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -147.74 96.46 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.817 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.8 t -90.08 131.06 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.028 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.9 mt -91.88 118.52 37.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.001 179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -100.2 161.39 13.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.976 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.67 171.69 0.99 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.835 179.949 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.73 127.22 7.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.656 2.237 . . . . 0.0 112.424 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.96 31.24 39.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.51 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -106.68 -174.88 2.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.816 0.341 . . . . 0.0 110.885 -179.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -147.09 -176.98 5.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.59 164.92 38.32 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.456 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 t -89.94 -30.19 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 111.042 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.7 m-85 -118.12 35.98 4.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.3 t 49.84 84.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -157.31 -42.62 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.461 ' CD1' ' N ' ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.681 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.868 0.366 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 20.4 t 64.47 159.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.118 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 62.56 101.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.786 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.1 -73.12 0.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -150.12 71.11 1.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.843 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.451 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 1.7 mp -99.67 -77.74 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.046 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 t -93.37 55.49 2.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.076 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 53.06 92.93 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.999 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.67 -46.17 9.62 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.504 2.136 . . . . 0.0 112.243 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . 0.435 ' HB3' ' HB2' ' A' ' 14' ' ' ALA . 9.6 m -59.88 161.45 6.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.621 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.87 28.96 4.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.188 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -149.18 18.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.511 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t70 71.83 50.43 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.17 0.509 . . . . 0.0 110.465 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.435 ' HB2' ' HB3' ' A' ' 10' ' ' CYS . . . -90.17 171.62 9.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.174 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.9 m -94.93 136.65 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.8 t -113.46 118.81 35.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.95 132.84 53.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -60.56 122.28 14.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -165.81 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pt -94.23 23.81 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.633 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.93 -37.78 0.87 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.675 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -100.06 177.33 5.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 110.894 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 44.3 p90 -102.14 146.63 27.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.02 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -116.76 92.01 3.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.002 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.96 113.53 25.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.813 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 18.0 mt -89.92 119.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.989 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.7 172.8 8.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.048 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.415 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -72.51 172.36 7.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.791 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_endo -76.47 62.56 7.05 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.499 2.133 . . . . 0.0 112.254 -179.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.57 43.11 0.1 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.467 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.415 ' CD1' ' HB2' ' A' ' 28' ' ' MET . 2.6 m-85 -109.93 -175.37 2.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -144.37 175.71 9.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.55 166.25 37.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.16 -33.82 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 0.0 111.159 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 17.4 m-85 -113.54 33.29 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.8 m 49.82 88.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -162.62 -43.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.434 HG22 HD12 ' A' ' 38' ' ' ILE . 26.9 mm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.071 179.999 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.837 0.351 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.27 142.37 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -152.98 149.39 28.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.0 -59.87 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 21.1 t -143.81 80.17 1.65 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.904 179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . 0.453 ' N ' ' CD1' ' A' ' 6' ' ' ILE . 1.6 mp -114.81 -76.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.69 55.34 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 53.44 90.05 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.066 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.6 -37.52 87.79 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.674 2.25 . . . . 0.0 112.323 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' CYS . . . . . . . . . . . . . 20.1 m -59.45 169.6 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.905 -179.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -131.26 26.75 4.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -149.88 18.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.563 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t0 70.61 48.95 0.42 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.126 0.488 . . . . 0.0 110.275 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -89.92 168.7 11.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.238 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 97.2 m -89.89 133.93 34.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.6 t -104.15 143.33 33.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.908 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -142.45 132.98 25.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 29.5 t0 -126.81 129.87 49.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -124.88 -62.15 1.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.6 mt -93.87 -67.73 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.108 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.12 33.29 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.494 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -135.1 158.01 45.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.494 ' CE2' ' CE1' ' A' ' 35' ' ' TYR . 51.1 p90 -95.05 123.23 38.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -105.21 102.6 12.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 42.6 t -90.03 128.39 36.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.069 -179.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 21.2 mt -106.87 106.7 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.808 179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.07 161.24 18.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.113 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -58.67 172.78 0.48 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.941 -179.927 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -78.05 119.32 4.64 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.536 2.157 . . . . 0.0 112.306 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.12 20.59 35.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.441 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -100.56 -177.04 3.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 110.734 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.07 -177.02 5.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.4 169.16 31.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.38 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.06 -36.05 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 111.145 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' TYR . . . . . 0.494 ' CE1' ' CE2' ' A' ' 23' ' ' PHE . 3.8 m-85 -111.1 26.27 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.988 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 37.8 t 51.66 92.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -162.29 -37.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.998 -179.837 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.798 0.332 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.9 t -99.88 84.83 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.992 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.1 mm -102.71 -66.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 t -109.02 56.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 56.93 90.88 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.836 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 17.8 Cg_endo -60.62 -32.45 93.35 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.486 2.124 . . . . 0.0 112.287 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 13.1 m -60.61 154.59 20.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.728 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -123.17 32.24 5.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.214 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -150.0 20.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.596 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 t0 70.66 43.62 0.73 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.106 0.479 . . . . 0.0 110.381 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.656 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -92.66 164.92 13.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.255 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.3 m -89.99 130.85 36.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.75 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.5 t -97.61 132.23 43.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.918 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.653 HD12 HD11 ' A' ' 26' ' ' ILE . 2.9 mt -121.07 -170.47 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.5 146.51 25.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -179.16 6.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -89.9 99.41 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.7 21.54 50.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.674 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -148.01 -179.39 6.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.869 0.366 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 39.2 p90 -104.63 157.51 17.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.039 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.13 88.02 2.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.93 108.33 19.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.656 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 27.1 mt -90.97 96.09 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.073 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 m -70.95 175.29 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.408 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -70.09 171.6 7.28 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.909 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.3 Cg_endo -76.02 101.4 1.49 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.501 2.134 . . . . 0.0 112.353 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.19 26.64 6.53 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -104.15 -175.48 2.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 0.0 110.863 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -146.12 178.57 8.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.21 165.9 32.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.522 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.01 -43.57 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.836 0.35 . . . . 0.0 111.117 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 1.9 m-85 -101.04 28.51 5.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 83.8 m 52.86 80.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.952 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -152.41 -44.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.093 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.825 0.345 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.79 79.57 2.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 mm -102.51 -67.13 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.293 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 t -108.85 54.56 0.65 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.93 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 55.3 t-20 53.69 93.06 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.002 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 18.1 Cg_endo -60.45 -32.49 93.85 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.487 2.124 . . . . 0.0 112.219 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.881 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 10.3 m -64.78 162.53 15.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.79 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.59 -29.71 7.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.448 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -90.04 12.07 18.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.709 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 74.12 56.35 0.09 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.198 0.523 . . . . 0.0 110.546 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.881 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -93.0 169.72 10.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.172 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.3 m -89.95 145.57 25.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.4 t -105.39 135.53 46.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 tp -127.3 141.0 51.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.81 155.89 16.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -137.87 -77.3 0.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.0 110.983 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.1 mt -146.69 -46.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.162 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -161.23 28.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.47 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -141.85 160.04 41.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 110.858 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -96.51 147.38 23.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.981 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.09 118.33 20.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 50.9 t -105.99 114.37 28.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.622 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 33.3 mt -89.98 105.25 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.948 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 t -86.4 166.36 15.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.078 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.09 172.51 0.71 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.935 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.89 109.59 2.75 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.618 2.212 . . . . 0.0 112.387 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.48 24.05 10.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.485 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -100.54 -176.07 3.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 0.0 110.838 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.93 -176.99 5.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.9 173.07 34.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.526 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.01 -51.36 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 111.083 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 18.0 m-85 -98.42 30.04 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.789 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.7 t 57.55 70.09 0.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.709 ' O ' HD13 ' A' ' 38' ' ' ILE . 4.2 tp10 -154.82 26.16 0.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.978 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.709 HD13 ' O ' ' A' ' 37' ' ' GLU . 22.0 mm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.711 0.291 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.5 t -89.92 84.25 6.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mm -107.73 -66.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.126 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -109.4 55.6 0.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.795 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 58.42 88.62 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.77 -38.78 46.8 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.47 2.113 . . . . 0.0 112.229 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 8.8 m -57.47 151.0 17.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.648 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -118.71 29.67 7.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.506 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -150.06 17.48 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t0 71.15 60.17 0.18 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.14 0.495 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.71 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -105.43 166.83 10.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.251 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.478 HG22 HD12 ' A' ' 17' ' ' LEU . 65.2 m -90.02 132.06 35.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.739 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' GLN . 53.4 t -102.83 127.58 49.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.478 HD12 HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -129.89 -171.83 2.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -141.64 164.34 30.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.49 -50.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.3 mt -144.8 -66.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.181 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.12 26.44 0.9 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.528 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -128.0 170.73 12.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.744 0.307 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CE2' ' CE1' ' A' ' 35' ' ' TYR . 48.0 p90 -98.43 137.26 37.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.029 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -115.36 146.22 41.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.78 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 52.2 t -141.45 115.98 9.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.716 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.675 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 27.7 mt -89.88 114.24 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.03 169.84 14.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.006 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.42 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -74.54 172.51 8.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.721 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 73.3 Cg_endo -75.36 81.61 2.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.475 2.116 . . . . 0.0 112.354 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.94 38.47 0.75 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.464 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -107.44 -176.1 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -149.11 177.84 9.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.86 170.79 41.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.95 -48.52 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.085 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CE1' ' CE2' ' A' ' 23' ' ' PHE . 2.3 m-85 -98.33 30.0 3.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.8 m 53.14 93.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -170.42 -39.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.857 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.9 mm . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.076 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.887 0.375 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.5 t -138.57 87.7 2.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.954 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.1 mm -116.29 -67.29 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.214 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 t -108.45 55.26 0.64 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 53.71 87.06 0.15 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.944 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.88 -26.64 75.15 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.549 2.166 . . . . 0.0 112.347 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.81 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 12.5 m -59.99 171.5 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.806 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -136.07 28.88 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -149.54 19.69 0.93 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.455 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.63 43.19 0.47 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.092 0.472 . . . . 0.0 110.544 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.81 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -89.98 170.62 10.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.125 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.698 ' HB ' HD12 ' A' ' 26' ' ' ILE . 96.9 m -99.95 153.67 18.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.015 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.8 t -103.94 127.45 51.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.568 ' HB2' HD11 ' A' ' 26' ' ' ILE . 1.5 tp -121.04 81.49 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.75 127.54 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.884 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.645 ' HB3' HD12 ' A' ' 20' ' ' ILE . 2.4 mm-40 -108.28 -52.35 2.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.08 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.645 HD12 ' HB3' ' A' ' 19' ' ' GLN . 4.2 mp -140.99 -75.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.343 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.82 -19.32 1.16 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.142 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.91 179.61 5.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 111.034 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.501 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 54.3 p90 -110.49 133.45 53.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -116.56 112.29 21.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.802 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 m -89.99 120.74 31.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.935 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.698 HD12 ' HB ' ' A' ' 15' ' ' THR . 34.2 mt -89.91 98.64 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.32 163.86 23.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.132 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.406 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -60.75 172.02 0.93 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.74 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.3 Cg_endo -76.08 72.88 5.13 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.484 2.123 . . . . 0.0 112.334 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.57 40.08 0.31 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.486 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -108.67 -175.75 2.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.747 0.308 . . . . 0.0 110.89 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -148.16 173.96 12.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.53 166.82 24.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.58 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.8 t -89.93 -47.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.501 ' CE1' ' CE1' ' A' ' 23' ' ' PHE . 2.4 m-85 -101.69 28.57 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.6 m 55.53 92.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.922 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -169.49 -41.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.961 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 27.2 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.093 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.851 0.358 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.31 79.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 mm -108.09 -65.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.191 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 t -108.3 54.44 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 53.95 89.08 0.11 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.099 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.93 -39.09 43.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.436 2.091 . . . . 0.0 112.336 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.864 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 17.1 m -58.11 155.21 11.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.803 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -122.15 27.5 7.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.409 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -149.77 17.06 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t70 72.19 59.92 0.14 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.107 0.48 . . . . 0.0 110.447 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.864 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -101.57 165.26 11.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.218 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.4 m -89.96 136.46 33.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.745 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -103.23 139.8 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.4 137.18 33.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.05 130.39 45.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -113.66 -78.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.978 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.2 mm -113.6 -66.7 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -158.04 27.77 0.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.409 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -127.66 176.38 7.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -105.51 123.47 47.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.014 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.6 118.09 35.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 52.5 t -110.06 114.07 27.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.994 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.415 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 30.7 mt -89.94 100.17 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.972 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.6 t -81.12 165.69 21.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.043 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.438 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -60.56 170.73 1.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.837 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.76 111.48 3.13 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.663 2.242 . . . . 0.0 112.357 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.42 26.53 9.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.532 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 28' ' ' MET . 7.4 m-85 -102.83 -175.86 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.784 0.326 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -145.99 178.86 7.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.93 166.46 38.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.554 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -90.04 -41.49 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.038 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -100.75 29.79 4.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.4 t 49.24 85.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.053 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -158.8 -43.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.65 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.774 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.711 0.291 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.0 t -89.84 86.89 6.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 111.024 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.6 mm -110.87 -66.11 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 t -107.44 55.88 0.64 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.427 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 51.1 t-20 58.52 96.33 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.448 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 16.3 Cg_endo -58.34 -46.85 22.27 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.421 2.081 . . . . 0.0 112.124 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 13.2 m -60.34 160.71 8.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.809 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 2.7 mm-40 -123.99 36.83 4.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.038 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -148.66 17.7 1.02 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.606 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t0 70.04 50.32 0.45 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.118 0.485 . . . . 0.0 110.298 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.443 ' HB1' ' HA ' ' A' ' 27' ' ' CYS . . . -101.11 175.44 5.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.281 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.4 m -89.99 156.53 18.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.741 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 t -131.0 130.91 43.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.487 HD13 ' H ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -115.96 152.16 34.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.487 ' H ' HD13 ' A' ' 17' ' ' LEU . 8.9 t70 -82.07 128.07 33.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.969 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -140.5 163.86 31.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.78 132.88 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.36 -56.01 4.93 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.516 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -124.99 163.59 22.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.339 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.48 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 9.3 p90 -90.88 157.33 17.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.03 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.03 127.02 48.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.763 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -132.28 112.75 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.5 mt -89.94 96.94 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' CYS . . . . . 0.443 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 28.1 p -89.38 -174.32 4.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -58.13 165.69 2.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.98 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -85.4 99.07 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.842 2.362 . . . . 0.0 112.604 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.61 32.65 1.56 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.636 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 28' ' ' MET . 3.4 m-30 -99.82 -177.76 3.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.816 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.99 -175.02 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.173 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.26 -169.15 32.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.587 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.88 -52.12 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 0.0 110.872 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.48 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 2.0 m-85 -99.06 28.3 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.638 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.1 m 54.52 32.75 17.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.605 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.725 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -102.47 30.07 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.037 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.725 HD13 ' O ' ' A' ' 37' ' ' GLU . 24.8 mm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.188 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 69.0 m -90.0 106.15 18.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.8 mm -122.45 -68.42 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.479 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 t -109.25 51.53 0.74 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.091 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 59.4 t-20 46.55 87.74 0.11 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.464 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 11.8 Cg_endo -56.54 -34.46 95.22 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.451 2.1 . . . . 0.0 112.192 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.671 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 1.8 m -58.2 173.62 0.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.98 29.29 2.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.232 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -149.01 19.76 0.98 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.54 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.05 63.83 0.3 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.245 0.545 . . . . 0.0 110.139 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.766 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -109.17 171.65 7.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.313 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.1 m -89.92 145.42 25.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.928 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.48 124.94 50.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.598 HD23 HD11 ' A' ' 26' ' ' ILE . 3.4 mm? -117.48 153.68 32.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.62 92.26 3.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.05 -57.32 1.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.806 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 21' ' ' GLY . 4.0 mt -98.3 160.37 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.939 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.506 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -49.81 -26.03 7.72 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.745 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . 0.494 ' OE2' HG21 ' A' ' 20' ' ' ILE . 1.2 pt-20 -89.89 -176.23 4.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.911 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -89.86 131.0 36.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -116.03 90.37 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.2 t -94.93 129.93 41.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.766 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 21.0 mt -89.93 121.17 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.024 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.81 172.61 9.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.017 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.408 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -74.44 171.27 11.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.816 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.9 Cg_endo -75.34 68.86 5.95 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.532 2.154 . . . . 0.0 112.338 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.97 41.85 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.469 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -108.98 -174.69 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.811 0.338 . . . . 0.0 110.821 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 -163.61 1.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.42 171.47 26.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.563 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.95 -36.63 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.871 0.367 . . . . 0.0 111.165 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.2 m-85 -111.94 31.15 6.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 90.1 m 51.77 78.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.715 ' O ' HD13 ' A' ' 38' ' ' ILE . 4.7 tp10 -155.88 27.39 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.715 HD13 ' O ' ' A' ' 37' ' ' GLU . 22.9 mm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.187 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.0 t -124.36 79.4 1.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.0 mm -101.8 -66.06 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.264 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 t -106.39 56.71 0.66 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.946 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 57.22 95.78 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.44 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 28.4 Cg_endo -63.72 -36.87 49.51 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.425 2.083 . . . . 0.0 112.399 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 16.6 m -59.26 163.42 3.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.93 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.49 -27.47 7.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.525 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -90.01 11.57 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.768 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t0 72.59 66.38 0.12 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.029 0.442 . . . . 0.0 110.325 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.859 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -106.67 -175.92 2.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.374 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 16' ' ' CYS . 86.8 m -96.49 161.68 13.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.448 ' N ' HG22 ' A' ' 15' ' ' THR . 8.2 t -130.97 137.04 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -126.07 3.41 7.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.463 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 59.24 161.3 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.92 0.39 . . . . 0.0 110.835 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.75 -178.28 6.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 pt -89.88 89.98 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.06 -28.39 15.91 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.494 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -127.56 174.87 8.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.432 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 24.9 p90 -90.01 148.1 23.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -123.79 81.55 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 t -93.98 128.38 40.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.859 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 27.4 mt -92.84 116.06 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.074 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 t -86.25 163.17 17.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.829 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.4 169.84 0.22 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.053 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.53 102.42 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.637 2.225 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.9 34.21 5.26 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.556 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -108.5 -175.49 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -149.4 174.45 12.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.58 173.64 21.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.427 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.0 t -90.09 -49.5 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 111.06 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.7 m-85 -105.36 34.33 3.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.868 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.2 t 49.18 94.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.988 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -169.94 -39.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.2 mm . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.071 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.761 0.315 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 47.7 t -114.84 85.32 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.025 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.7 mm -111.04 -66.11 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.7 t -107.99 55.8 0.64 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 57.83 91.08 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 23.7 Cg_endo -62.39 -29.45 79.35 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.554 2.169 . . . . 0.0 112.373 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.872 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 11.4 m -62.69 163.58 8.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.731 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.65 -30.53 6.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.535 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -90.91 13.41 16.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.831 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 t0 73.76 56.4 0.1 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.082 0.468 . . . . 0.0 110.548 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.872 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -93.7 175.79 6.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.185 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.8 m -89.94 139.56 30.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.1 t -123.44 108.26 12.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 17' ' ' LEU . 29.9 mt -99.94 154.37 18.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.22 89.75 3.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -130.42 -46.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 21' ' ' GLY . 22.0 mt -98.24 160.42 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.057 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -51.51 -25.99 14.55 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.679 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -100.18 177.1 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.772 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -89.99 147.74 23.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.23 99.62 6.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.555 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 49.5 t -97.38 111.1 23.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.503 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 20.2 mt -89.95 101.9 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.923 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.05 173.24 12.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.989 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.47 171.01 0.43 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.973 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.25 95.18 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.642 2.228 . . . . 0.0 112.509 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.47 46.41 1.68 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.607 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -114.87 -174.49 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.34 -167.52 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.16 168.25 40.3 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.01 -43.96 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.795 0.331 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.5 m-85 -108.27 35.2 3.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.855 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 53.8 t 54.85 89.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.831 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -171.97 -39.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 mm . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.125 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.747 0.308 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.13 77.43 1.31 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.912 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.1 mm -102.93 -67.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.2 t -110.82 55.59 0.65 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 57.56 91.96 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.96 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 33.9 Cg_endo -64.94 -38.62 28.35 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.489 2.126 . . . . 0.0 112.207 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 11.7 m -57.92 134.18 56.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.721 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 20.4 mm-40 -97.58 34.49 1.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.342 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -149.37 13.83 0.86 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 70.53 55.86 0.27 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.136 0.493 . . . . 0.0 110.435 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.786 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -99.46 -179.7 4.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.267 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.8 m -98.58 157.28 16.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -129.81 140.62 50.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.969 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.736 HD12 ' OE1' ' A' ' 19' ' ' GLN . 0.4 OUTLIER -130.64 88.12 2.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.767 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.55 85.67 2.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.98 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.736 ' OE1' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -110.64 -32.79 6.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.763 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 21' ' ' GLY . 1.6 mp -117.34 163.45 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.835 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -46.95 -28.51 3.97 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.729 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -90.92 168.96 11.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.759 0.314 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -90.6 138.25 31.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.98 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -126.38 88.25 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.838 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.36 127.05 36.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.786 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 31.2 mt -89.96 116.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.4 m -71.66 178.02 3.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.048 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.57 169.56 15.2 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.77 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -73.23 64.41 4.34 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.499 2.133 . . . . 0.0 112.295 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.47 41.61 0.22 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.54 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -114.56 -175.14 2.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.82 0.343 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -150.15 -177.94 6.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.81 -175.55 25.41 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.592 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.91 -54.8 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.393 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 4.3 m-85 -98.22 29.6 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.795 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.2 m 54.46 30.39 12.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.016 0.436 . . . . 0.0 110.435 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 4.1 pt-20 -99.34 23.29 9.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.254 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 37' ' ' GLU . 18.5 mm . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.733 0.301 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.49 97.15 7.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.995 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.3 mm -109.92 -69.16 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 t -114.37 54.9 0.75 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.772 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 56.01 88.61 0.12 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.027 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.01 -37.24 78.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.54 2.16 . . . . 0.0 112.349 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.484 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 7.8 m -58.83 171.39 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.77 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 2.1 mm-40 -130.43 30.59 4.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.051 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -145.32 16.28 1.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.593 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 t0 69.37 48.11 0.66 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.158 0.504 . . . . 0.0 110.103 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.739 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -89.9 174.34 7.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.511 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 16' ' ' CYS . 96.3 m -89.9 162.11 15.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' N ' HG22 ' A' ' 15' ' ' THR . 51.4 t -135.84 156.09 49.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.561 HD12 ' HG3' ' A' ' 19' ' ' GLN . 0.3 OUTLIER -138.03 -47.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t0 56.05 103.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.043 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.561 ' HG3' HD12 ' A' ' 17' ' ' LEU . 1.8 mt-30 -133.38 -46.57 0.83 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.586 HG22 ' H ' ' A' ' 21' ' ' GLY . 1.9 mm -95.41 174.02 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.784 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.586 ' H ' HG22 ' A' ' 20' ' ' ILE . . . -47.97 -27.36 4.96 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.657 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -96.26 172.39 7.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.337 . . . . 0.0 110.823 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.491 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 52.8 p90 -92.19 133.0 36.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.07 93.16 4.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 44.1 t -104.51 120.03 40.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.946 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.739 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 29.4 mt -89.94 126.04 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.017 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.7 p -113.14 -174.87 2.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.03 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.452 ' CB ' ' CE1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.58 163.14 2.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.6 100.16 0.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.815 2.343 . . . . 0.0 112.522 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.9 23.64 3.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.798 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.452 ' CE1' ' CB ' ' A' ' 28' ' ' MET . 3.2 m-85 -94.8 179.71 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.748 0.309 . . . . 0.0 110.82 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -150.22 -177.31 5.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.46 -174.3 23.71 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.632 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 t -89.84 -32.27 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 110.794 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.491 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 5.8 m-85 -121.11 26.73 8.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.682 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m 53.85 32.88 15.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.726 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.595 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -97.64 31.47 2.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.028 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.595 HD13 ' O ' ' A' ' 37' ' ' GLU . 23.6 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.118 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.92 0.39 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.0 t -142.46 102.91 4.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.963 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.6 mm -121.99 -66.9 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t -110.42 55.41 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.963 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 57.09 94.49 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 26.5 Cg_endo -62.99 -38.22 48.16 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.358 2.039 . . . . 0.0 112.257 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.763 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 6.4 m -58.1 143.85 42.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.744 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 2.7 mm-40 -107.43 30.19 6.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.343 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -147.0 15.26 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 t70 71.09 60.4 0.18 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.123 0.487 . . . . 0.0 110.508 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.875 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -110.26 177.42 4.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.205 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 16' ' ' CYS . 51.0 m -89.9 161.53 15.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.82 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.429 ' N ' HG22 ' A' ' 15' ' ' THR . 51.1 t -141.27 74.93 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.62 HD12 HD11 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -62.7 86.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.756 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.16 118.42 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.972 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -149.97 -47.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.496 HG22 ' N ' ' A' ' 21' ' ' GLY . 21.9 mm -92.14 161.52 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.953 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLY . . . . . 0.496 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -49.12 -26.86 6.57 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.726 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -95.19 165.82 12.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 110.797 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -89.97 130.22 36.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -119.4 95.0 4.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.949 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -94.2 128.31 40.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.782 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.875 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 19.7 mt -89.9 122.12 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.018 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.1 m -82.92 174.7 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.022 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.429 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -79.08 171.51 12.32 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.615 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 61.2 Cg_endo -72.4 80.16 1.69 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.391 2.061 . . . . 0.0 112.342 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.38 57.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.466 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -118.32 -174.28 2.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -142.22 -176.81 4.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.55 172.93 46.02 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.97 -49.08 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.1 m-85 -98.15 27.49 4.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.3 97.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 11' ' ' GLN . 5.3 tp10 -168.89 -38.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.826 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.7 mm . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.097 179.976 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 . . . . . 0 CA--C 1.527 0.058 0 CA-C-O 120.804 0.335 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.604 ' O ' HD13 ' A' ' 6' ' ' ILE . 1.8 t -89.85 93.76 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.972 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 5' ' ' CYS . 21.4 mm -128.19 -65.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.166 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.1 t -99.35 53.32 0.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 52.74 89.61 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.14 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.88 -58.43 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.431 2.087 . . . . 0.0 112.213 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.756 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 5.7 m -50.1 132.21 23.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -96.28 30.94 2.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.543 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -149.21 12.8 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.5 t0 69.48 66.28 0.26 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.193 0.52 . . . . 0.0 110.351 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.817 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -109.92 179.19 4.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.32 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.6 m -90.0 140.13 29.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.692 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.1 t -134.42 92.44 2.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.825 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -71.35 124.08 23.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.953 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.17 112.32 3.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.29 161.09 23.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.5 mt -91.3 92.0 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.23 -76.93 0.26 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.545 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -123.44 179.14 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.878 0.371 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -97.31 129.85 44.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.978 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -107.71 87.47 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.17 114.86 27.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.972 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.817 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 27.6 mt -89.94 122.67 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.998 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 164.9 19.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.067 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.03 171.39 1.55 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.809 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.37 79.69 3.1 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.553 2.169 . . . . 0.0 112.462 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.47 37.78 0.71 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.449 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -109.35 -175.16 2.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -144.78 -178.15 5.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.03 169.75 46.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.02 -47.93 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -99.74 27.98 5.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.9 m 54.1 100.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.972 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -174.54 -38.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.95 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.81 0.338 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -137.49 77.46 1.64 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.802 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.0 mm -108.98 -66.46 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.212 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.36 55.86 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 56.08 88.76 0.12 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 30.6 Cg_endo -64.61 -39.3 27.99 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.512 2.142 . . . . 0.0 112.277 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 4.3 m -70.05 150.84 46.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.74 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 20.3 mm-40 -118.46 27.94 8.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.34 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -146.83 15.14 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 72.11 50.26 0.22 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.135 0.493 . . . . 0.0 110.562 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.698 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -90.13 172.73 8.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.179 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.689 ' HB ' HD12 ' A' ' 26' ' ' ILE . 61.1 m -97.57 132.5 43.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.797 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 t -99.47 131.59 45.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.406 HD13 ' H ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -119.21 142.95 47.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.406 ' H ' HD13 ' A' ' 17' ' ' LEU . 1.5 m-20 -99.85 117.7 34.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.754 ' HB3' HD12 ' A' ' 20' ' ' ILE . 6.6 mt-30 -102.87 -77.88 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.754 HD12 ' HB3' ' A' ' 19' ' ' GLN . 3.8 mp -141.52 -66.47 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.186 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -140.11 28.38 2.49 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -141.36 171.31 14.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.41 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 52.1 p90 -102.58 136.75 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.987 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -117.05 92.78 3.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 52.0 t -89.98 119.74 30.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.692 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 26.3 mt -89.92 113.64 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.5 m -74.75 174.06 9.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.141 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.44 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -70.53 172.72 5.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.565 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 64.2 Cg_endo -73.1 66.78 4.2 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.343 2.028 . . . . 0.0 112.32 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.77 41.03 0.25 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.526 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 28' ' ' MET . 4.3 m-85 -113.8 -176.47 2.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.449 ' HG3' HG21 ' A' ' 38' ' ' ILE . 2.2 pt-20 -150.22 -177.95 6.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.14 -175.92 28.84 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.626 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 t -89.97 -54.09 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.456 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 10.3 m-85 -96.97 26.18 4.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.792 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 m 51.66 32.6 9.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.957 0.408 . . . . 0.0 110.586 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 1.9 pt-20 -99.06 29.85 3.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.109 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.449 HG21 ' HG3' ' A' ' 32' ' ' GLU . 23.8 mm . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.824 0.345 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.71 85.6 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.837 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.5 mm -94.89 -69.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.226 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t -116.05 55.17 0.8 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 55.16 91.3 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.48 -27.72 46.41 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.483 2.122 . . . . 0.0 112.381 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 14.2 m -55.43 135.69 50.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -102.2 32.52 3.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.192 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -146.43 14.14 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 t0 68.53 43.85 1.32 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.199 0.524 . . . . 0.0 110.218 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -89.95 178.82 6.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.411 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.0 m -99.25 145.51 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.808 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.3 t -106.67 137.6 44.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.712 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.444 ' HB2' HD11 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -133.18 118.53 18.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -69.7 122.87 20.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.89 -76.57 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.9 mt -145.28 -46.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.167 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.64 -38.16 0.06 OUTLIER Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.844 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -89.79 178.63 6.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.388 . . . . 0.0 111.004 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -100.17 153.84 18.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.053 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -132.36 112.66 12.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.795 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -90.01 109.94 20.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.452 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 31.0 mt -99.44 90.88 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.827 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 p -97.32 -176.37 3.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.068 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.439 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -51.38 168.51 0.26 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.105 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD2' ' CG ' ' A' ' 28' ' ' MET . 86.9 Cg_endo -82.07 138.73 10.35 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.697 2.264 . . . . 0.0 112.448 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.82 24.06 62.97 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.714 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CE1' ' HB3' ' A' ' 28' ' ' MET . 2.6 m-85 -90.38 -176.37 4.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.726 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -150.09 -178.47 6.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.124 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.12 176.0 30.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.522 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.2 t -89.88 -48.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.996 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -100.38 28.91 4.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.799 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.2 m 58.85 51.95 6.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.875 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -113.86 -33.43 5.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.823 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.59 ' O ' HG22 ' A' ' 38' ' ' ILE . 28.7 mm . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.06 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.759 0.314 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.439 ' C ' HD12 ' A' ' 6' ' ' ILE . 12.6 t -100.11 83.28 2.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.053 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 6' ' ' ILE . 1.7 mp -102.09 -75.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.808 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -107.97 55.91 0.64 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.809 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 59.15 90.26 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.31 -38.31 81.93 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.581 2.187 . . . . 0.0 112.313 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 4.6 m -57.13 168.21 0.74 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.823 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 1.6 mm-40 -127.99 27.26 5.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.285 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -146.13 17.19 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.518 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 69.71 52.65 0.42 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.305 0.574 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.738 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -97.53 176.55 5.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.256 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.0 m -90.03 149.85 22.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.816 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.0 t -125.89 139.15 53.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -126.34 126.16 43.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -65.02 137.54 57.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLN . . . . . 0.464 ' OE1' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -149.48 163.54 37.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.991 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.464 HD12 ' OE1' ' A' ' 19' ' ' GLN . 2.6 mp -90.36 90.21 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.176 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.41 -82.19 0.23 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.518 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -113.31 178.02 4.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.85 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.472 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 54.8 p90 -89.96 142.33 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.999 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -109.39 96.77 6.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -106.29 119.16 38.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.667 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 29.8 mt -90.06 116.57 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.4 m -73.56 178.48 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.045 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.449 ' CB ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -75.66 170.79 14.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.45 72.6 4.86 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.526 2.151 . . . . 0.0 112.475 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.37 38.78 0.47 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.621 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.449 ' CD1' ' CB ' ' A' ' 28' ' ' MET . 4.9 m-85 -112.16 -175.95 2.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -150.04 179.23 8.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.8 -177.7 29.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.03 -50.54 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.472 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 6.3 m-85 -98.21 28.69 3.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.2 m 54.12 30.73 12.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.968 0.413 . . . . 0.0 110.753 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 15.1 pt-20 -100.56 -23.66 14.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.212 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 mm . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.08 -179.942 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.583 0.23 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.3 m -89.91 73.84 7.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.3 mm -101.59 -67.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.226 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.64 53.57 0.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.016 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 49.44 91.72 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.29 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.96 -39.36 41.05 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.519 2.146 . . . . 0.0 112.221 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.739 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 1.9 m -49.5 151.37 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 7.3 mm-40 -114.08 32.07 6.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.31 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -149.6 17.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t0 69.98 57.91 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.197 0.522 . . . . 0.0 110.482 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.859 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -108.1 -175.6 2.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.251 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 16' ' ' CYS . 89.4 m -105.57 160.62 15.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.054 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' CYS . . . . . 0.416 ' N ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -122.01 148.41 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.781 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 18' ' ' ASP . 0.3 OUTLIER -142.98 159.68 41.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.414 ' H ' HD23 ' A' ' 17' ' ' LEU . 1.4 t70 -113.29 158.66 20.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.86 -77.03 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.93 -67.43 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.089 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.32 26.96 1.39 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.399 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.33 -178.98 5.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 0.0 110.968 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -106.53 137.26 44.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -124.93 94.95 4.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.644 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.94 130.54 36.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.859 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 29.1 mt -89.91 122.87 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.987 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -84.36 -176.1 6.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.048 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.425 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -84.75 172.1 9.65 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.611 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.9 Cg_endo -74.17 75.46 3.29 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.403 2.069 . . . . 0.0 112.356 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.98 38.57 0.56 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.557 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -112.95 -176.21 2.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -150.1 -177.26 5.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.36 174.03 41.84 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.491 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 t -89.96 -53.4 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.82 0.343 . . . . 0.0 110.954 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -97.81 25.62 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.815 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.17 100.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.934 0.397 . . . . 0.0 111.068 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 11' ' ' GLN . 3.9 tp10 -173.84 -33.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.976 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.1 mm . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.979 -179.941 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.812 0.339 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.51 ' C ' HD12 ' A' ' 6' ' ' ILE . 1.2 m -106.72 90.24 3.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 6' ' ' ILE . 1.6 mp -106.14 -77.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.941 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.9 53.97 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 53.4 86.3 0.17 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.169 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' PRO . . . . . 0.467 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 17.4 Cg_endo -58.9 -37.39 93.88 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.529 2.152 . . . . 0.0 112.249 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 1.3 m -56.97 177.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.925 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -134.95 28.14 3.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.251 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -146.36 15.75 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.716 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 70.23 49.68 0.45 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.085 0.469 . . . . 0.0 110.209 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.814 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -89.97 175.1 7.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.203 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.7 m -90.04 154.22 19.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -112.9 131.07 55.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.743 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 112.58 6.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -80.57 151.05 29.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -118.75 -80.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 mt -129.2 -68.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.28 -37.45 0.6 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.546 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.87 172.48 8.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -97.64 162.87 13.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.014 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -147.74 96.46 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.817 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.8 t -90.08 131.06 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.028 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.814 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 28.9 mt -91.88 118.52 37.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.001 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -100.2 161.39 13.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.976 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.406 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -60.67 171.69 0.99 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.835 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.73 127.22 7.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.656 2.237 . . . . 0.0 112.424 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.96 31.24 39.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.51 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.406 ' CD1' ' HB3' ' A' ' 28' ' ' MET . 5.2 m-85 -106.68 -174.88 2.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.816 0.341 . . . . 0.0 110.885 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -147.09 -176.98 5.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.59 164.92 38.32 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.456 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 t -89.94 -30.19 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 111.042 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.7 m-85 -118.12 35.98 4.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.3 t 49.84 84.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -157.31 -42.62 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.681 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.78 0.324 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.403 ' C ' HD12 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -150.12 71.11 1.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.843 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 6' ' ' ILE . 1.7 mp -99.67 -77.74 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.046 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 t -93.37 55.49 2.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.076 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 53.06 92.93 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.999 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.67 -46.17 9.62 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.504 2.136 . . . . 0.0 112.243 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.796 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 9.6 m -59.88 161.45 6.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.621 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -130.87 28.96 4.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.188 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -149.18 18.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.511 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t70 71.83 50.43 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.17 0.509 . . . . 0.0 110.465 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.796 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -90.17 171.62 9.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.174 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.497 ' HB ' HD12 ' A' ' 26' ' ' ILE . 96.9 m -94.93 136.65 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.8 t -113.46 118.81 35.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.95 132.84 53.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -60.56 122.28 14.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -165.81 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pt -94.23 23.81 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.633 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.93 -37.78 0.87 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.675 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -100.06 177.33 5.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 110.894 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 44.3 p90 -102.14 146.63 27.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.02 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -116.76 92.01 3.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.002 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.96 113.53 25.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.813 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.58 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 18.0 mt -89.92 119.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.989 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.7 172.8 8.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.048 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.44 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -72.51 172.36 7.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.791 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 28' ' ' MET . 71.7 Cg_endo -76.47 62.56 7.05 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.499 2.133 . . . . 0.0 112.254 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.57 43.11 0.1 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.467 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 28' ' ' MET . 2.6 m-85 -109.93 -175.37 2.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -144.37 175.71 9.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.55 166.25 37.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.16 -33.82 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 0.0 111.159 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 17.4 m-85 -113.54 33.29 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.8 m 49.82 88.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -162.62 -43.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.9 mm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.071 179.999 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.834 0.349 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' CYS . . . . . 0.67 ' C ' HD12 ' A' ' 6' ' ' ILE . 21.1 t -143.81 80.17 1.65 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . 0.67 HD12 ' C ' ' A' ' 5' ' ' CYS . 1.6 mp -114.81 -76.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.69 55.34 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 53.44 90.05 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.066 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.6 -37.52 87.79 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.674 2.25 . . . . 0.0 112.323 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' CYS . . . . . 0.849 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 20.1 m -59.45 169.6 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.905 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -131.26 26.75 4.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -149.88 18.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.563 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t0 70.61 48.95 0.42 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.126 0.488 . . . . 0.0 110.275 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.849 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -89.92 168.7 11.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.238 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' THR . . . . . 0.543 ' HB ' HD12 ' A' ' 26' ' ' ILE . 97.2 m -89.89 133.93 34.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.6 t -104.15 143.33 33.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.908 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -142.45 132.98 25.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ASP . . . . . 0.518 ' N ' HD13 ' A' ' 17' ' ' LEU . 29.5 t0 -126.81 129.87 49.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -124.88 -62.15 1.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.6 mt -93.87 -67.73 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.108 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.12 33.29 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.494 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -135.1 158.01 45.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.494 ' CE2' ' CE1' ' A' ' 35' ' ' TYR . 51.1 p90 -95.05 123.23 38.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -105.21 102.6 12.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 42.6 t -90.03 128.39 36.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.069 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . 0.543 HD12 ' HB ' ' A' ' 15' ' ' THR . 21.2 mt -106.87 106.7 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.808 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.07 161.24 18.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.113 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.412 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -58.67 172.78 0.48 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.941 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 28' ' ' MET . 87.1 Cg_endo -78.05 119.32 4.64 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.536 2.157 . . . . 0.0 112.306 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.12 20.59 35.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.441 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -100.56 -177.04 3.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 110.734 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.07 -177.02 5.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.4 169.16 31.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.38 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.06 -36.05 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 111.145 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' TYR . . . . . 0.494 ' CE1' ' CE2' ' A' ' 23' ' ' PHE . 3.8 m-85 -111.1 26.27 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.988 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 37.8 t 51.66 92.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -162.29 -37.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.998 -179.837 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.795 0.331 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t 63.24 145.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.058 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.535 ' HB2' HD11 ' A' ' 6' ' ' ILE . 67.8 m-20 -114.73 -177.0 3.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -111.51 -34.09 6.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.9 t -99.88 84.83 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.992 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 3' ' ' ASN . 20.1 mm -102.71 -66.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 t -109.02 56.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 56.93 90.88 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.836 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 17.8 Cg_endo -60.62 -32.45 93.35 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.486 2.124 . . . . 0.0 112.287 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 13.1 m -60.61 154.59 20.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.728 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -123.17 32.24 5.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.214 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -150.0 20.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.596 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 t0 70.66 43.62 0.73 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.106 0.479 . . . . 0.0 110.381 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.656 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -92.66 164.92 13.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.255 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.3 m -89.99 130.85 36.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.75 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.5 t -97.61 132.23 43.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.918 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.653 HD12 HD11 ' A' ' 26' ' ' ILE . 2.9 mt -121.07 -170.47 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.5 146.51 25.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -179.16 6.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -89.9 99.41 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.7 21.54 50.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.674 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -148.01 -179.39 6.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.869 0.366 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 39.2 p90 -104.63 157.51 17.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.039 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.13 88.02 2.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.93 108.33 19.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.656 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 27.1 mt -90.97 96.09 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.073 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 m -70.95 175.29 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.408 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -70.09 171.6 7.28 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.909 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.3 Cg_endo -76.02 101.4 1.49 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.501 2.134 . . . . 0.0 112.353 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.19 26.64 6.53 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -104.15 -175.48 2.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 0.0 110.863 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -146.12 178.57 8.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.21 165.9 32.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.522 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.01 -43.57 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.836 0.35 . . . . 0.0 111.117 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 1.9 m-85 -101.04 28.51 5.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 83.8 m 52.86 80.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.952 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -152.41 -44.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.093 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.879 0.371 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.639 HG22 HD13 ' A' ' 6' ' ' ILE . 7.5 p -136.36 76.85 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.066 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -115.56 -37.25 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.967 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.04 -36.28 15.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.88 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.79 79.57 2.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.639 HD13 HG22 ' A' ' 2' ' ' VAL . 21.5 mm -102.51 -67.13 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.293 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 t -108.85 54.56 0.65 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.93 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 55.3 t-20 53.69 93.06 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.002 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 18.1 Cg_endo -60.45 -32.49 93.85 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.487 2.124 . . . . 0.0 112.219 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.881 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 10.3 m -64.78 162.53 15.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.79 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.59 -29.71 7.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.448 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -90.04 12.07 18.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.709 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 74.12 56.35 0.09 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.198 0.523 . . . . 0.0 110.546 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.881 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -93.0 169.72 10.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.172 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.3 m -89.95 145.57 25.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.4 t -105.39 135.53 46.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 tp -127.3 141.0 51.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.81 155.89 16.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -137.87 -77.3 0.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.0 110.983 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.1 mt -146.69 -46.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.162 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -161.23 28.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.47 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -141.85 160.04 41.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 110.858 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -96.51 147.38 23.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.981 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.09 118.33 20.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 50.9 t -105.99 114.37 28.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.622 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 33.3 mt -89.98 105.25 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.948 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 t -86.4 166.36 15.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.078 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.09 172.51 0.71 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.935 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.89 109.59 2.75 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.618 2.212 . . . . 0.0 112.387 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.48 24.05 10.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.485 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -100.54 -176.07 3.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 0.0 110.838 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.93 -176.99 5.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.9 173.07 34.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.526 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.01 -51.36 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 111.083 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 18.0 m-85 -98.42 30.04 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.789 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.7 t 57.55 70.09 0.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.709 ' O ' HD13 ' A' ' 38' ' ' ILE . 4.2 tp10 -154.82 26.16 0.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.978 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.709 HD13 ' O ' ' A' ' 37' ' ' GLU . 22.0 mm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.571 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.82 0.343 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.08 143.36 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.03 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -95.47 151.19 19.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.0 -24.71 10.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.5 t -89.92 84.25 6.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mm -107.73 -66.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.126 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -109.4 55.6 0.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.795 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 58.42 88.62 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.77 -38.78 46.8 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.47 2.113 . . . . 0.0 112.229 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 8.8 m -57.47 151.0 17.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.648 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -118.71 29.67 7.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.506 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -150.06 17.48 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t0 71.15 60.17 0.18 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.14 0.495 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.71 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -105.43 166.83 10.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.251 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.478 HG22 HD12 ' A' ' 17' ' ' LEU . 65.2 m -90.02 132.06 35.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.739 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' GLN . 53.4 t -102.83 127.58 49.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.478 HD12 HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -129.89 -171.83 2.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -141.64 164.34 30.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.49 -50.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.3 mt -144.8 -66.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.181 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.12 26.44 0.9 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.528 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -128.0 170.73 12.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.744 0.307 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CE2' ' CE1' ' A' ' 35' ' ' TYR . 48.0 p90 -98.43 137.26 37.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.029 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -115.36 146.22 41.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.78 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 52.2 t -141.45 115.98 9.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.716 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.675 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 27.7 mt -89.88 114.24 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.03 169.84 14.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.006 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.42 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -74.54 172.51 8.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.721 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 73.3 Cg_endo -75.36 81.61 2.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.475 2.116 . . . . 0.0 112.354 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.94 38.47 0.75 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.464 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -107.44 -176.1 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -149.11 177.84 9.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.86 170.79 41.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.95 -48.52 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.085 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CE1' ' CE2' ' A' ' 23' ' ' PHE . 2.3 m-85 -98.33 30.0 3.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.8 m 53.14 93.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -170.42 -39.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.857 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.9 mm . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.076 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.792 0.329 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.63 143.15 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.041 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -130.07 -46.12 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -139.56 -67.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.5 t -138.57 87.7 2.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.954 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.1 mm -116.29 -67.29 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.214 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 t -108.45 55.26 0.64 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 53.71 87.06 0.15 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.944 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.88 -26.64 75.15 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.549 2.166 . . . . 0.0 112.347 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.81 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 12.5 m -59.99 171.5 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.806 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -136.07 28.88 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -149.54 19.69 0.93 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.455 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.63 43.19 0.47 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.092 0.472 . . . . 0.0 110.544 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.81 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -89.98 170.62 10.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.125 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.698 ' HB ' HD12 ' A' ' 26' ' ' ILE . 96.9 m -99.95 153.67 18.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.015 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.8 t -103.94 127.45 51.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.568 ' HB2' HD11 ' A' ' 26' ' ' ILE . 1.5 tp -121.04 81.49 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.75 127.54 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.884 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.645 ' HB3' HD12 ' A' ' 20' ' ' ILE . 2.4 mm-40 -108.28 -52.35 2.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.08 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.645 HD12 ' HB3' ' A' ' 19' ' ' GLN . 4.2 mp -140.99 -75.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.343 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.82 -19.32 1.16 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.142 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.91 179.61 5.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 111.034 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.501 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 54.3 p90 -110.49 133.45 53.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -116.56 112.29 21.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.802 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 m -89.99 120.74 31.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.935 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.698 HD12 ' HB ' ' A' ' 15' ' ' THR . 34.2 mt -89.91 98.64 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.32 163.86 23.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.132 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.406 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -60.75 172.02 0.93 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.74 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.3 Cg_endo -76.08 72.88 5.13 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.484 2.123 . . . . 0.0 112.334 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.57 40.08 0.31 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.486 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -108.67 -175.75 2.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.747 0.308 . . . . 0.0 110.89 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -148.16 173.96 12.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.53 166.82 24.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.58 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.8 t -89.93 -47.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.501 ' CE1' ' CE1' ' A' ' 23' ' ' PHE . 2.4 m-85 -101.69 28.57 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.6 m 55.53 92.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.922 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -169.49 -41.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.961 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 27.2 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.093 -179.992 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.529 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.754 0.312 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.72 129.54 66.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.074 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -107.26 118.82 37.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.02 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.95 -79.27 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.874 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.31 79.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 mm -108.09 -65.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.191 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 t -108.3 54.44 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 53.95 89.08 0.11 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.099 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.93 -39.09 43.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.436 2.091 . . . . 0.0 112.336 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.864 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 17.1 m -58.11 155.21 11.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.803 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -122.15 27.5 7.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.409 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -149.77 17.06 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t70 72.19 59.92 0.14 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.107 0.48 . . . . 0.0 110.447 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.864 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -101.57 165.26 11.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.218 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.4 m -89.96 136.46 33.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.745 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -103.23 139.8 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.4 137.18 33.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.05 130.39 45.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -113.66 -78.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.978 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.2 mm -113.6 -66.7 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -158.04 27.77 0.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.409 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -127.66 176.38 7.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -105.51 123.47 47.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.014 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.6 118.09 35.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 52.5 t -110.06 114.07 27.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.994 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.415 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 30.7 mt -89.94 100.17 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.972 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.6 t -81.12 165.69 21.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.043 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.438 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -60.56 170.73 1.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.837 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.76 111.48 3.13 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.663 2.242 . . . . 0.0 112.357 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.42 26.53 9.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.532 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 28' ' ' MET . 7.4 m-85 -102.83 -175.86 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.784 0.326 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -145.99 178.86 7.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.93 166.46 38.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.554 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -90.04 -41.49 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.038 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -100.75 29.79 4.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.4 t 49.24 85.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.053 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -158.8 -43.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.65 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.774 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.839 0.352 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.54 95.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -93.27 143.09 26.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -110.3 -23.8 11.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.0 t -89.84 86.89 6.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 111.024 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.6 mm -110.87 -66.11 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 t -107.44 55.88 0.64 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.427 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 51.1 t-20 58.52 96.33 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 16.3 Cg_endo -58.34 -46.85 22.27 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.421 2.081 . . . . 0.0 112.124 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 13.2 m -60.34 160.71 8.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.809 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 2.7 mm-40 -123.99 36.83 4.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.038 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -148.66 17.7 1.02 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.606 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t0 70.04 50.32 0.45 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.118 0.485 . . . . 0.0 110.298 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.443 ' HB1' ' HA ' ' A' ' 27' ' ' CYS . . . -101.11 175.44 5.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.281 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.4 m -89.99 156.53 18.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.741 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 t -131.0 130.91 43.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.487 HD13 ' H ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -115.96 152.16 34.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.487 ' H ' HD13 ' A' ' 17' ' ' LEU . 8.9 t70 -82.07 128.07 33.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.969 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 6.7 mt-30 -140.5 163.86 31.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.78 132.88 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.36 -56.01 4.93 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.516 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -124.99 163.59 22.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.339 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.48 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 9.3 p90 -90.88 157.33 17.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.03 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.03 127.02 48.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.763 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -132.28 112.75 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.5 mt -89.94 96.94 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' CYS . . . . . 0.443 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 28.1 p -89.38 -174.32 4.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -58.13 165.69 2.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.98 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -85.4 99.07 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.842 2.362 . . . . 0.0 112.604 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.61 32.65 1.56 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.636 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 28' ' ' MET . 3.4 m-30 -99.82 -177.76 3.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.816 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.99 -175.02 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.173 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.26 -169.15 32.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.587 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.88 -52.12 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 0.0 110.872 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.48 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 2.0 m-85 -99.06 28.3 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.638 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.1 m 54.52 32.75 17.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.605 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.725 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -102.47 30.07 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.037 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.725 HD13 ' O ' ' A' ' 37' ' ' GLU . 24.8 mm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.188 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.802 0.334 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.595 HG12 HD12 ' A' ' 6' ' ' ILE . 30.8 m -132.99 150.26 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -113.22 -66.55 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.952 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -150.05 -54.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.941 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 69.0 m -90.0 106.15 18.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.595 HD12 HG12 ' A' ' 2' ' ' VAL . 28.8 mm -122.45 -68.42 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.479 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 t -109.25 51.53 0.74 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.091 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 59.4 t-20 46.55 87.74 0.11 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.464 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 11.8 Cg_endo -56.54 -34.46 95.22 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.451 2.1 . . . . 0.0 112.192 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.671 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 1.8 m -58.2 173.62 0.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.98 29.29 2.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.232 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -149.01 19.76 0.98 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.54 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.05 63.83 0.3 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.245 0.545 . . . . 0.0 110.139 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.766 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -109.17 171.65 7.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.313 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.1 m -89.92 145.42 25.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.928 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.48 124.94 50.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.598 HD23 HD11 ' A' ' 26' ' ' ILE . 3.4 mm? -117.48 153.68 32.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.62 92.26 3.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -121.05 -57.32 1.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.806 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 21' ' ' GLY . 4.0 mt -98.3 160.37 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.939 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.506 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -49.81 -26.03 7.72 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.745 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . 0.494 ' OE2' HG21 ' A' ' 20' ' ' ILE . 1.2 pt-20 -89.89 -176.23 4.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.911 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -89.86 131.0 36.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -116.03 90.37 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.2 t -94.93 129.93 41.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.766 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 21.0 mt -89.93 121.17 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.024 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.81 172.61 9.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.017 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.408 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -74.44 171.27 11.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.816 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.9 Cg_endo -75.34 68.86 5.95 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.532 2.154 . . . . 0.0 112.338 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.97 41.85 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.469 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -108.98 -174.69 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.811 0.338 . . . . 0.0 110.821 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 -163.61 1.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.42 171.47 26.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.563 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.95 -36.63 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.871 0.367 . . . . 0.0 111.165 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.2 m-85 -111.94 31.15 6.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 90.1 m 51.77 78.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.715 ' O ' HD13 ' A' ' 38' ' ' ILE . 4.7 tp10 -155.88 27.39 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.715 HD13 ' O ' ' A' ' 37' ' ' GLU . 22.9 mm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.187 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.715 0.293 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.7 m -145.09 164.33 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.1 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 60.33 170.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.57 -78.15 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.0 t -124.36 79.4 1.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.0 mm -101.8 -66.06 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.264 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 t -106.39 56.71 0.66 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.946 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 57.22 95.78 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.44 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 28.4 Cg_endo -63.72 -36.87 49.51 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.425 2.083 . . . . 0.0 112.399 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 16.6 m -59.26 163.42 3.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.93 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.49 -27.47 7.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.525 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -90.01 11.57 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.768 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t0 72.59 66.38 0.12 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.029 0.442 . . . . 0.0 110.325 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.859 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -106.67 -175.92 2.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.374 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 16' ' ' CYS . 86.8 m -96.49 161.68 13.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.448 ' N ' HG22 ' A' ' 15' ' ' THR . 8.2 t -130.97 137.04 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -126.07 3.41 7.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.463 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 59.24 161.3 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.92 0.39 . . . . 0.0 110.835 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.75 -178.28 6.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 pt -89.88 89.98 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.06 -28.39 15.91 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.494 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -127.56 174.87 8.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.432 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 24.9 p90 -90.01 148.1 23.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -123.79 81.55 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 t -93.98 128.38 40.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.859 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 27.4 mt -92.84 116.06 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.074 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 t -86.25 163.17 17.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.829 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.4 169.84 0.22 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.053 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.53 102.42 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.637 2.225 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.9 34.21 5.26 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.556 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -108.5 -175.49 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -149.4 174.45 12.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.58 173.64 21.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.427 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.0 t -90.09 -49.5 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 111.06 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.7 m-85 -105.36 34.33 3.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.868 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.2 t 49.18 94.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.988 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -169.94 -39.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.2 mm . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.071 -179.948 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.6 t0 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.772 0.32 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 2' ' ' VAL . 5.9 m -143.34 95.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -176.62 141.49 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.844 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -109.3 31.26 5.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 47.7 t -114.84 85.32 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.025 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.7 mm -111.04 -66.11 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.7 t -107.99 55.8 0.64 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 57.83 91.08 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 23.7 Cg_endo -62.39 -29.45 79.35 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.554 2.169 . . . . 0.0 112.373 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.872 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 11.4 m -62.69 163.58 8.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.731 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.65 -30.53 6.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.535 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -90.91 13.41 16.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.831 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 t0 73.76 56.4 0.1 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.082 0.468 . . . . 0.0 110.548 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.872 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -93.7 175.79 6.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.185 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.8 m -89.94 139.56 30.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.1 t -123.44 108.26 12.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 17' ' ' LEU . 29.9 mt -99.94 154.37 18.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.22 89.75 3.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -130.42 -46.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 21' ' ' GLY . 22.0 mt -98.24 160.42 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.057 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -51.51 -25.99 14.55 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.679 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -100.18 177.1 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.772 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -89.99 147.74 23.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.23 99.62 6.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.555 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 49.5 t -97.38 111.1 23.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.503 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 20.2 mt -89.95 101.9 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.923 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.05 173.24 12.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.989 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.47 171.01 0.43 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.973 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.25 95.18 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.642 2.228 . . . . 0.0 112.509 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.47 46.41 1.68 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.607 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -114.87 -174.49 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.34 -167.52 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.16 168.25 40.3 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.01 -43.96 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.795 0.331 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.5 m-85 -108.27 35.2 3.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.855 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 53.8 t 54.85 89.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.831 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -171.97 -39.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 mm . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.125 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.7 p30 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.0 m -80.42 141.43 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.144 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -161.92 77.43 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -128.73 -81.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.13 77.43 1.31 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.912 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.1 mm -102.93 -67.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.2 t -110.82 55.59 0.65 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 57.56 91.96 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.96 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 33.9 Cg_endo -64.94 -38.62 28.35 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.489 2.126 . . . . 0.0 112.207 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 11.7 m -57.92 134.18 56.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.721 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 20.4 mm-40 -97.58 34.49 1.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.342 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -149.37 13.83 0.86 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 70.53 55.86 0.27 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.136 0.493 . . . . 0.0 110.435 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.786 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -99.46 -179.7 4.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.267 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.8 m -98.58 157.28 16.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -129.81 140.62 50.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.969 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.736 HD12 ' OE1' ' A' ' 19' ' ' GLN . 0.4 OUTLIER -130.64 88.12 2.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.767 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.55 85.67 2.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.98 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.736 ' OE1' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -110.64 -32.79 6.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.763 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 21' ' ' GLY . 1.6 mp -117.34 163.45 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.835 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -46.95 -28.51 3.97 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.729 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -90.92 168.96 11.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.759 0.314 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -90.6 138.25 31.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.98 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -126.38 88.25 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.838 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.36 127.05 36.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.786 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 31.2 mt -89.96 116.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.4 m -71.66 178.02 3.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.048 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.57 169.56 15.2 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.77 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -73.23 64.41 4.34 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.499 2.133 . . . . 0.0 112.295 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.47 41.61 0.22 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.54 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -114.56 -175.14 2.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.82 0.343 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -150.15 -177.94 6.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.81 -175.55 25.41 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.592 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.91 -54.8 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.393 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 4.3 m-85 -98.22 29.6 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.795 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.2 m 54.46 30.39 12.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.016 0.436 . . . . 0.0 110.435 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 4.1 pt-20 -99.34 23.29 9.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.254 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 37' ' ' GLU . 18.5 mm . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.811 0.339 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 m -101.88 134.15 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.17 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.433 ' CG ' HD11 ' A' ' 6' ' ' ILE . 2.4 t-20 -79.1 106.42 11.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.787 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -110.71 -33.09 6.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.49 97.15 7.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.995 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.433 HD11 ' CG ' ' A' ' 3' ' ' ASN . 24.3 mm -109.92 -69.16 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 t -114.37 54.9 0.75 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.772 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 56.01 88.61 0.12 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.027 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.01 -37.24 78.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.54 2.16 . . . . 0.0 112.349 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.484 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 7.8 m -58.83 171.39 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.77 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 2.1 mm-40 -130.43 30.59 4.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.051 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -145.32 16.28 1.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.593 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 t0 69.37 48.11 0.66 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.158 0.504 . . . . 0.0 110.103 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.739 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -89.9 174.34 7.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.511 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 16' ' ' CYS . 96.3 m -89.9 162.11 15.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' N ' HG22 ' A' ' 15' ' ' THR . 51.4 t -135.84 156.09 49.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.561 HD12 ' HG3' ' A' ' 19' ' ' GLN . 0.3 OUTLIER -138.03 -47.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t0 56.05 103.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.043 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.561 ' HG3' HD12 ' A' ' 17' ' ' LEU . 1.8 mt-30 -133.38 -46.57 0.83 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.586 HG22 ' H ' ' A' ' 21' ' ' GLY . 1.9 mm -95.41 174.02 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.784 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.586 ' H ' HG22 ' A' ' 20' ' ' ILE . . . -47.97 -27.36 4.96 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.657 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -96.26 172.39 7.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.337 . . . . 0.0 110.823 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.491 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 52.8 p90 -92.19 133.0 36.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.07 93.16 4.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 44.1 t -104.51 120.03 40.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.946 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.739 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 29.4 mt -89.94 126.04 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.017 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.7 p -113.14 -174.87 2.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.03 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.452 ' CB ' ' CE1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.58 163.14 2.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.6 100.16 0.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.815 2.343 . . . . 0.0 112.522 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.9 23.64 3.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.798 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.452 ' CE1' ' CB ' ' A' ' 28' ' ' MET . 3.2 m-85 -94.8 179.71 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.748 0.309 . . . . 0.0 110.82 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -150.22 -177.31 5.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.46 -174.3 23.71 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.632 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 t -89.84 -32.27 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 110.794 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.491 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 5.8 m-85 -121.11 26.73 8.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.682 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m 53.85 32.88 15.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.726 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.595 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -97.64 31.47 2.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.028 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.595 HD13 ' O ' ' A' ' 37' ' ' GLU . 23.6 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.118 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.78 0.324 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t 62.06 83.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.163 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -129.17 49.84 2.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.93 -74.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.0 t -142.46 102.91 4.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.963 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.6 mm -121.99 -66.9 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t -110.42 55.41 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.963 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 57.09 94.49 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 26.5 Cg_endo -62.99 -38.22 48.16 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.358 2.039 . . . . 0.0 112.257 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.763 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 6.4 m -58.1 143.85 42.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.744 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 2.7 mm-40 -107.43 30.19 6.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.343 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -147.0 15.26 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 t70 71.09 60.4 0.18 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.123 0.487 . . . . 0.0 110.508 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.875 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -110.26 177.42 4.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.205 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 16' ' ' CYS . 51.0 m -89.9 161.53 15.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.82 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.429 ' N ' HG22 ' A' ' 15' ' ' THR . 51.1 t -141.27 74.93 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.62 HD12 HD11 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -62.7 86.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.756 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.16 118.42 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.972 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -149.97 -47.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.496 HG22 ' N ' ' A' ' 21' ' ' GLY . 21.9 mm -92.14 161.52 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.953 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLY . . . . . 0.496 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -49.12 -26.86 6.57 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.726 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -95.19 165.82 12.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 110.797 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -89.97 130.22 36.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -119.4 95.0 4.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.949 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -94.2 128.31 40.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.782 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.875 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 19.7 mt -89.9 122.12 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.018 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.1 m -82.92 174.7 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.022 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.429 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -79.08 171.51 12.32 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.615 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 61.2 Cg_endo -72.4 80.16 1.69 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.391 2.061 . . . . 0.0 112.342 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.38 57.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.466 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -118.32 -174.28 2.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -142.22 -176.81 4.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.55 172.93 46.02 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.97 -49.08 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.1 m-85 -98.15 27.49 4.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.3 97.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 11' ' ' GLN . 5.3 tp10 -168.89 -38.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.826 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.7 mm . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.097 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.8 t0 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.807 0.337 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.583 HG12 HD12 ' A' ' 6' ' ' ILE . 31.6 m -90.94 146.49 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.078 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.483 ' H ' HD11 ' A' ' 6' ' ' ILE . 19.1 t-20 -170.95 -66.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -132.72 -43.07 0.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.156 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.604 ' O ' HD13 ' A' ' 6' ' ' ILE . 1.8 t -89.85 93.76 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.972 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 5' ' ' CYS . 21.4 mm -128.19 -65.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.166 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.1 t -99.35 53.32 0.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 52.74 89.61 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.14 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.88 -58.43 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.431 2.087 . . . . 0.0 112.213 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.756 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 5.7 m -50.1 132.21 23.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -96.28 30.94 2.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.543 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -149.21 12.8 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.5 t0 69.48 66.28 0.26 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.193 0.52 . . . . 0.0 110.351 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.817 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -109.92 179.19 4.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.32 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.6 m -90.0 140.13 29.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.692 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.1 t -134.42 92.44 2.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.825 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -71.35 124.08 23.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.953 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.17 112.32 3.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.29 161.09 23.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.5 mt -91.3 92.0 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.23 -76.93 0.26 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.545 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -123.44 179.14 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.878 0.371 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -97.31 129.85 44.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.978 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -107.71 87.47 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.17 114.86 27.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.972 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.817 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 27.6 mt -89.94 122.67 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.998 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 164.9 19.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.067 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.03 171.39 1.55 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.809 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.37 79.69 3.1 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.553 2.169 . . . . 0.0 112.462 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.47 37.78 0.71 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.449 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -109.35 -175.16 2.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -144.78 -178.15 5.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.03 169.75 46.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.02 -47.93 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -99.74 27.98 5.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.9 m 54.1 100.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.972 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -174.54 -38.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.95 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.804 0.335 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t 64.1 112.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.069 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.9 138.28 35.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.09 -78.62 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.816 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -137.49 77.46 1.64 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.802 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.0 mm -108.98 -66.46 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.212 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.36 55.86 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 56.08 88.76 0.12 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 30.6 Cg_endo -64.61 -39.3 27.99 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.512 2.142 . . . . 0.0 112.277 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 4.3 m -70.05 150.84 46.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.74 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 20.3 mm-40 -118.46 27.94 8.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.34 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -146.83 15.14 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 72.11 50.26 0.22 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.135 0.493 . . . . 0.0 110.562 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.698 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -90.13 172.73 8.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.179 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.689 ' HB ' HD12 ' A' ' 26' ' ' ILE . 61.1 m -97.57 132.5 43.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.797 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 t -99.47 131.59 45.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.406 HD13 ' H ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -119.21 142.95 47.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.406 ' H ' HD13 ' A' ' 17' ' ' LEU . 1.5 m-20 -99.85 117.7 34.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.754 ' HB3' HD12 ' A' ' 20' ' ' ILE . 6.6 mt-30 -102.87 -77.88 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.754 HD12 ' HB3' ' A' ' 19' ' ' GLN . 3.8 mp -141.52 -66.47 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.186 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -140.11 28.38 2.49 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -141.36 171.31 14.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.41 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 52.1 p90 -102.58 136.75 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.987 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -117.05 92.78 3.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 52.0 t -89.98 119.74 30.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.692 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 26.3 mt -89.92 113.64 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.5 m -74.75 174.06 9.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.141 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.44 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -70.53 172.72 5.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.565 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 64.2 Cg_endo -73.1 66.78 4.2 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.343 2.028 . . . . 0.0 112.32 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.77 41.03 0.25 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.526 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 28' ' ' MET . 4.3 m-85 -113.8 -176.47 2.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.449 ' HG3' HG21 ' A' ' 38' ' ' ILE . 2.2 pt-20 -150.22 -177.95 6.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.14 -175.92 28.84 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.626 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 t -89.97 -54.09 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.456 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 10.3 m-85 -96.97 26.18 4.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.792 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 m 51.66 32.6 9.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.957 0.408 . . . . 0.0 110.586 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 1.9 pt-20 -99.06 29.85 3.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.109 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.449 HG21 ' HG3' ' A' ' 32' ' ' GLU . 23.8 mm . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.861 0.362 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 3' ' ' ASN . 21.5 t -107.49 155.18 8.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.076 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.421 ' N ' HG12 ' A' ' 2' ' ' VAL . 12.1 m-20 -160.4 95.92 1.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.855 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.75 -80.27 0.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.71 85.6 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.837 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.5 mm -94.89 -69.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.226 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t -116.05 55.17 0.8 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 55.16 91.3 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.48 -27.72 46.41 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.483 2.122 . . . . 0.0 112.381 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 14.2 m -55.43 135.69 50.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -102.2 32.52 3.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.192 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -146.43 14.14 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 t0 68.53 43.85 1.32 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.199 0.524 . . . . 0.0 110.218 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -89.95 178.82 6.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.411 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.0 m -99.25 145.51 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.808 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.3 t -106.67 137.6 44.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.712 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.444 ' HB2' HD11 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -133.18 118.53 18.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -69.7 122.87 20.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.89 -76.57 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.9 mt -145.28 -46.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.167 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.64 -38.16 0.06 OUTLIER Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.844 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -89.79 178.63 6.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.388 . . . . 0.0 111.004 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -100.17 153.84 18.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.053 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.0 tt0 -132.36 112.66 12.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.795 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -90.01 109.94 20.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.452 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 31.0 mt -99.44 90.88 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.827 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 p -97.32 -176.37 3.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.068 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.439 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -51.38 168.51 0.26 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.105 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD2' ' CG ' ' A' ' 28' ' ' MET . 86.9 Cg_endo -82.07 138.73 10.35 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.697 2.264 . . . . 0.0 112.448 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.82 24.06 62.97 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.714 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CE1' ' HB3' ' A' ' 28' ' ' MET . 2.6 m-85 -90.38 -176.37 4.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.726 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -150.09 -178.47 6.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.124 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.12 176.0 30.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.522 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.2 t -89.88 -48.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.996 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -100.38 28.91 4.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.799 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.2 m 58.85 51.95 6.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.875 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -113.86 -33.43 5.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.823 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.59 ' O ' HG22 ' A' ' 38' ' ' ILE . 28.7 mm . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.06 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.795 0.331 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.484 HG23 ' OE2' ' A' ' 4' ' ' GLU . 9.5 m -95.38 147.37 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.182 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -76.8 133.31 39.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . 0.484 ' OE2' HG23 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -126.38 -79.67 0.6 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.946 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.439 ' C ' HD12 ' A' ' 6' ' ' ILE . 12.6 t -100.11 83.28 2.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.053 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 6' ' ' ILE . 1.7 mp -102.09 -75.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.808 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -107.97 55.91 0.64 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.809 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 59.15 90.26 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.31 -38.31 81.93 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.581 2.187 . . . . 0.0 112.313 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 4.6 m -57.13 168.21 0.74 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.823 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 1.6 mm-40 -127.99 27.26 5.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.285 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -146.13 17.19 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.518 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 69.71 52.65 0.42 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.305 0.574 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.738 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -97.53 176.55 5.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.256 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.0 m -90.03 149.85 22.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.816 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.0 t -125.89 139.15 53.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -126.34 126.16 43.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -65.02 137.54 57.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLN . . . . . 0.464 ' OE1' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -149.48 163.54 37.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.991 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.464 HD12 ' OE1' ' A' ' 19' ' ' GLN . 2.6 mp -90.36 90.21 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.176 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.41 -82.19 0.23 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.518 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -113.31 178.02 4.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.85 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.472 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 54.8 p90 -89.96 142.33 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.999 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -109.39 96.77 6.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -106.29 119.16 38.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.667 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 29.8 mt -90.06 116.57 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.4 m -73.56 178.48 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.045 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.449 ' CB ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -75.66 170.79 14.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.45 72.6 4.86 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.526 2.151 . . . . 0.0 112.475 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.37 38.78 0.47 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.621 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.449 ' CD1' ' CB ' ' A' ' 28' ' ' MET . 4.9 m-85 -112.16 -175.95 2.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -150.04 179.23 8.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.8 -177.7 29.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.03 -50.54 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.472 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 6.3 m-85 -98.21 28.69 3.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.2 m 54.12 30.73 12.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.968 0.413 . . . . 0.0 110.753 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 15.1 pt-20 -100.56 -23.66 14.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.212 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 mm . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.08 -179.942 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.8 t -78.57 88.87 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -122.32 146.22 47.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -115.9 -9.41 11.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.435 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.3 m -89.91 73.84 7.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.3 mm -101.59 -67.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.226 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.64 53.57 0.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.016 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 49.44 91.72 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.29 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.96 -39.36 41.05 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.519 2.146 . . . . 0.0 112.221 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.739 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 1.9 m -49.5 151.37 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 7.3 mm-40 -114.08 32.07 6.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.31 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -149.6 17.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t0 69.98 57.91 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.197 0.522 . . . . 0.0 110.482 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.859 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -108.1 -175.6 2.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.251 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 16' ' ' CYS . 89.4 m -105.57 160.62 15.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.054 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' CYS . . . . . 0.416 ' N ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -122.01 148.41 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.781 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 18' ' ' ASP . 0.3 OUTLIER -142.98 159.68 41.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.414 ' H ' HD23 ' A' ' 17' ' ' LEU . 1.4 t70 -113.29 158.66 20.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.86 -77.03 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.93 -67.43 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.089 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.32 26.96 1.39 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.399 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.33 -178.98 5.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 0.0 110.968 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -106.53 137.26 44.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -124.93 94.95 4.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.644 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.94 130.54 36.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.859 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 29.1 mt -89.91 122.87 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.987 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -84.36 -176.1 6.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.048 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.425 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -84.75 172.1 9.65 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.611 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.9 Cg_endo -74.17 75.46 3.29 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.403 2.069 . . . . 0.0 112.356 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.98 38.57 0.56 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.557 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -112.95 -176.21 2.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -150.1 -177.26 5.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.36 174.03 41.84 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.491 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 t -89.96 -53.4 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.82 0.343 . . . . 0.0 110.954 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -97.81 25.62 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.815 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.17 100.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.934 0.397 . . . . 0.0 111.068 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 11' ' ' GLN . 3.9 tp10 -173.84 -33.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.976 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.1 mm . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.979 -179.941 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.761 0.315 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 2' ' ' VAL . 5.8 m -64.62 93.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.077 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -121.7 82.96 2.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.38 -79.42 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.997 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.51 ' C ' HD12 ' A' ' 6' ' ' ILE . 1.2 m -106.72 90.24 3.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 6' ' ' ILE . 1.6 mp -106.14 -77.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.941 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.9 53.97 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 53.4 86.3 0.17 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.169 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' PRO . . . . . 0.467 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 17.4 Cg_endo -58.9 -37.39 93.88 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.529 2.152 . . . . 0.0 112.249 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 1.3 m -56.97 177.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.925 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -134.95 28.14 3.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.251 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -146.36 15.75 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.716 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 70.23 49.68 0.45 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.085 0.469 . . . . 0.0 110.209 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.814 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -89.97 175.1 7.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.203 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.7 m -90.04 154.22 19.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -112.9 131.07 55.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.743 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 112.58 6.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -80.57 151.05 29.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -118.75 -80.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 mt -129.2 -68.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.28 -37.45 0.6 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.546 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.87 172.48 8.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -97.64 162.87 13.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.014 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -147.74 96.46 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.817 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.8 t -90.08 131.06 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.028 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.814 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 28.9 mt -91.88 118.52 37.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.001 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -100.2 161.39 13.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.976 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.406 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -60.67 171.69 0.99 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.835 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.73 127.22 7.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.656 2.237 . . . . 0.0 112.424 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.96 31.24 39.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.51 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.406 ' CD1' ' HB3' ' A' ' 28' ' ' MET . 5.2 m-85 -106.68 -174.88 2.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.816 0.341 . . . . 0.0 110.885 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -147.09 -176.98 5.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.59 164.92 38.32 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.456 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 t -89.94 -30.19 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 111.042 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.7 m-85 -118.12 35.98 4.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.3 t 49.84 84.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -157.31 -42.62 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.681 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.868 0.366 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 3' ' ' ASN . 20.4 t 64.47 159.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.118 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ASN . . . . . 0.487 ' N ' HG12 ' A' ' 2' ' ' VAL . 1.3 m-20 62.56 101.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.786 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.1 -73.12 0.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.403 ' C ' HD12 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -150.12 71.11 1.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.843 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 6' ' ' ILE . 1.7 mp -99.67 -77.74 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.046 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 t -93.37 55.49 2.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.076 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 53.06 92.93 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.999 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.67 -46.17 9.62 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.504 2.136 . . . . 0.0 112.243 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.796 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 9.6 m -59.88 161.45 6.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.621 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.0 mm-40 -130.87 28.96 4.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.188 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -149.18 18.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.511 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t70 71.83 50.43 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.17 0.509 . . . . 0.0 110.465 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.796 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -90.17 171.62 9.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.174 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.497 ' HB ' HD12 ' A' ' 26' ' ' ILE . 96.9 m -94.93 136.65 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.8 t -113.46 118.81 35.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.95 132.84 53.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -60.56 122.28 14.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -165.81 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pt -94.23 23.81 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.633 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.93 -37.78 0.87 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.675 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -100.06 177.33 5.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 110.894 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 44.3 p90 -102.14 146.63 27.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.02 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -116.76 92.01 3.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.002 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.96 113.53 25.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.813 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.58 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 18.0 mt -89.92 119.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.989 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.7 172.8 8.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.048 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.44 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -72.51 172.36 7.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.791 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 28' ' ' MET . 71.7 Cg_endo -76.47 62.56 7.05 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.499 2.133 . . . . 0.0 112.254 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.57 43.11 0.1 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.467 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 28' ' ' MET . 2.6 m-85 -109.93 -175.37 2.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -144.37 175.71 9.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.55 166.25 37.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.16 -33.82 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 0.0 111.159 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 17.4 m-85 -113.54 33.29 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.8 m 49.82 88.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -162.62 -43.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.9 mm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.071 179.999 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.449 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.837 0.351 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.27 142.37 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -152.98 149.39 28.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.0 -59.87 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' CYS . . . . . 0.67 ' C ' HD12 ' A' ' 6' ' ' ILE . 21.1 t -143.81 80.17 1.65 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . 0.67 HD12 ' C ' ' A' ' 5' ' ' CYS . 1.6 mp -114.81 -76.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.69 55.34 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 53.44 90.05 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.066 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.6 -37.52 87.79 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.674 2.25 . . . . 0.0 112.323 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' CYS . . . . . 0.849 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 20.1 m -59.45 169.6 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.905 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -131.26 26.75 4.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -149.88 18.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.563 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t0 70.61 48.95 0.42 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.126 0.488 . . . . 0.0 110.275 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.849 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -89.92 168.7 11.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.238 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.543 ' HB ' HD12 ' A' ' 26' ' ' ILE . 97.2 m -89.89 133.93 34.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.6 t -104.15 143.33 33.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.908 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -142.45 132.98 25.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ASP . . . . . 0.518 ' N ' HD13 ' A' ' 17' ' ' LEU . 29.5 t0 -126.81 129.87 49.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -124.88 -62.15 1.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.6 mt -93.87 -67.73 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.108 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.12 33.29 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.494 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -135.1 158.01 45.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.494 ' CE2' ' CE1' ' A' ' 35' ' ' TYR . 51.1 p90 -95.05 123.23 38.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -105.21 102.6 12.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 42.6 t -90.03 128.39 36.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.069 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . 0.543 HD12 ' HB ' ' A' ' 15' ' ' THR . 21.2 mt -106.87 106.7 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.808 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.07 161.24 18.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.113 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.412 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -58.67 172.78 0.48 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.941 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 28' ' ' MET . 87.1 Cg_endo -78.05 119.32 4.64 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.536 2.157 . . . . 0.0 112.306 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.12 20.59 35.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.441 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -100.56 -177.04 3.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 110.734 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.07 -177.02 5.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.4 169.16 31.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.38 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.06 -36.05 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 111.145 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' TYR . . . . . 0.494 ' CE1' ' CE2' ' A' ' 23' ' ' PHE . 3.8 m-85 -111.1 26.27 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.988 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 37.8 t 51.66 92.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -162.29 -37.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.998 -179.837 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 39' ' ' FUC . . . . . 0.455 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 C--O 1.232 0.184 0 CA-C-O 120.798 0.332 . . . . 0.0 110.907 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.9 t -99.88 84.83 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.992 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.1 mm -102.71 -66.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 t -109.02 56.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 56.93 90.88 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.836 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 17.8 Cg_endo -60.62 -32.45 93.35 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.486 2.124 . . . . 0.0 112.287 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 13.1 m -60.61 154.59 20.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.728 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -123.17 32.24 5.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.214 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -150.0 20.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.596 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 t0 70.66 43.62 0.73 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.106 0.479 . . . . 0.0 110.381 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.656 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -92.66 164.92 13.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.255 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.3 m -89.99 130.85 36.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.75 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.5 t -97.61 132.23 43.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.918 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.653 HD12 HD11 ' A' ' 26' ' ' ILE . 2.9 mt -121.07 -170.47 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.5 146.51 25.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -179.16 6.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -89.9 99.41 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.7 21.54 50.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.674 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -148.01 -179.39 6.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.869 0.366 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 39.2 p90 -104.63 157.51 17.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.039 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.13 88.02 2.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.93 108.33 19.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.656 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 27.1 mt -90.97 96.09 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.073 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 m -70.95 175.29 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.408 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -70.09 171.6 7.28 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.909 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.3 Cg_endo -76.02 101.4 1.49 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.501 2.134 . . . . 0.0 112.353 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.19 26.64 6.53 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -104.15 -175.48 2.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 0.0 110.863 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -146.12 178.57 8.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.21 165.9 32.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.522 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.01 -43.57 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.836 0.35 . . . . 0.0 111.117 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 1.9 m-85 -101.04 28.51 5.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 83.8 m 52.86 80.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.952 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -152.41 -44.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.093 179.987 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.23 0.064 0 CA-C-O 120.825 0.345 . . . . 0.0 110.88 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.79 79.57 2.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.5 mm -102.51 -67.13 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.293 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 t -108.85 54.56 0.65 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.93 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 55.3 t-20 53.69 93.06 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.002 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 18.1 Cg_endo -60.45 -32.49 93.85 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.487 2.124 . . . . 0.0 112.219 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.881 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 10.3 m -64.78 162.53 15.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.79 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.59 -29.71 7.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.448 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -90.04 12.07 18.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.709 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 74.12 56.35 0.09 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.198 0.523 . . . . 0.0 110.546 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.881 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -93.0 169.72 10.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.172 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.3 m -89.95 145.57 25.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.4 t -105.39 135.53 46.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 tp -127.3 141.0 51.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.81 155.89 16.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -137.87 -77.3 0.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.0 110.983 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.1 mt -146.69 -46.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.162 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -161.23 28.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.47 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -141.85 160.04 41.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 110.858 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -96.51 147.38 23.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.981 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.09 118.33 20.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 50.9 t -105.99 114.37 28.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.622 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 33.3 mt -89.98 105.25 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.948 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 t -86.4 166.36 15.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.078 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.09 172.51 0.71 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.935 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.89 109.59 2.75 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.618 2.212 . . . . 0.0 112.387 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.48 24.05 10.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.485 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -100.54 -176.07 3.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 0.0 110.838 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.93 -176.99 5.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.9 173.07 34.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.526 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.01 -51.36 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 111.083 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 18.0 m-85 -98.42 30.04 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.789 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.7 t 57.55 70.09 0.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.709 ' O ' HD13 ' A' ' 38' ' ' ILE . 4.2 tp10 -154.82 26.16 0.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.978 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.709 HD13 ' O ' ' A' ' 37' ' ' GLU . 22.0 mm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.711 0.291 . . . . 0.0 111.145 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.5 t -89.92 84.25 6.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mm -107.73 -66.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.126 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -109.4 55.6 0.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.795 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 58.42 88.62 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.77 -38.78 46.8 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.47 2.113 . . . . 0.0 112.229 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 8.8 m -57.47 151.0 17.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.648 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -118.71 29.67 7.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.506 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -150.06 17.48 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t0 71.15 60.17 0.18 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.14 0.495 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.71 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -105.43 166.83 10.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.251 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.478 HG22 HD12 ' A' ' 17' ' ' LEU . 65.2 m -90.02 132.06 35.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.739 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' GLN . 53.4 t -102.83 127.58 49.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.478 HD12 HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -129.89 -171.83 2.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -141.64 164.34 30.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.49 -50.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.3 mt -144.8 -66.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.181 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.12 26.44 0.9 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.528 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -128.0 170.73 12.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.744 0.307 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CE2' ' CE1' ' A' ' 35' ' ' TYR . 48.0 p90 -98.43 137.26 37.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.029 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -115.36 146.22 41.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.78 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 52.2 t -141.45 115.98 9.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.716 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.675 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 27.7 mt -89.88 114.24 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.03 169.84 14.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.006 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.42 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -74.54 172.51 8.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.721 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 73.3 Cg_endo -75.36 81.61 2.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.475 2.116 . . . . 0.0 112.354 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.94 38.47 0.75 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.464 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -107.44 -176.1 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -149.11 177.84 9.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.86 170.79 41.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.95 -48.52 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.085 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CE1' ' CE2' ' A' ' 23' ' ' PHE . 2.3 m-85 -98.33 30.0 3.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.8 m 53.14 93.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -170.42 -39.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.857 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.9 mm . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.076 -179.988 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 . . . . . 0 N--CA 1.457 -0.081 0 CA-C-O 120.887 0.375 . . . . 0.0 110.912 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.5 t -138.57 87.7 2.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.954 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.1 mm -116.29 -67.29 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.214 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 t -108.45 55.26 0.64 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 53.71 87.06 0.15 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.944 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.88 -26.64 75.15 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.549 2.166 . . . . 0.0 112.347 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.81 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 12.5 m -59.99 171.5 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.806 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -136.07 28.88 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -149.54 19.69 0.93 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.455 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.63 43.19 0.47 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.092 0.472 . . . . 0.0 110.544 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.81 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -89.98 170.62 10.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.125 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.698 ' HB ' HD12 ' A' ' 26' ' ' ILE . 96.9 m -99.95 153.67 18.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.015 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.8 t -103.94 127.45 51.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.568 ' HB2' HD11 ' A' ' 26' ' ' ILE . 1.5 tp -121.04 81.49 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.75 127.54 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.884 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.645 ' HB3' HD12 ' A' ' 20' ' ' ILE . 2.4 mm-40 -108.28 -52.35 2.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.08 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.645 HD12 ' HB3' ' A' ' 19' ' ' GLN . 4.2 mp -140.99 -75.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.343 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.82 -19.32 1.16 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.142 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.91 179.61 5.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 111.034 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.501 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 54.3 p90 -110.49 133.45 53.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -116.56 112.29 21.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.802 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 m -89.99 120.74 31.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.935 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.698 HD12 ' HB ' ' A' ' 15' ' ' THR . 34.2 mt -89.91 98.64 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.32 163.86 23.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.132 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.406 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -60.75 172.02 0.93 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.74 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.3 Cg_endo -76.08 72.88 5.13 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.484 2.123 . . . . 0.0 112.334 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.57 40.08 0.31 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.486 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -108.67 -175.75 2.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.747 0.308 . . . . 0.0 110.89 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -148.16 173.96 12.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.53 166.82 24.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.58 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.8 t -89.93 -47.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.501 ' CE1' ' CE1' ' A' ' 23' ' ' PHE . 2.4 m-85 -101.69 28.57 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.6 m 55.53 92.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.922 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -169.49 -41.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.961 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 27.2 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.093 -179.992 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.851 0.358 . . . . 0.0 110.874 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.31 79.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 mm -108.09 -65.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.191 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 t -108.3 54.44 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 53.95 89.08 0.11 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.099 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.93 -39.09 43.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.436 2.091 . . . . 0.0 112.336 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.864 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 17.1 m -58.11 155.21 11.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.803 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -122.15 27.5 7.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.409 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -149.77 17.06 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t70 72.19 59.92 0.14 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.107 0.48 . . . . 0.0 110.447 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.864 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -101.57 165.26 11.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.218 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.4 m -89.96 136.46 33.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.745 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -103.23 139.8 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.4 137.18 33.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.05 130.39 45.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -113.66 -78.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.978 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.2 mm -113.6 -66.7 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -158.04 27.77 0.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.409 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -127.66 176.38 7.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -105.51 123.47 47.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.014 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.6 118.09 35.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 52.5 t -110.06 114.07 27.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.994 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.415 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 30.7 mt -89.94 100.17 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.972 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.6 t -81.12 165.69 21.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.043 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.438 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -60.56 170.73 1.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.837 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.76 111.48 3.13 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.663 2.242 . . . . 0.0 112.357 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.42 26.53 9.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.532 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 28' ' ' MET . 7.4 m-85 -102.83 -175.86 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.784 0.326 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -145.99 178.86 7.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.93 166.46 38.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.554 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -90.04 -41.49 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.038 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -100.75 29.79 4.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.4 t 49.24 85.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.053 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -158.8 -43.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.65 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.774 179.996 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.711 0.291 . . . . 0.0 111.142 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.0 t -89.84 86.89 6.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 111.024 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.6 mm -110.87 -66.11 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 t -107.44 55.88 0.64 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.427 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 51.1 t-20 58.52 96.33 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.448 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 16.3 Cg_endo -58.34 -46.85 22.27 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.421 2.081 . . . . 0.0 112.124 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 13.2 m -60.34 160.71 8.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.809 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 2.7 mm-40 -123.99 36.83 4.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.038 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -148.66 17.7 1.02 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.606 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t0 70.04 50.32 0.45 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.118 0.485 . . . . 0.0 110.298 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.443 ' HB1' ' HA ' ' A' ' 27' ' ' CYS . . . -101.11 175.44 5.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.281 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.4 m -89.99 156.53 18.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.741 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 t -131.0 130.91 43.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.487 HD13 ' H ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -115.96 152.16 34.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.487 ' H ' HD13 ' A' ' 17' ' ' LEU . 8.9 t70 -82.07 128.07 33.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.969 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -140.5 163.86 31.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.78 132.88 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.36 -56.01 4.93 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.516 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -124.99 163.59 22.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.339 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.48 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 9.3 p90 -90.88 157.33 17.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.03 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.03 127.02 48.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.763 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -132.28 112.75 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.5 mt -89.94 96.94 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . 0.443 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 28.1 p -89.38 -174.32 4.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -58.13 165.69 2.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.98 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -85.4 99.07 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.842 2.362 . . . . 0.0 112.604 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.61 32.65 1.56 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.636 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 28' ' ' MET . 3.4 m-30 -99.82 -177.76 3.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.816 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.99 -175.02 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.173 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.26 -169.15 32.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.587 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.88 -52.12 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 0.0 110.872 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.48 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 2.0 m-85 -99.06 28.3 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.638 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.1 m 54.52 32.75 17.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.605 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.725 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -102.47 30.07 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.037 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.725 HD13 ' O ' ' A' ' 37' ' ' GLU . 24.8 mm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.188 179.98 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.866 0.365 . . . . 0.0 110.941 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 69.0 m -90.0 106.15 18.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 28.8 mm -122.45 -68.42 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.479 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 t -109.25 51.53 0.74 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.091 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 59.4 t-20 46.55 87.74 0.11 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.464 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 11.8 Cg_endo -56.54 -34.46 95.22 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.451 2.1 . . . . 0.0 112.192 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.671 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 1.8 m -58.2 173.62 0.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.98 29.29 2.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.232 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -149.01 19.76 0.98 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.54 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.05 63.83 0.3 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.245 0.545 . . . . 0.0 110.139 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.766 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -109.17 171.65 7.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.313 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.1 m -89.92 145.42 25.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.928 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.48 124.94 50.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.598 HD23 HD11 ' A' ' 26' ' ' ILE . 3.4 mm? -117.48 153.68 32.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.62 92.26 3.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -121.05 -57.32 1.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.806 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 21' ' ' GLY . 4.0 mt -98.3 160.37 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.939 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.506 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -49.81 -26.03 7.72 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.745 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . 0.494 ' OE2' HG21 ' A' ' 20' ' ' ILE . 1.2 pt-20 -89.89 -176.23 4.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.911 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -89.86 131.0 36.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -116.03 90.37 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.2 t -94.93 129.93 41.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.766 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 21.0 mt -89.93 121.17 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.024 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.81 172.61 9.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.017 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.408 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -74.44 171.27 11.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.816 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.9 Cg_endo -75.34 68.86 5.95 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.532 2.154 . . . . 0.0 112.338 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.97 41.85 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.469 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -108.98 -174.69 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.811 0.338 . . . . 0.0 110.821 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 -163.61 1.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.42 171.47 26.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.563 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.95 -36.63 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.871 0.367 . . . . 0.0 111.165 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.2 m-85 -111.94 31.15 6.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 90.1 m 51.77 78.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.715 ' O ' HD13 ' A' ' 38' ' ' ILE . 4.7 tp10 -155.88 27.39 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.715 HD13 ' O ' ' A' ' 37' ' ' GLU . 22.9 mm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.187 179.948 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.877 0.37 . . . . 0.0 110.893 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.0 t -124.36 79.4 1.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.0 mm -101.8 -66.06 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.264 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 t -106.39 56.71 0.66 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.946 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 57.22 95.78 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.44 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 28.4 Cg_endo -63.72 -36.87 49.51 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.425 2.083 . . . . 0.0 112.399 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 16.6 m -59.26 163.42 3.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.93 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.49 -27.47 7.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.525 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -90.01 11.57 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.768 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t0 72.59 66.38 0.12 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.029 0.442 . . . . 0.0 110.325 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.859 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -106.67 -175.92 2.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.374 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 16' ' ' CYS . 86.8 m -96.49 161.68 13.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.448 ' N ' HG22 ' A' ' 15' ' ' THR . 8.2 t -130.97 137.04 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -126.07 3.41 7.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.463 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 59.24 161.3 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.92 0.39 . . . . 0.0 110.835 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.75 -178.28 6.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 pt -89.88 89.98 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.06 -28.39 15.91 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.494 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -127.56 174.87 8.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.432 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 24.9 p90 -90.01 148.1 23.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -123.79 81.55 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 t -93.98 128.38 40.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.859 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 27.4 mt -92.84 116.06 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.074 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 t -86.25 163.17 17.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.829 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.4 169.84 0.22 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.053 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.53 102.42 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.637 2.225 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.9 34.21 5.26 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.556 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -108.5 -175.49 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -149.4 174.45 12.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.58 173.64 21.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.427 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.0 t -90.09 -49.5 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 111.06 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.7 m-85 -105.36 34.33 3.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.868 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.2 t 49.18 94.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.988 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -169.94 -39.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.2 mm . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.071 -179.948 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 . . . . . 0 C--O 1.23 0.079 0 CA-C-O 120.761 0.315 . . . . 0.0 110.954 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 47.7 t -114.84 85.32 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.025 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.7 mm -111.04 -66.11 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.7 t -107.99 55.8 0.64 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 57.83 91.08 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 23.7 Cg_endo -62.39 -29.45 79.35 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.554 2.169 . . . . 0.0 112.373 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.872 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 11.4 m -62.69 163.58 8.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.731 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.65 -30.53 6.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.535 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -90.91 13.41 16.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.831 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 t0 73.76 56.4 0.1 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.082 0.468 . . . . 0.0 110.548 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.872 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -93.7 175.79 6.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.185 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.8 m -89.94 139.56 30.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.1 t -123.44 108.26 12.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 17' ' ' LEU . 29.9 mt -99.94 154.37 18.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.22 89.75 3.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -130.42 -46.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 21' ' ' GLY . 22.0 mt -98.24 160.42 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.057 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -51.51 -25.99 14.55 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.679 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -100.18 177.1 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.772 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -89.99 147.74 23.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.23 99.62 6.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.555 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 49.5 t -97.38 111.1 23.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.503 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 20.2 mt -89.95 101.9 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.923 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.05 173.24 12.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.989 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.47 171.01 0.43 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.973 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.25 95.18 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.642 2.228 . . . . 0.0 112.509 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.47 46.41 1.68 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.607 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -114.87 -174.49 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.34 -167.52 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.16 168.25 40.3 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.01 -43.96 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.795 0.331 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.5 m-85 -108.27 35.2 3.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.855 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 53.8 t 54.85 89.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.831 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -171.97 -39.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 mm . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.125 179.984 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 . . . . . 0 CA--C 1.527 0.069 0 CA-C-O 120.747 0.308 . . . . 0.0 110.845 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.13 77.43 1.31 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.912 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.1 mm -102.93 -67.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.2 t -110.82 55.59 0.65 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 57.56 91.96 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.96 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 33.9 Cg_endo -64.94 -38.62 28.35 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.489 2.126 . . . . 0.0 112.207 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 11.7 m -57.92 134.18 56.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.721 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 20.4 mm-40 -97.58 34.49 1.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.342 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -149.37 13.83 0.86 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 70.53 55.86 0.27 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.136 0.493 . . . . 0.0 110.435 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.786 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -99.46 -179.7 4.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.267 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.8 m -98.58 157.28 16.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -129.81 140.62 50.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.969 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.736 HD12 ' OE1' ' A' ' 19' ' ' GLN . 0.4 OUTLIER -130.64 88.12 2.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.767 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.55 85.67 2.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.98 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.736 ' OE1' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -110.64 -32.79 6.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.763 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 21' ' ' GLY . 1.6 mp -117.34 163.45 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.835 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -46.95 -28.51 3.97 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.729 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -90.92 168.96 11.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.759 0.314 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -90.6 138.25 31.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.98 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -126.38 88.25 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.838 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.36 127.05 36.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.786 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 31.2 mt -89.96 116.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.4 m -71.66 178.02 3.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.048 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.57 169.56 15.2 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.77 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -73.23 64.41 4.34 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.499 2.133 . . . . 0.0 112.295 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.47 41.61 0.22 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.54 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -114.56 -175.14 2.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.82 0.343 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -150.15 -177.94 6.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.81 -175.55 25.41 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.592 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.91 -54.8 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.393 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 4.3 m-85 -98.22 29.6 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.795 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.2 m 54.46 30.39 12.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.016 0.436 . . . . 0.0 110.435 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 4.1 pt-20 -99.34 23.29 9.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.254 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 37' ' ' GLU . 18.5 mm . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 . . . . . 0 C--O 1.231 0.125 0 CA-C-O 120.733 0.301 . . . . 0.0 110.878 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.49 97.15 7.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.995 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.3 mm -109.92 -69.16 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.907 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 t -114.37 54.9 0.75 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.772 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 56.01 88.61 0.12 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.027 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.01 -37.24 78.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.54 2.16 . . . . 0.0 112.349 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.484 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 7.8 m -58.83 171.39 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.77 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 2.1 mm-40 -130.43 30.59 4.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.051 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -145.32 16.28 1.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.593 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 t0 69.37 48.11 0.66 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.158 0.504 . . . . 0.0 110.103 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.739 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -89.9 174.34 7.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.511 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 16' ' ' CYS . 96.3 m -89.9 162.11 15.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.457 ' N ' HG22 ' A' ' 15' ' ' THR . 51.4 t -135.84 156.09 49.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.561 HD12 ' HG3' ' A' ' 19' ' ' GLN . 0.3 OUTLIER -138.03 -47.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t0 56.05 103.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.043 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.561 ' HG3' HD12 ' A' ' 17' ' ' LEU . 1.8 mt-30 -133.38 -46.57 0.83 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.586 HG22 ' H ' ' A' ' 21' ' ' GLY . 1.9 mm -95.41 174.02 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.784 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.586 ' H ' HG22 ' A' ' 20' ' ' ILE . . . -47.97 -27.36 4.96 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.657 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -96.26 172.39 7.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.337 . . . . 0.0 110.823 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.491 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 52.8 p90 -92.19 133.0 36.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.07 93.16 4.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 44.1 t -104.51 120.03 40.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.946 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.739 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 29.4 mt -89.94 126.04 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.017 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.7 p -113.14 -174.87 2.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.03 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.452 ' CB ' ' CE1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.58 163.14 2.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.6 100.16 0.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.815 2.343 . . . . 0.0 112.522 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.9 23.64 3.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.798 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.452 ' CE1' ' CB ' ' A' ' 28' ' ' MET . 3.2 m-85 -94.8 179.71 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.748 0.309 . . . . 0.0 110.82 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -150.22 -177.31 5.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.46 -174.3 23.71 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.632 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 t -89.84 -32.27 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 110.794 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.491 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 5.8 m-85 -121.11 26.73 8.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.682 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m 53.85 32.88 15.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.726 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.595 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -97.64 31.47 2.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.028 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.595 HD13 ' O ' ' A' ' 37' ' ' GLU . 23.6 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.118 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.92 0.39 . . . . 0.0 110.875 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.0 t -142.46 102.91 4.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.963 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.6 mm -121.99 -66.9 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t -110.42 55.41 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.963 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 57.09 94.49 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 26.5 Cg_endo -62.99 -38.22 48.16 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.358 2.039 . . . . 0.0 112.257 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.763 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 6.4 m -58.1 143.85 42.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.744 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 2.7 mm-40 -107.43 30.19 6.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.343 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -147.0 15.26 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 t70 71.09 60.4 0.18 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.123 0.487 . . . . 0.0 110.508 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.875 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -110.26 177.42 4.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.205 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 16' ' ' CYS . 51.0 m -89.9 161.53 15.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.82 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.429 ' N ' HG22 ' A' ' 15' ' ' THR . 51.1 t -141.27 74.93 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.62 HD12 HD11 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -62.7 86.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.756 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.16 118.42 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.972 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -149.97 -47.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.496 HG22 ' N ' ' A' ' 21' ' ' GLY . 21.9 mm -92.14 161.52 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.953 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . 0.496 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -49.12 -26.86 6.57 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.726 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -95.19 165.82 12.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 110.797 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -89.97 130.22 36.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -119.4 95.0 4.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.949 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -94.2 128.31 40.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.782 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.875 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 19.7 mt -89.9 122.12 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.018 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.1 m -82.92 174.7 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.022 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.429 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -79.08 171.51 12.32 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.615 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 61.2 Cg_endo -72.4 80.16 1.69 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.391 2.061 . . . . 0.0 112.342 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.38 57.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.466 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -118.32 -174.28 2.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -142.22 -176.81 4.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.55 172.93 46.02 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.97 -49.08 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.1 m-85 -98.15 27.49 4.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.3 97.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 11' ' ' GLN . 5.3 tp10 -168.89 -38.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.826 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.7 mm . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.097 179.976 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 . . . . . 0 CA--C 1.527 0.058 0 CA-C-O 120.804 0.335 . . . . 0.0 111.156 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.604 ' O ' HD13 ' A' ' 6' ' ' ILE . 1.8 t -89.85 93.76 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.972 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 5' ' ' CYS . 21.4 mm -128.19 -65.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.166 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.1 t -99.35 53.32 0.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 52.74 89.61 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.14 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.88 -58.43 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.431 2.087 . . . . 0.0 112.213 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.756 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 5.7 m -50.1 132.21 23.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -96.28 30.94 2.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.543 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -149.21 12.8 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.5 t0 69.48 66.28 0.26 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.193 0.52 . . . . 0.0 110.351 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.817 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -109.92 179.19 4.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.32 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.6 m -90.0 140.13 29.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.692 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.1 t -134.42 92.44 2.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.825 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -71.35 124.08 23.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.953 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.17 112.32 3.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.29 161.09 23.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.5 mt -91.3 92.0 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.23 -76.93 0.26 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.545 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -123.44 179.14 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.878 0.371 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -97.31 129.85 44.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.978 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -107.71 87.47 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.17 114.86 27.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.972 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.817 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 27.6 mt -89.94 122.67 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.998 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 164.9 19.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.067 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.03 171.39 1.55 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.809 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.37 79.69 3.1 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.553 2.169 . . . . 0.0 112.462 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.47 37.78 0.71 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.449 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -109.35 -175.16 2.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -144.78 -178.15 5.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.03 169.75 46.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.02 -47.93 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -99.74 27.98 5.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.9 m 54.1 100.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.972 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -174.54 -38.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.95 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.81 0.338 . . . . 0.0 110.816 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -137.49 77.46 1.64 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.802 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.0 mm -108.98 -66.46 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.212 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.36 55.86 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 56.08 88.76 0.12 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 30.6 Cg_endo -64.61 -39.3 27.99 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.512 2.142 . . . . 0.0 112.277 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 4.3 m -70.05 150.84 46.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.74 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 20.3 mm-40 -118.46 27.94 8.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.34 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -146.83 15.14 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 72.11 50.26 0.22 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.135 0.493 . . . . 0.0 110.562 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.698 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -90.13 172.73 8.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.179 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.689 ' HB ' HD12 ' A' ' 26' ' ' ILE . 61.1 m -97.57 132.5 43.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.797 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 t -99.47 131.59 45.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.406 HD13 ' H ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -119.21 142.95 47.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.406 ' H ' HD13 ' A' ' 17' ' ' LEU . 1.5 m-20 -99.85 117.7 34.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.754 ' HB3' HD12 ' A' ' 20' ' ' ILE . 6.6 mt-30 -102.87 -77.88 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.754 HD12 ' HB3' ' A' ' 19' ' ' GLN . 3.8 mp -141.52 -66.47 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.186 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -140.11 28.38 2.49 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -141.36 171.31 14.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.41 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 52.1 p90 -102.58 136.75 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.987 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -117.05 92.78 3.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 52.0 t -89.98 119.74 30.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.692 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 26.3 mt -89.92 113.64 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.5 m -74.75 174.06 9.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.141 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.44 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -70.53 172.72 5.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.565 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 64.2 Cg_endo -73.1 66.78 4.2 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.343 2.028 . . . . 0.0 112.32 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.77 41.03 0.25 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.526 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 28' ' ' MET . 4.3 m-85 -113.8 -176.47 2.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.449 ' HG3' HG21 ' A' ' 38' ' ' ILE . 2.2 pt-20 -150.22 -177.95 6.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.14 -175.92 28.84 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.626 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 t -89.97 -54.09 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.456 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 10.3 m-85 -96.97 26.18 4.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.792 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 m 51.66 32.6 9.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.957 0.408 . . . . 0.0 110.586 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 1.9 pt-20 -99.06 29.85 3.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.109 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.449 HG21 ' HG3' ' A' ' 32' ' ' GLU . 23.8 mm . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.231 0.107 0 CA-C-O 120.824 0.345 . . . . 0.0 110.87 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.71 85.6 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.837 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.5 mm -94.89 -69.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.226 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t -116.05 55.17 0.8 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 55.16 91.3 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.48 -27.72 46.41 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.483 2.122 . . . . 0.0 112.381 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 14.2 m -55.43 135.69 50.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -102.2 32.52 3.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.192 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -146.43 14.14 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 t0 68.53 43.85 1.32 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.199 0.524 . . . . 0.0 110.218 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -89.95 178.82 6.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.411 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.0 m -99.25 145.51 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.808 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.3 t -106.67 137.6 44.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.712 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.444 ' HB2' HD11 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -133.18 118.53 18.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -69.7 122.87 20.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.89 -76.57 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.9 mt -145.28 -46.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.167 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.64 -38.16 0.06 OUTLIER Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.844 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -89.79 178.63 6.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.388 . . . . 0.0 111.004 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -100.17 153.84 18.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.053 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -132.36 112.66 12.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.795 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -90.01 109.94 20.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.452 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 31.0 mt -99.44 90.88 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.827 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 p -97.32 -176.37 3.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.068 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.439 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -51.38 168.51 0.26 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.105 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD2' ' CG ' ' A' ' 28' ' ' MET . 86.9 Cg_endo -82.07 138.73 10.35 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.697 2.264 . . . . 0.0 112.448 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.82 24.06 62.97 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.714 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CE1' ' HB3' ' A' ' 28' ' ' MET . 2.6 m-85 -90.38 -176.37 4.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.726 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -150.09 -178.47 6.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.124 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.12 176.0 30.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.522 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.2 t -89.88 -48.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.996 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -100.38 28.91 4.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.799 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.2 m 58.85 51.95 6.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.875 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -113.86 -33.43 5.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.823 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.59 ' O ' HG22 ' A' ' 38' ' ' ILE . 28.7 mm . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.06 -179.996 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.759 0.314 . . . . 0.0 110.946 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.439 ' C ' HD12 ' A' ' 6' ' ' ILE . 12.6 t -100.11 83.28 2.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.053 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 6' ' ' ILE . 1.7 mp -102.09 -75.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.808 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -107.97 55.91 0.64 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.809 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 59.15 90.26 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.31 -38.31 81.93 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.581 2.187 . . . . 0.0 112.313 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 4.6 m -57.13 168.21 0.74 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.823 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 1.6 mm-40 -127.99 27.26 5.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.285 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -146.13 17.19 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.518 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 69.71 52.65 0.42 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.305 0.574 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.738 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -97.53 176.55 5.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.256 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.0 m -90.03 149.85 22.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.816 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.0 t -125.89 139.15 53.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -126.34 126.16 43.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -65.02 137.54 57.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . 0.464 ' OE1' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -149.48 163.54 37.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.991 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.464 HD12 ' OE1' ' A' ' 19' ' ' GLN . 2.6 mp -90.36 90.21 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.176 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.41 -82.19 0.23 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.518 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -113.31 178.02 4.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.85 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.472 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 54.8 p90 -89.96 142.33 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.999 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -109.39 96.77 6.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -106.29 119.16 38.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.667 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 29.8 mt -90.06 116.57 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.4 m -73.56 178.48 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.045 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.449 ' CB ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -75.66 170.79 14.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.45 72.6 4.86 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.526 2.151 . . . . 0.0 112.475 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.37 38.78 0.47 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.621 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.449 ' CD1' ' CB ' ' A' ' 28' ' ' MET . 4.9 m-85 -112.16 -175.95 2.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -150.04 179.23 8.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.8 -177.7 29.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.03 -50.54 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.472 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 6.3 m-85 -98.21 28.69 3.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.2 m 54.12 30.73 12.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.968 0.413 . . . . 0.0 110.753 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 15.1 pt-20 -100.56 -23.66 14.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.212 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 mm . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.08 -179.942 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.583 0.23 . . . . 0.0 111.435 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.3 m -89.91 73.84 7.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.3 mm -101.59 -67.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.226 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.64 53.57 0.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.016 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 49.44 91.72 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.29 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.96 -39.36 41.05 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.519 2.146 . . . . 0.0 112.221 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.739 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 1.9 m -49.5 151.37 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 7.3 mm-40 -114.08 32.07 6.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.31 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -149.6 17.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t0 69.98 57.91 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.197 0.522 . . . . 0.0 110.482 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.859 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -108.1 -175.6 2.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.251 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 16' ' ' CYS . 89.4 m -105.57 160.62 15.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.054 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . 0.416 ' N ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -122.01 148.41 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.781 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 18' ' ' ASP . 0.3 OUTLIER -142.98 159.68 41.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.414 ' H ' HD23 ' A' ' 17' ' ' LEU . 1.4 t70 -113.29 158.66 20.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.86 -77.03 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.93 -67.43 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.089 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.32 26.96 1.39 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.399 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.33 -178.98 5.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 0.0 110.968 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -106.53 137.26 44.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -124.93 94.95 4.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.644 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.94 130.54 36.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.859 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 29.1 mt -89.91 122.87 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.987 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -84.36 -176.1 6.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.048 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.425 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -84.75 172.1 9.65 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.611 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.9 Cg_endo -74.17 75.46 3.29 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.403 2.069 . . . . 0.0 112.356 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.98 38.57 0.56 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.557 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -112.95 -176.21 2.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -150.1 -177.26 5.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.36 174.03 41.84 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.491 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 t -89.96 -53.4 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.82 0.343 . . . . 0.0 110.954 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -97.81 25.62 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.815 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.17 100.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.934 0.397 . . . . 0.0 111.068 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 11' ' ' GLN . 3.9 tp10 -173.84 -33.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.976 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.1 mm . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.979 -179.941 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.119 0 CA-C-O 120.812 0.339 . . . . 0.0 110.997 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.51 ' C ' HD12 ' A' ' 6' ' ' ILE . 1.2 m -106.72 90.24 3.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 6' ' ' ILE . 1.6 mp -106.14 -77.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.941 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.9 53.97 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 53.4 86.3 0.17 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.169 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . 0.467 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 17.4 Cg_endo -58.9 -37.39 93.88 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.529 2.152 . . . . 0.0 112.249 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 1.3 m -56.97 177.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.925 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -134.95 28.14 3.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.251 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -146.36 15.75 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.716 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 70.23 49.68 0.45 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.085 0.469 . . . . 0.0 110.209 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.814 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -89.97 175.1 7.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.203 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.7 m -90.04 154.22 19.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -112.9 131.07 55.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.743 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 112.58 6.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -80.57 151.05 29.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -118.75 -80.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 mt -129.2 -68.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.28 -37.45 0.6 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.546 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.87 172.48 8.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -97.64 162.87 13.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.014 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -147.74 96.46 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.817 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.8 t -90.08 131.06 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.028 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.814 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 28.9 mt -91.88 118.52 37.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.001 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -100.2 161.39 13.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.976 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.406 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -60.67 171.69 0.99 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.835 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.73 127.22 7.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.656 2.237 . . . . 0.0 112.424 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.96 31.24 39.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.51 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.406 ' CD1' ' HB3' ' A' ' 28' ' ' MET . 5.2 m-85 -106.68 -174.88 2.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.816 0.341 . . . . 0.0 110.885 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -147.09 -176.98 5.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.59 164.92 38.32 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.456 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 t -89.94 -30.19 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 111.042 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.7 m-85 -118.12 35.98 4.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.3 t 49.84 84.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -157.31 -42.62 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.681 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.78 0.324 . . . . 0.0 110.916 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.403 ' C ' HD12 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -150.12 71.11 1.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.843 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 6' ' ' ILE . 1.7 mp -99.67 -77.74 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.046 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 t -93.37 55.49 2.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.076 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 53.06 92.93 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.999 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.67 -46.17 9.62 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.504 2.136 . . . . 0.0 112.243 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.796 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 9.6 m -59.88 161.45 6.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.621 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.87 28.96 4.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.188 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -149.18 18.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.511 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t70 71.83 50.43 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.17 0.509 . . . . 0.0 110.465 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.796 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -90.17 171.62 9.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.174 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.497 ' HB ' HD12 ' A' ' 26' ' ' ILE . 96.9 m -94.93 136.65 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.8 t -113.46 118.81 35.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.95 132.84 53.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -60.56 122.28 14.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -165.81 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pt -94.23 23.81 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.633 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.93 -37.78 0.87 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.675 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -100.06 177.33 5.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 110.894 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 44.3 p90 -102.14 146.63 27.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.02 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -116.76 92.01 3.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.002 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.96 113.53 25.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.813 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.58 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 18.0 mt -89.92 119.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.989 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.7 172.8 8.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.048 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.44 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -72.51 172.36 7.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.791 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 28' ' ' MET . 71.7 Cg_endo -76.47 62.56 7.05 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.499 2.133 . . . . 0.0 112.254 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.57 43.11 0.1 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.467 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 28' ' ' MET . 2.6 m-85 -109.93 -175.37 2.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -144.37 175.71 9.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.55 166.25 37.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.16 -33.82 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 0.0 111.159 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 17.4 m-85 -113.54 33.29 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.8 m 49.82 88.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -162.62 -43.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.9 mm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.071 179.999 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.834 0.349 . . . . 0.0 110.872 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' CYS . . . . . 0.67 ' C ' HD12 ' A' ' 6' ' ' ILE . 21.1 t -143.81 80.17 1.65 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . 0.67 HD12 ' C ' ' A' ' 5' ' ' CYS . 1.6 mp -114.81 -76.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.69 55.34 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 53.44 90.05 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.066 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.6 -37.52 87.79 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.674 2.25 . . . . 0.0 112.323 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' CYS . . . . . 0.849 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 20.1 m -59.45 169.6 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.905 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -131.26 26.75 4.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -149.88 18.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.563 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t0 70.61 48.95 0.42 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.126 0.488 . . . . 0.0 110.275 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.849 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -89.92 168.7 11.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.238 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' THR . . . . . 0.543 ' HB ' HD12 ' A' ' 26' ' ' ILE . 97.2 m -89.89 133.93 34.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.6 t -104.15 143.33 33.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.908 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -142.45 132.98 25.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ASP . . . . . 0.518 ' N ' HD13 ' A' ' 17' ' ' LEU . 29.5 t0 -126.81 129.87 49.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -124.88 -62.15 1.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.6 mt -93.87 -67.73 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.108 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.12 33.29 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.494 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -135.1 158.01 45.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.494 ' CE2' ' CE1' ' A' ' 35' ' ' TYR . 51.1 p90 -95.05 123.23 38.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -105.21 102.6 12.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 42.6 t -90.03 128.39 36.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.069 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . 0.543 HD12 ' HB ' ' A' ' 15' ' ' THR . 21.2 mt -106.87 106.7 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.808 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.07 161.24 18.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.113 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.412 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -58.67 172.78 0.48 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.941 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 28' ' ' MET . 87.1 Cg_endo -78.05 119.32 4.64 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.536 2.157 . . . . 0.0 112.306 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.12 20.59 35.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.441 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -100.56 -177.04 3.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 110.734 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.07 -177.02 5.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.4 169.16 31.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.38 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.06 -36.05 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 111.145 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' TYR . . . . . 0.494 ' CE1' ' CE2' ' A' ' 23' ' ' PHE . 3.8 m-85 -111.1 26.27 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.988 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 37.8 t 51.66 92.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -162.29 -37.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.998 -179.837 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 10.9 p-10 . . . . . 0 C--O 1.231 0.084 0 CA-C-O 120.795 0.331 . . . . 0.0 110.889 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t 63.24 145.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.058 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.535 ' HB2' HD11 ' A' ' 6' ' ' ILE . 67.8 m-20 -114.73 -177.0 3.02 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.923 179.974 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -111.51 -34.09 6.19 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.907 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 48.9 t -99.88 84.83 2.96 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.992 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.535 HD11 ' HB2' ' A' ' 3' ' ' ASN . 20.1 mm -102.71 -66.81 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.224 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.5 t -109.02 56.02 0.62 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.927 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 56.93 90.88 0.08 OUTLIER Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.836 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.449 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 17.8 Cg_endo -60.62 -32.45 93.35 Favored 'Trans proline' 0 C--N 1.345 0.394 0 C-N-CA 122.486 2.124 . . . . 0.0 112.287 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 13.1 m -60.61 154.59 20.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.728 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.4 mm-40 -123.17 32.24 5.74 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.328 -0.396 . . . . 0.0 111.214 -179.641 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.8 m-20 -150.0 20.05 0.88 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.572 -0.285 . . . . 0.0 111.596 -179.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.6 t0 70.66 43.62 0.73 Allowed 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.106 0.479 . . . . 0.0 110.381 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.656 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -92.66 164.92 13.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.642 -0.708 . . . . 0.0 111.255 -179.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 95.3 m -89.99 130.85 36.13 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.75 -179.955 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 9.5 t -97.61 132.23 43.46 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.918 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.653 HD12 HD11 ' A' ' 26' ' ' ILE . 2.9 mt -121.07 -170.47 2.02 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -98.5 146.51 25.7 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.16 -179.16 6.54 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.88 179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 2.4 pt -89.9 99.41 9.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.467 . . . . 0.0 111.093 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 58.7 21.54 50.9 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.719 -0.753 . . . . 0.0 112.674 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -148.01 -179.39 6.88 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.869 0.366 . . . . 0.0 110.887 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.5 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 39.2 p90 -104.63 157.51 17.13 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.039 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -122.13 88.02 2.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.839 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -89.93 108.33 19.65 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.869 -179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.656 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 27.1 mt -90.97 96.09 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-N 116.174 -0.466 . . . . 0.0 111.073 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 12.3 m -70.95 175.29 5.23 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.132 -179.877 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.408 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -70.09 171.6 7.28 Favored Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.909 179.929 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.3 Cg_endo -76.02 101.4 1.49 Allowed 'Trans proline' 0 C--N 1.345 0.368 0 C-N-CA 122.501 2.134 . . . . 0.0 112.353 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.19 26.64 6.53 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.479 -179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -104.15 -175.48 2.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.881 0.372 . . . . 0.0 110.863 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.8 mt-10 -146.12 178.57 8.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.868 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 97.21 165.9 32.54 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.744 -0.741 . . . . 0.0 112.522 -179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.01 -43.57 14.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.836 0.35 . . . . 0.0 111.117 179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.5 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 1.9 m-85 -101.04 28.51 5.25 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.937 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 83.8 m 52.86 80.63 0.1 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.952 -179.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -152.41 -44.45 0.1 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.178 -0.465 . . . . 0.0 110.933 -179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.093 179.987 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 20.3 m-20 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.879 0.371 . . . . 0.0 110.898 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.639 HG22 HD13 ' A' ' 6' ' ' ILE . 7.5 p -136.36 76.85 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.066 -179.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 56.8 m-20 -115.56 -37.25 4.03 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.967 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -90.04 -36.28 15.0 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.88 -179.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -99.79 79.57 2.24 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.881 179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.639 HD13 HG22 ' A' ' 2' ' ' VAL . 21.5 mm -102.51 -67.13 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.196 -0.457 . . . . 0.0 111.293 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.6 t -108.85 54.56 0.65 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.033 -0.53 . . . . 0.0 110.93 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.403 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 55.3 t-20 53.69 93.06 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.002 179.836 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 18.1 Cg_endo -60.45 -32.49 93.85 Favored 'Trans proline' 0 C--N 1.346 0.437 0 C-N-CA 122.487 2.124 . . . . 0.0 112.219 -179.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.881 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 10.3 m -64.78 162.53 15.88 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.342 -0.39 . . . . 0.0 110.79 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -113.59 -29.71 7.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.448 -179.353 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 25.7 m-20 -90.04 12.07 18.79 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.709 -179.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 74.12 56.35 0.09 Allowed 'General case' 0 C--O 1.232 0.174 0 CA-C-O 121.198 0.523 . . . . 0.0 110.546 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.881 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -93.0 169.72 10.21 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.749 -0.66 . . . . 0.0 111.172 -179.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 96.3 m -89.95 145.57 25.02 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.897 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.4 t -105.39 135.53 46.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.9 -179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 3.8 tp -127.3 141.0 51.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.908 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -96.81 155.89 16.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.948 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -137.87 -77.3 0.38 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.005 0.431 . . . . 0.0 110.983 179.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 28.1 mt -146.69 -46.64 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.098 -0.501 . . . . 0.0 111.162 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -161.23 28.63 0.3 Allowed Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.843 -0.694 . . . . 0.0 112.47 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 mt-10 -141.85 160.04 41.01 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.823 0.344 . . . . 0.0 110.858 -179.968 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 55.7 p90 -96.51 147.38 23.91 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.981 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.09 118.33 20.38 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.82 179.959 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.547 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 50.9 t -105.99 114.37 28.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.939 -179.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.622 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 33.3 mt -89.98 105.25 15.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.948 179.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.7 t -86.4 166.36 15.62 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.078 -179.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -60.09 172.51 0.71 Allowed Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.935 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -77.89 109.59 2.75 Favored 'Trans proline' 0 C--N 1.345 0.366 0 C-N-CA 122.618 2.212 . . . . 0.0 112.387 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.48 24.05 10.52 Favored Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.766 -0.731 . . . . 0.0 112.485 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -100.54 -176.07 3.09 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.765 0.317 . . . . 0.0 110.838 -179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -149.93 -176.99 5.65 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.924 -179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 96.9 173.07 34.56 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.791 -0.718 . . . . 0.0 112.526 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.5 t -90.01 -51.36 12.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.809 0.338 . . . . 0.0 111.083 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 18.0 m-85 -98.42 30.04 3.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.789 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 53.7 t 57.55 70.09 0.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.224 -0.443 . . . . 0.0 110.866 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.709 ' O ' HD13 ' A' ' 38' ' ' ILE . 4.2 tp10 -154.82 26.16 0.44 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.978 -179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.709 HD13 ' O ' ' A' ' 37' ' ' GLU . 22.0 mm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.095 179.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.571 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.3 p30 . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.82 0.343 . . . . 0.0 110.892 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -138.08 143.36 33.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.03 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 8.4 m-20 -95.47 151.19 19.52 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.849 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -111.0 -24.71 10.2 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 111.145 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 7.5 t -89.92 84.25 6.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.886 0.374 . . . . 0.0 110.992 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.8 mm -107.73 -66.77 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.126 179.832 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 22.8 t -109.4 55.6 0.63 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.795 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 58.42 88.62 0.12 Allowed Pre-proline 0 C--N 1.329 -0.306 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.903 -179.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -62.77 -38.78 46.8 Favored 'Trans proline' 0 C--N 1.345 0.38 0 C-N-CA 122.47 2.113 . . . . 0.0 112.229 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 8.8 m -57.47 151.0 17.47 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.648 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 -118.71 29.67 7.6 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.506 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.4 m-20 -150.06 17.48 0.86 Allowed 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 111.76 0.281 . . . . 0.0 111.76 -179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 22.3 t0 71.15 60.17 0.18 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.14 0.495 . . . . 0.0 110.447 179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.71 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -105.43 166.83 10.15 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.733 -0.667 . . . . 0.0 111.251 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.478 HG22 HD12 ' A' ' 17' ' ' LEU . 65.2 m -90.02 132.06 35.57 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.739 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 24' ' ' GLN . 53.4 t -102.83 127.58 49.95 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.195 -0.457 . . . . 0.0 111.026 -179.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.478 HD12 HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -129.89 -171.83 2.62 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.889 -179.978 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -141.64 164.34 30.46 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.864 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.49 -50.7 0.42 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.9 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.3 mt -144.8 -66.99 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 115.984 -0.553 . . . . 0.0 111.181 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -152.12 26.44 0.9 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.877 -0.677 . . . . 0.0 112.528 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 2.9 mm-40 -128.0 170.73 12.55 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.744 0.307 . . . . 0.0 110.882 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.421 ' CE2' ' CE1' ' A' ' 35' ' ' TYR . 48.0 p90 -98.43 137.26 37.38 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.029 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . 0.4 ' O ' ' HA ' ' A' ' 16' ' ' CYS . 0.0 OUTLIER -115.36 146.22 41.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.78 179.957 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.469 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 52.2 t -141.45 115.98 9.58 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.716 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.675 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 27.7 mt -89.88 114.24 27.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.037 -179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -84.03 169.84 14.54 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.006 -179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.42 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -74.54 172.51 8.62 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.721 179.842 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.42 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 73.3 Cg_endo -75.36 81.61 2.25 Favored 'Trans proline' 0 C--N 1.344 0.315 0 C-N-CA 122.475 2.116 . . . . 0.0 112.354 -179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 118.94 38.47 0.75 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.811 -0.709 . . . . 0.0 112.464 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -107.44 -176.1 2.97 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.806 0.336 . . . . 0.0 110.91 -179.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.9 mm-40 -149.11 177.84 9.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.837 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.86 170.79 41.78 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.501 179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.95 -48.52 14.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 120.823 0.344 . . . . 0.0 111.085 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.421 ' CE1' ' CE2' ' A' ' 23' ' ' PHE . 2.3 m-85 -98.33 30.0 3.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.891 179.916 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 47.8 m 53.14 93.16 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.938 -179.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -170.42 -39.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.103 -0.498 . . . . 0.0 110.857 -179.88 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.9 mm . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.345 -0.388 . . . . 0.0 111.076 -179.988 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 23.5 m-20 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.792 0.329 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t -133.63 143.15 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.041 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 18.5 m-20 -130.07 -46.12 1.13 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.858 -179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.2 mp0 -139.56 -67.42 0.44 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.912 -179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.5 t -138.57 87.7 2.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.954 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 24.1 mm -116.29 -67.29 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.244 -0.434 . . . . 0.0 111.214 -179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.2 t -108.45 55.26 0.64 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.917 -179.937 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 54.2 t-20 53.71 87.06 0.15 Allowed Pre-proline 0 C--N 1.331 -0.235 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.944 179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.88 -26.64 75.15 Favored 'Trans proline' 0 C--N 1.344 0.325 0 C-N-CA 122.549 2.166 . . . . 0.0 112.347 -179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.81 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 12.5 m -59.99 171.5 0.95 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.806 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -136.07 28.88 3.13 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.176 -0.466 . . . . 0.0 111.04 -179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -149.54 19.69 0.93 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.443 -0.344 . . . . 0.0 111.455 -179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 72.63 43.19 0.47 Allowed 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.092 0.472 . . . . 0.0 110.544 -179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.81 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -89.98 170.62 10.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.734 -0.666 . . . . 0.0 111.125 -179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.698 ' HB ' HD12 ' A' ' 26' ' ' ILE . 96.9 m -99.95 153.67 18.99 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.015 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 3.8 t -103.94 127.45 51.47 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.828 179.956 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.568 ' HB2' HD11 ' A' ' 26' ' ' ILE . 1.5 tp -121.04 81.49 1.78 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.926 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -58.75 127.54 32.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.884 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.645 ' HB3' HD12 ' A' ' 20' ' ' ILE . 2.4 mm-40 -108.28 -52.35 2.77 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.08 -179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.645 HD12 ' HB3' ' A' ' 19' ' ' GLN . 4.2 mp -140.99 -75.71 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.343 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -131.82 -19.32 1.16 Allowed Glycine 0 CA--C 1.52 0.352 0 C-N-CA 120.671 -0.776 . . . . 0.0 113.142 -179.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -89.91 179.61 5.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.972 0.415 . . . . 0.0 111.034 -179.705 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.501 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 54.3 p90 -110.49 133.45 53.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.965 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 16.0 mm100 -116.56 112.29 21.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.802 179.898 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.2 m -89.99 120.74 31.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.935 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.698 HD12 ' HB ' ' A' ' 15' ' ' THR . 34.2 mt -89.91 98.64 8.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.929 179.839 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -80.32 163.86 23.6 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.031 -0.532 . . . . 0.0 111.132 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.406 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -60.75 172.02 0.93 Allowed Pre-proline 0 C--N 1.328 -0.346 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.74 179.84 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.406 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.3 Cg_endo -76.08 72.88 5.13 Favored 'Trans proline' 0 C--N 1.345 0.373 0 C-N-CA 122.484 2.123 . . . . 0.0 112.334 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.57 40.08 0.31 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.486 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -108.67 -175.75 2.86 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.747 0.308 . . . . 0.0 110.89 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -148.16 173.96 12.45 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.036 -179.96 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 104.53 166.82 24.54 Favored Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.688 -0.768 . . . . 0.0 112.58 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 20.8 t -89.93 -47.42 14.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 111.022 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.501 ' CE1' ' CE1' ' A' ' 23' ' ' PHE . 2.4 m-85 -101.69 28.57 5.5 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.89 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 2.6 m 55.53 92.42 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.922 -179.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -169.49 -41.04 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.961 -179.737 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 27.2 mm . . . . . 0 C--N 1.328 -0.34 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.093 -179.992 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.529 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.12 0 CA-C-O 120.754 0.312 . . . . 0.0 110.851 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.6 t -129.72 129.54 66.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.18 -0.464 . . . . 0.0 111.074 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 54.8 t30 -107.26 118.82 37.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.02 179.926 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.95 -79.27 0.55 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.24 -0.437 . . . . 0.0 110.874 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.31 79.18 1.65 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.909 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 19.0 mm -108.09 -65.97 1.37 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.191 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.9 t -108.3 54.44 0.66 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.821 -179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.7 t-20 53.95 89.08 0.11 Allowed Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.099 179.867 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -62.93 -39.09 43.0 Favored 'Trans proline' 0 C--N 1.344 0.342 0 C-N-CA 122.436 2.091 . . . . 0.0 112.336 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.864 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 17.1 m -58.11 155.21 11.47 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.803 -179.864 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 3.3 mm100 -122.15 27.5 7.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.409 -179.399 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 m-20 -149.77 17.06 0.89 Allowed 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 111.709 0.263 . . . . 0.0 111.709 -179.771 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t70 72.19 59.92 0.14 Allowed 'General case' 0 C--N 1.332 -0.193 0 CA-C-O 121.107 0.48 . . . . 0.0 110.447 179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.864 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -101.57 165.26 11.33 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.732 -0.667 . . . . 0.0 111.218 -179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 55.4 m -89.96 136.46 33.03 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.745 179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -103.23 139.8 38.22 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.888 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -140.4 137.18 33.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.927 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -99.05 130.39 45.38 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.921 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 48.8 mt-30 -113.66 -78.08 0.58 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.978 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 24.2 mm -113.6 -66.7 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.155 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -158.04 27.77 0.45 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.774 -0.727 . . . . 0.0 112.409 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 72.2 mt-10 -127.66 176.38 7.56 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.848 0.356 . . . . 0.0 110.894 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 38.1 p90 -105.51 123.47 47.94 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.014 -179.99 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -107.6 118.09 35.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.879 179.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.421 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 52.5 t -110.06 114.07 27.28 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.994 -179.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.415 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 30.7 mt -89.94 100.17 10.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.972 179.672 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 2.6 t -81.12 165.69 21.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.043 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.438 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -60.56 170.73 1.24 Allowed Pre-proline 0 C--N 1.33 -0.267 0 CA-C-N 116.053 -0.522 . . . . 0.0 110.837 -179.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 90.4 Cg_endo -77.76 111.48 3.13 Favored 'Trans proline' 0 C--N 1.344 0.334 0 C-N-CA 122.663 2.242 . . . . 0.0 112.357 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 97.42 26.53 9.95 Favored Glycine 0 N--CA 1.451 -0.312 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.532 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.438 ' CD1' ' HB3' ' A' ' 28' ' ' MET . 7.4 m-85 -102.83 -175.86 2.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.784 0.326 . . . . 0.0 110.863 179.985 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -145.99 178.86 7.88 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.927 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.93 166.46 38.6 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.786 -0.721 . . . . 0.0 112.554 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 24.2 t -90.04 -41.49 13.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.776 0.322 . . . . 0.0 111.038 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 27.4 m-85 -100.75 29.79 4.34 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.894 -179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 48.4 t 49.24 85.83 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.053 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 56.9 tt0 -158.8 -43.9 0.06 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.892 -179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.65 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.774 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 6.9 p-10 . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.839 0.352 . . . . 0.0 110.888 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.3 t -148.54 95.39 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.205 -0.452 . . . . 0.0 111.082 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 75.1 m-20 -93.27 143.09 26.6 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.897 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 18.6 mm-40 -110.3 -23.8 11.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.142 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 16.0 t -89.84 86.89 6.76 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.836 0.351 . . . . 0.0 111.024 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.6 mm -110.87 -66.11 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.164 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 7.7 t -107.44 55.88 0.64 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.913 179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.427 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 51.1 t-20 58.52 96.33 0.04 OUTLIER Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.83 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.448 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 16.3 Cg_endo -58.34 -46.85 22.27 Favored 'Trans proline' 0 C--N 1.346 0.395 0 C-N-CA 122.421 2.081 . . . . 0.0 112.124 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.44 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 13.2 m -60.34 160.71 8.2 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.809 179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.473 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 2.7 mm-40 -123.99 36.83 4.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.038 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 56.4 m-20 -148.66 17.7 1.02 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.359 -0.382 . . . . 0.0 111.606 -179.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 21.2 t0 70.04 50.32 0.45 Allowed 'General case' 0 C--N 1.333 -0.134 0 CA-C-O 121.118 0.485 . . . . 0.0 110.298 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.443 ' HB1' ' HA ' ' A' ' 27' ' ' CYS . . . -101.11 175.44 5.59 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.611 -0.722 . . . . 0.0 111.281 -179.491 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 82.4 m -89.99 156.53 18.35 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.741 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 44.4 t -131.0 130.91 43.96 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.821 179.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.487 HD13 ' H ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -115.96 152.16 34.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.891 -179.95 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.487 ' H ' HD13 ' A' ' 17' ' ' LEU . 8.9 t70 -82.07 128.07 33.75 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.969 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -140.5 163.86 31.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.895 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.7 mp -95.78 132.88 38.79 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.19 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 85.36 -56.01 4.93 Favored Glycine 0 N--CA 1.449 -0.44 0 C-N-CA 120.768 -0.73 . . . . 0.0 112.516 179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.4 mt-10 -124.99 163.59 22.0 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.813 0.339 . . . . 0.0 110.892 179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.48 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 9.3 p90 -90.88 157.33 17.4 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.03 -179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.03 127.02 48.21 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.763 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.3 t -132.28 112.75 12.49 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.976 -179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 28.5 mt -89.94 96.94 6.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.186 -0.461 . . . . 0.0 110.917 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . 0.443 ' HA ' ' HB1' ' A' ' 14' ' ' ALA . 28.1 p -89.38 -174.32 4.34 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.079 -179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -58.13 165.69 2.55 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.98 179.994 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -85.4 99.07 0.65 Allowed 'Trans proline' 0 N--CA 1.46 -0.47 0 C-N-CA 122.842 2.362 . . . . 0.0 112.604 -179.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.61 32.65 1.56 Allowed Glycine 0 N--CA 1.453 -0.233 0 C-N-CA 120.618 -0.801 . . . . 0.0 112.636 179.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.442 ' CZ ' ' HB2' ' A' ' 28' ' ' MET . 3.4 m-30 -99.82 -177.76 3.65 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.736 0.303 . . . . 0.0 110.816 179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -149.99 -175.02 4.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.173 -179.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 91.26 -169.15 32.93 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.804 -0.713 . . . . 0.0 112.587 179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -89.88 -52.12 11.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.876 0.37 . . . . 0.0 110.872 179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.48 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 2.0 m-85 -99.06 28.3 4.51 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.638 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 3.1 m 54.52 32.75 17.47 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.605 -179.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.725 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -102.47 30.07 4.84 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.856 -0.611 . . . . 0.0 111.037 -179.638 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.725 HD13 ' O ' ' A' ' 37' ' ' GLU . 24.8 mm . . . . . 0 C--N 1.329 -0.283 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.188 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 . . . . . 0 C--O 1.231 0.105 0 CA-C-O 120.802 0.334 . . . . 0.0 110.918 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.595 HG12 HD12 ' A' ' 6' ' ' ILE . 30.8 m -132.99 150.26 32.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 0.0 111.161 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -113.22 -66.55 1.07 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.952 -179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 74.1 mm-40 -150.05 -54.83 0.16 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.941 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 69.0 m -90.0 106.15 18.29 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.059 -0.519 . . . . 0.0 110.858 179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.595 HD12 HG12 ' A' ' 2' ' ' VAL . 28.8 mm -122.45 -68.42 0.89 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.479 -179.947 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.8 t -109.25 51.53 0.74 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.093 -0.503 . . . . 0.0 111.091 -179.854 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.426 ' HA ' ' HD2' ' A' ' 9' ' ' PRO . 59.4 t-20 46.55 87.74 0.11 Allowed Pre-proline 0 C--N 1.327 -0.374 0 CA-C-N 115.954 -0.566 . . . . 0.0 111.464 179.78 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.443 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 11.8 Cg_endo -56.54 -34.46 95.22 Favored 'Trans proline' 0 C--N 1.346 0.422 0 C-N-CA 122.451 2.1 . . . . 0.0 112.192 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.671 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 1.8 m -58.2 173.62 0.34 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.85 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.98 29.29 2.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.232 -179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.9 m-20 -149.01 19.76 0.98 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.479 -0.328 . . . . 0.0 111.54 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 69.05 63.83 0.3 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.245 0.545 . . . . 0.0 110.139 -179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.766 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -109.17 171.65 7.31 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.626 -0.716 . . . . 0.0 111.313 -179.352 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 88.1 m -89.92 145.42 25.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.928 -179.929 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -117.48 124.94 50.01 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.252 -0.431 . . . . 0.0 110.78 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.598 HD23 HD11 ' A' ' 26' ' ' ILE . 3.4 mm? -117.48 153.68 32.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.947 179.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -116.62 92.26 3.82 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.916 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -121.05 -57.32 1.88 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.806 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.506 HG22 ' N ' ' A' ' 21' ' ' GLY . 4.0 mt -98.3 160.37 3.15 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.957 -0.565 . . . . 0.0 110.939 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.506 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -49.81 -26.03 7.72 Favored Glycine 0 C--N 1.331 0.301 0 C-N-CA 120.852 -0.689 . . . . 0.0 112.745 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . 0.494 ' OE2' HG21 ' A' ' 20' ' ' ILE . 1.2 pt-20 -89.89 -176.23 4.86 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.821 0.343 . . . . 0.0 110.911 179.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 45.8 p90 -89.86 131.0 36.01 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.927 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 22.9 tt0 -116.03 90.37 3.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.849 -179.96 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.2 t -94.93 129.93 41.76 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.831 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.766 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 21.0 mt -89.93 121.17 39.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.024 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -87.81 172.61 9.52 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.127 -0.488 . . . . 0.0 111.017 -179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.408 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -74.44 171.27 11.76 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.816 179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.408 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.9 Cg_endo -75.34 68.86 5.95 Favored 'Trans proline' 0 C--N 1.344 0.318 0 C-N-CA 122.532 2.154 . . . . 0.0 112.338 179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 128.97 41.85 0.25 Allowed Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.81 -0.709 . . . . 0.0 112.469 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -108.98 -174.69 2.57 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.811 0.338 . . . . 0.0 110.821 179.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -146.93 -163.61 1.8 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.87 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 74.42 171.47 26.18 Favored Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.704 -0.76 . . . . 0.0 112.563 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -89.95 -36.63 8.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.871 0.367 . . . . 0.0 111.165 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.443 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 2.2 m-85 -111.94 31.15 6.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.903 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 90.1 m 51.77 78.68 0.12 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.985 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.715 ' O ' HD13 ' A' ' 38' ' ' ILE . 4.7 tp10 -155.88 27.39 0.37 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.905 -179.852 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.715 HD13 ' O ' ' A' ' 37' ' ' GLU . 22.9 mm . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 111.187 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.3 t0 . . . . . 0 C--O 1.231 0.111 0 CA-C-O 120.715 0.293 . . . . 0.0 110.905 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 15.7 m -145.09 164.33 12.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.1 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 80.3 m-20 60.33 170.9 0.09 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.868 179.96 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.57 -78.15 0.59 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.893 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 42.0 t -124.36 79.4 1.74 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.91 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.0 mm -101.8 -66.06 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.264 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 34.1 t -106.39 56.71 0.66 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.946 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.2 t-20 57.22 95.78 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.941 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.44 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 28.4 Cg_endo -63.72 -36.87 49.51 Favored 'Trans proline' 0 C--N 1.346 0.433 0 C-N-CA 122.425 2.083 . . . . 0.0 112.399 -179.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 16.6 m -59.26 163.42 3.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.93 -179.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -113.49 -27.47 7.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.525 -179.255 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 44.2 m-20 -90.01 11.57 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.503 -0.317 . . . . 0.0 111.768 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 17.3 t0 72.59 66.38 0.12 Allowed 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 121.029 0.442 . . . . 0.0 110.325 -179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.859 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -106.67 -175.92 2.93 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.721 -0.672 . . . . 0.0 111.374 -179.412 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.448 HG22 ' N ' ' A' ' 16' ' ' CYS . 86.8 m -96.49 161.68 13.81 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.926 -179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.448 ' N ' HG22 ' A' ' 15' ' ' THR . 8.2 t -130.97 137.04 49.07 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.943 179.903 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.443 HD23 ' O ' ' A' ' 17' ' ' LEU . 0.4 OUTLIER -126.07 3.41 7.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.318 -0.401 . . . . 0.0 111.463 -179.935 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 9.8 t70 59.24 161.3 0.04 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.92 0.39 . . . . 0.0 110.835 179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.75 -178.28 6.02 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.864 -179.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.5 pt -89.88 89.98 3.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.129 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 100.06 -28.39 15.91 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.494 -179.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -127.56 174.87 8.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.857 0.361 . . . . 0.0 110.833 179.987 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.432 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 24.9 p90 -90.01 148.1 23.28 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.96 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 12.2 tt0 -123.79 81.55 1.92 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.916 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 2.0 t -93.98 128.38 40.28 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.835 -179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.859 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 27.4 mt -92.84 116.06 33.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.074 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.4 t -86.25 163.17 17.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.279 -0.419 . . . . 0.0 110.829 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -51.4 169.84 0.22 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.053 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.5 Cg_endo -78.53 102.42 1.55 Allowed 'Trans proline' 0 C--N 1.345 0.356 0 C-N-CA 122.637 2.225 . . . . 0.0 112.538 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.9 34.21 5.26 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.556 179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -108.5 -175.49 2.79 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.851 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -149.4 174.45 12.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.218 -0.447 . . . . 0.0 110.852 179.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 108.58 173.64 21.53 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.782 -0.723 . . . . 0.0 112.427 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 29.0 t -90.09 -49.5 13.69 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-O 120.791 0.329 . . . . 0.0 111.06 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.44 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.7 m-85 -105.36 34.33 3.29 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.868 179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 31.2 t 49.18 94.08 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.988 -179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -169.94 -39.06 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 0.0 110.915 -179.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.2 mm . . . . . 0 C--N 1.329 -0.287 0 CA-C-N 116.357 -0.383 . . . . 0.0 111.071 -179.948 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 24.6 t0 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.772 0.32 . . . . 0.0 110.859 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.442 ' O ' HG23 ' A' ' 2' ' ' VAL . 5.9 m -143.34 95.45 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.153 179.965 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 7.1 m-20 -176.62 141.49 0.39 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.844 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -109.3 31.26 5.88 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.954 -179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 47.7 t -114.84 85.32 2.23 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.025 179.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.7 mm -111.04 -66.11 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.089 179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 31.7 t -107.99 55.8 0.64 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.848 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 57.83 91.08 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.307 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.919 179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.444 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 23.7 Cg_endo -62.39 -29.45 79.35 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.554 2.169 . . . . 0.0 112.373 -179.907 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.872 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 11.4 m -62.69 163.58 8.98 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.335 -0.393 . . . . 0.0 110.731 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -113.65 -30.53 6.78 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.535 -179.342 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.9 m-20 -90.91 13.41 16.6 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.501 -0.318 . . . . 0.0 111.831 -179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 t0 73.76 56.4 0.1 Allowed 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.082 0.468 . . . . 0.0 110.548 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.872 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -93.7 175.79 6.6 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.708 -0.678 . . . . 0.0 111.185 -179.668 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 90.8 m -89.94 139.56 30.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.718 179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 5.1 t -123.44 108.26 12.49 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.905 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.415 HD23 ' HA ' ' A' ' 17' ' ' LEU . 29.9 mt -99.94 154.37 18.43 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.884 179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -119.22 89.75 3.19 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.896 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 21.0 mt-30 -130.42 -46.05 1.09 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.933 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.477 HG22 ' N ' ' A' ' 21' ' ' GLY . 22.0 mt -98.24 160.42 3.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.057 -179.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.477 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -51.51 -25.99 14.55 Favored Glycine 0 C--N 1.33 0.239 0 C-N-CA 120.803 -0.713 . . . . 0.0 112.679 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 -100.18 177.1 5.17 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.772 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 54.1 p90 -89.99 147.74 23.5 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.993 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -121.23 99.62 6.59 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.853 179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.555 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 49.5 t -97.38 111.1 23.5 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.891 179.978 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.503 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 20.2 mt -89.95 101.9 12.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.923 179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -82.05 173.24 12.36 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.989 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.47 171.01 0.43 Allowed Pre-proline 0 C--N 1.328 -0.343 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.973 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -76.25 95.18 1.03 Allowed 'Trans proline' 0 C--N 1.344 0.339 0 C-N-CA 122.642 2.228 . . . . 0.0 112.509 -179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 101.47 46.41 1.68 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.676 -0.774 . . . . 0.0 112.607 179.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -114.87 -174.49 2.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.802 0.334 . . . . 0.0 110.906 -179.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -142.34 -167.52 2.5 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 -179.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.16 168.25 40.3 Favored Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.684 -0.77 . . . . 0.0 112.513 -179.961 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.01 -43.96 14.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 120.795 0.331 . . . . 0.0 111.094 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.444 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.5 m-85 -108.27 35.2 3.25 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.855 179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . 0.554 ' SG ' ' HB2' ' A' ' 14' ' ' ALA . 53.8 t 54.85 89.47 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.831 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 49.1 tp10 -171.97 -39.75 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.863 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.3 mm . . . . . 0 C--N 1.328 -0.345 0 CA-C-N 116.295 -0.411 . . . . 0.0 111.125 179.984 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.7 p30 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.799 0.333 . . . . 0.0 110.855 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 30.0 m -80.42 141.43 15.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.144 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 -161.92 77.43 0.51 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.972 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 76.9 mt-10 -128.73 -81.87 0.58 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.845 179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -150.13 77.43 1.31 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.301 -0.409 . . . . 0.0 110.912 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 20.1 mm -102.93 -67.21 1.07 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.168 179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.2 t -110.82 55.59 0.65 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.855 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 52.7 t-20 57.56 91.96 0.07 OUTLIER Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.96 179.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.447 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 33.9 Cg_endo -64.94 -38.62 28.35 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.489 2.126 . . . . 0.0 112.207 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.714 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 11.7 m -57.92 134.18 56.11 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.721 179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.455 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 20.4 mm-40 -97.58 34.49 1.83 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.18 -0.463 . . . . 0.0 111.342 -179.481 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 57.0 m-20 -149.37 13.83 0.86 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 111.927 0.343 . . . . 0.0 111.927 -179.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 70.53 55.86 0.27 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 121.136 0.493 . . . . 0.0 110.435 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.786 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -99.46 -179.7 4.3 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.683 -0.69 . . . . 0.0 111.267 -179.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.8 m -98.58 157.28 16.34 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.912 -179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.9 t -129.81 140.62 50.99 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.969 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.736 HD12 ' OE1' ' A' ' 19' ' ' GLN . 0.4 OUTLIER -130.64 88.12 2.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.767 179.882 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -74.55 85.67 2.07 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.98 -179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.736 ' OE1' HD12 ' A' ' 17' ' ' LEU . 0.0 OUTLIER -110.64 -32.79 6.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.763 179.857 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.471 HG22 ' N ' ' A' ' 21' ' ' GLY . 1.6 mp -117.34 163.45 14.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.835 -179.987 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.471 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -46.95 -28.51 3.97 Favored Glycine 0 CA--C 1.519 0.302 0 C-N-CA 120.908 -0.663 . . . . 0.0 112.729 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.5 mm-40 -90.92 168.96 11.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.759 0.314 . . . . 0.0 110.789 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.8 p90 -90.6 138.25 31.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.98 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 3.5 tt0 -126.38 88.25 2.8 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.838 -179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -90.36 127.05 36.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.831 179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.786 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 31.2 mt -89.96 116.34 31.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.142 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 16.4 m -71.66 178.02 3.8 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.162 -0.472 . . . . 0.0 111.048 -179.957 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -71.57 169.56 15.2 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.77 179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -73.23 64.41 4.34 Favored 'Trans proline' 0 C--N 1.343 0.264 0 C-N-CA 122.499 2.133 . . . . 0.0 112.295 179.986 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 130.47 41.61 0.22 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.54 179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -114.56 -175.14 2.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.82 0.343 . . . . 0.0 110.896 -179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.7 pm0 -150.15 -177.94 6.21 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.961 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 101.81 -175.55 25.41 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.71 -0.757 . . . . 0.0 112.592 179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -89.91 -54.8 7.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.924 0.393 . . . . 0.0 110.962 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.447 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 4.3 m-85 -98.22 29.6 3.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.795 179.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.2 m 54.46 30.39 12.81 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.016 0.436 . . . . 0.0 110.435 -179.722 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.455 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 4.1 pt-20 -99.34 23.29 9.46 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.908 -0.587 . . . . 0.0 111.254 -179.532 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.44 HD13 ' O ' ' A' ' 37' ' ' GLU . 18.5 mm . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.131 -179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.4 t70 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.811 0.339 . . . . 0.0 110.868 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.9 m -101.88 134.15 43.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.228 -0.442 . . . . 0.0 111.17 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.433 ' CG ' HD11 ' A' ' 6' ' ' ILE . 2.4 t-20 -79.1 106.42 11.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.787 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.6 mm-40 -110.71 -33.09 6.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.878 179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -100.49 97.15 7.9 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.995 179.991 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.433 HD11 ' CG ' ' A' ' 3' ' ' ASN . 24.3 mm -109.92 -69.16 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.084 179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 5.2 t -114.37 54.9 0.75 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.772 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.1 t-20 56.01 88.61 0.12 Allowed Pre-proline 0 C--N 1.329 -0.311 0 CA-C-N 116.099 -0.501 . . . . 0.0 111.027 179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -53.01 -37.24 78.46 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.54 2.16 . . . . 0.0 112.349 -179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.484 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 7.8 m -58.83 171.39 0.67 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.77 -179.995 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.432 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 2.1 mm-40 -130.43 30.59 4.7 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.051 -179.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 64.5 m-20 -145.32 16.28 1.5 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.408 -0.36 . . . . 0.0 111.593 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 8.5 t0 69.37 48.11 0.66 Allowed 'General case' 0 C--N 1.333 -0.149 0 CA-C-O 121.158 0.504 . . . . 0.0 110.103 -179.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.739 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -89.9 174.34 7.74 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.542 -0.754 . . . . 0.0 111.511 -179.494 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.457 HG22 ' N ' ' A' ' 16' ' ' CYS . 96.3 m -89.9 162.11 15.61 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.897 179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.457 ' N ' HG22 ' A' ' 15' ' ' THR . 51.4 t -135.84 156.09 49.33 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.86 179.834 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.561 HD12 ' HG3' ' A' ' 19' ' ' GLN . 0.3 OUTLIER -138.03 -47.47 0.54 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 179.943 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 21.2 t0 56.05 103.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.045 -0.525 . . . . 0.0 111.043 179.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.561 ' HG3' HD12 ' A' ' 17' ' ' LEU . 1.8 mt-30 -133.38 -46.57 0.83 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.882 179.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.586 HG22 ' H ' ' A' ' 21' ' ' GLY . 1.9 mm -95.41 174.02 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.784 179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.586 ' H ' HG22 ' A' ' 20' ' ' ILE . . . -47.97 -27.36 4.96 Favored Glycine 0 C--N 1.331 0.277 0 C-N-CA 120.897 -0.668 . . . . 0.0 112.657 -179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -96.26 172.39 7.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.807 0.337 . . . . 0.0 110.823 179.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.491 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 52.8 p90 -92.19 133.0 36.2 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.959 179.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -111.07 93.16 4.34 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.813 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.444 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 44.1 t -104.51 120.03 40.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.121 -0.491 . . . . 0.0 110.946 -179.909 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.739 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 29.4 mt -89.94 126.04 42.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.202 -0.453 . . . . 0.0 111.017 179.937 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 26.7 p -113.14 -174.87 2.54 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.03 -179.954 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.452 ' CB ' ' CE1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -56.58 163.14 2.8 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.106 -179.925 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -83.6 100.16 0.87 Allowed 'Trans proline' 0 N--CA 1.462 -0.365 0 C-N-CA 122.815 2.343 . . . . 0.0 112.522 -179.784 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 116.9 23.64 3.88 Favored Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 0.0 112.798 179.705 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.452 ' CE1' ' CB ' ' A' ' 28' ' ' MET . 3.2 m-85 -94.8 179.71 5.15 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.748 0.309 . . . . 0.0 110.82 179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.4 mt-10 -150.22 -177.31 5.86 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.128 -179.894 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 102.46 -174.3 23.71 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.836 -0.697 . . . . 0.0 112.632 179.895 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.7 t -89.84 -32.27 5.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-O 120.901 0.381 . . . . 0.0 110.794 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.491 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 5.8 m-85 -121.11 26.73 8.82 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.022 -0.536 . . . . 0.0 110.682 179.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.5 m 53.85 32.88 15.89 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.726 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.595 ' O ' HD13 ' A' ' 38' ' ' ILE . 0.1 OUTLIER -97.64 31.47 2.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.979 -0.555 . . . . 0.0 111.028 -179.749 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.595 HD13 ' O ' ' A' ' 37' ' ' GLU . 23.6 mm . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.277 -0.42 . . . . 0.0 111.118 -179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 2.9 p30 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.78 0.324 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t 62.06 83.3 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.2 -0.454 . . . . 0.0 111.163 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -129.17 49.84 2.2 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.918 179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -89.93 -74.86 0.47 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.875 179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 5.0 t -142.46 102.91 4.16 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.963 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 22.6 mm -121.99 -66.9 1.1 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.186 179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 2.5 t -110.42 55.41 0.65 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.005 -0.543 . . . . 0.0 110.963 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 57.09 94.49 0.05 OUTLIER Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.908 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.437 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 26.5 Cg_endo -62.99 -38.22 48.16 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.358 2.039 . . . . 0.0 112.257 179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.763 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 6.4 m -58.1 143.85 42.24 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.744 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.406 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 2.7 mm-40 -107.43 30.19 6.48 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.343 -179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 16.7 m-20 -147.0 15.26 1.18 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 111.771 0.286 . . . . 0.0 111.771 -179.896 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.0 t70 71.09 60.4 0.18 Allowed 'General case' 0 C--N 1.333 -0.137 0 CA-C-O 121.123 0.487 . . . . 0.0 110.508 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.875 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -110.26 177.42 4.71 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.205 -179.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.429 HG22 ' N ' ' A' ' 16' ' ' CYS . 51.0 m -89.9 161.53 15.89 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.82 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.429 ' N ' HG22 ' A' ' 15' ' ' THR . 51.1 t -141.27 74.93 1.48 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.896 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.62 HD12 HD11 ' A' ' 26' ' ' ILE . 0.4 OUTLIER -62.7 86.7 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.756 180.0 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -75.16 118.42 18.07 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.972 -179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 7.1 mt-30 -149.97 -47.49 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.861 179.926 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.496 HG22 ' N ' ' A' ' 21' ' ' GLY . 21.9 mm -92.14 161.52 2.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.916 -0.584 . . . . 0.0 110.953 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . 0.496 ' N ' HG22 ' A' ' 20' ' ' ILE . . . -49.12 -26.86 6.57 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.868 -0.682 . . . . 0.0 112.726 -179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.2 mm-40 -95.19 165.82 12.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.722 0.296 . . . . 0.0 110.797 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -89.97 130.22 36.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.243 -0.435 . . . . 0.0 111.036 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 9.9 mt-30 -119.4 95.0 4.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.949 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -94.2 128.31 40.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.782 179.89 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.875 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 19.7 mt -89.9 122.12 40.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.018 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.1 m -82.92 174.7 10.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.022 -179.845 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.429 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -79.08 171.51 12.32 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.615 179.732 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.429 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 61.2 Cg_endo -72.4 80.16 1.69 Allowed 'Trans proline' 0 C--N 1.345 0.353 0 C-N-CA 122.391 2.061 . . . . 0.0 112.342 -179.98 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 108.38 57.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.835 -0.698 . . . . 0.0 112.466 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -118.32 -174.28 2.63 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.881 0.372 . . . . 0.0 110.935 -179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 48.5 mm-40 -142.22 -176.81 4.96 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.841 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 80.55 172.93 46.02 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.766 -0.73 . . . . 0.0 112.516 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -89.97 -49.08 14.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 120.813 0.34 . . . . 0.0 111.089 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.437 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.1 m-85 -98.15 27.49 4.58 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.877 179.87 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.3 97.29 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.9 -179.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.406 ' HB2' ' HB2' ' A' ' 11' ' ' GLN . 5.3 tp10 -168.89 -38.46 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.826 -179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.7 mm . . . . . 0 C--N 1.33 -0.247 0 CA-C-N 116.275 -0.42 . . . . 0.0 111.097 179.976 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 27.8 t0 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.807 0.337 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.583 HG12 HD12 ' A' ' 6' ' ' ILE . 31.6 m -90.94 146.49 6.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.215 -0.448 . . . . 0.0 111.078 179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.483 ' H ' HD11 ' A' ' 6' ' ' ILE . 19.1 t-20 -170.95 -66.64 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.203 -0.453 . . . . 0.0 111.018 -179.977 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 35.8 mm-40 -132.72 -43.07 0.91 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.156 -179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.604 ' O ' HD13 ' A' ' 6' ' ' ILE . 1.8 t -89.85 93.76 9.55 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.972 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.604 HD13 ' O ' ' A' ' 5' ' ' CYS . 21.4 mm -128.19 -65.66 0.8 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.109 -0.496 . . . . 0.0 111.166 179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 20.1 t -99.35 53.32 0.95 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.881 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.3 t-20 52.74 89.61 0.1 OUTLIER Pre-proline 0 C--N 1.33 -0.263 0 CA-C-N 116.011 -0.541 . . . . 0.0 111.14 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -60.88 -58.43 0.47 Allowed 'Trans proline' 0 C--N 1.345 0.387 0 C-N-CA 122.431 2.087 . . . . 0.0 112.213 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.756 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 5.7 m -50.1 132.21 23.46 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.895 179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 8.4 mm-40 -96.28 30.94 2.33 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.115 -0.493 . . . . 0.0 111.543 -179.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 28.6 m-20 -149.21 12.8 0.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 112.136 0.421 . . . . 0.0 112.136 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 20.5 t0 69.48 66.28 0.26 Allowed 'General case' 0 C--N 1.332 -0.157 0 CA-C-O 121.193 0.52 . . . . 0.0 110.351 179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.817 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -109.92 179.19 4.18 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.67 -0.695 . . . . 0.0 111.32 -179.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.6 m -90.0 140.13 29.93 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.692 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 54.1 t -134.42 92.44 2.92 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.825 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 1.6 mp -71.35 124.08 23.76 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.953 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -65.17 112.32 3.35 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.94 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -122.29 161.09 23.96 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.909 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 6.5 mt -91.3 92.0 3.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.164 -0.471 . . . . 0.0 111.098 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 147.23 -76.93 0.26 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.769 -0.729 . . . . 0.0 112.545 180.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 36.0 mt-10 -123.44 179.14 4.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.878 0.371 . . . . 0.0 110.907 -179.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.4 p90 -97.31 129.85 44.55 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.978 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 7.0 mm-40 -107.71 87.47 2.51 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.852 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -92.17 114.86 27.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.972 -179.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.817 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 27.6 mt -89.94 122.67 41.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.998 179.892 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -83.45 164.9 19.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.067 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -62.03 171.39 1.55 Allowed Pre-proline 0 C--N 1.329 -0.287 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.809 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -77.37 79.69 3.1 Favored 'Trans proline' 0 C--N 1.345 0.383 0 C-N-CA 122.553 2.169 . . . . 0.0 112.462 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 120.47 37.78 0.71 Allowed Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.755 -0.736 . . . . 0.0 112.449 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -109.35 -175.16 2.68 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.795 0.331 . . . . 0.0 110.878 -179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -144.78 -178.15 5.87 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.912 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 86.03 169.75 46.27 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.779 -0.724 . . . . 0.0 112.504 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.2 t -90.02 -47.93 14.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.808 0.337 . . . . 0.0 111.189 179.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -99.74 27.98 5.03 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.973 -179.922 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 87.9 m 54.1 100.27 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 CA-C-N 116.365 -0.379 . . . . 0.0 110.972 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.3 tp10 -174.54 -38.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.95 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.652 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.762 179.933 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 22.3 m-20 . . . . . 0 C--O 1.231 0.128 0 CA-C-O 120.804 0.335 . . . . 0.0 110.876 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 21.5 t 64.1 112.04 0.03 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.069 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -81.9 138.28 35.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.904 179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -120.09 -78.62 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.816 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.3 OUTLIER -137.49 77.46 1.64 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.802 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 21.0 mm -108.98 -66.46 1.3 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.108 -0.497 . . . . 0.0 111.212 -179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -107.36 55.86 0.65 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.896 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 56.08 88.76 0.12 Allowed Pre-proline 0 C--N 1.329 -0.31 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.889 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.456 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 30.6 Cg_endo -64.61 -39.3 27.99 Favored 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.512 2.142 . . . . 0.0 112.277 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.698 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 4.3 m -70.05 150.84 46.19 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.74 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.449 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 20.3 mm-40 -118.46 27.94 8.64 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.34 -179.463 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -146.83 15.14 1.21 Allowed 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.914 0.339 . . . . 0.0 111.914 -179.621 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 13.2 t70 72.11 50.26 0.22 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 121.135 0.493 . . . . 0.0 110.562 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.698 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -90.13 172.73 8.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.714 -0.676 . . . . 0.0 111.179 -179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.689 ' HB ' HD12 ' A' ' 26' ' ' ILE . 61.1 m -97.57 132.5 43.18 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.797 179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.7 t -99.47 131.59 45.37 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.913 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.406 HD13 ' H ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -119.21 142.95 47.55 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.889 -179.958 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.406 ' H ' HD13 ' A' ' 17' ' ' LEU . 1.5 m-20 -99.85 117.7 34.73 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.906 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.754 ' HB3' HD12 ' A' ' 20' ' ' ILE . 6.6 mt-30 -102.87 -77.88 0.55 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.96 179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.754 HD12 ' HB3' ' A' ' 19' ' ' GLN . 3.8 mp -141.52 -66.47 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.089 -0.505 . . . . 0.0 111.186 179.905 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -140.11 28.38 2.49 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.77 -0.729 . . . . 0.0 112.521 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -141.36 171.31 14.23 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.807 0.337 . . . . 0.0 110.944 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.41 ' CE1' ' CE1' ' A' ' 35' ' ' TYR . 52.1 p90 -102.58 136.75 41.84 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.987 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 mm100 -117.05 92.78 3.95 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.817 179.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.479 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 52.0 t -89.98 119.74 30.6 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.891 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.692 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 26.3 mt -89.92 113.64 26.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.934 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 9.5 m -74.75 174.06 9.67 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.141 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.44 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -70.53 172.72 5.59 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.565 179.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.434 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 64.2 Cg_endo -73.1 66.78 4.2 Favored 'Trans proline' 0 C--N 1.345 0.349 0 C-N-CA 122.343 2.028 . . . . 0.0 112.32 179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 129.77 41.03 0.25 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.526 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 28' ' ' MET . 4.3 m-85 -113.8 -176.47 2.91 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.781 0.324 . . . . 0.0 110.927 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.449 ' HG3' HG21 ' A' ' 38' ' ' ILE . 2.2 pt-20 -150.22 -177.95 6.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.105 -0.498 . . . . 0.0 111.017 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.14 -175.92 28.84 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.784 -0.722 . . . . 0.0 112.626 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.2 t -89.97 -54.09 8.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.824 0.345 . . . . 0.0 110.895 179.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.456 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 10.3 m-85 -96.97 26.18 4.83 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.792 179.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.9 m 51.66 32.6 9.5 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.957 0.408 . . . . 0.0 110.586 -179.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.449 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 1.9 pt-20 -99.06 29.85 3.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.109 -179.587 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.449 HG21 ' HG3' ' A' ' 32' ' ' GLU . 23.8 mm . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.229 -0.441 . . . . 0.0 111.101 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.861 0.362 . . . . 0.0 110.856 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.421 HG12 ' N ' ' A' ' 3' ' ' ASN . 21.5 t -107.49 155.18 8.3 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.076 -179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.421 ' N ' HG12 ' A' ' 2' ' ' VAL . 12.1 m-20 -160.4 95.92 1.15 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.855 -179.989 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -135.75 -80.27 0.42 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.87 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -126.71 85.6 2.4 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.837 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 26.5 mm -94.89 -69.95 0.65 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.226 -179.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 4.8 t -116.05 55.17 0.8 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.826 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.1 t-20 55.16 91.3 0.08 OUTLIER Pre-proline 0 C--N 1.329 -0.322 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.895 179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -66.48 -27.72 46.41 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 122.483 2.122 . . . . 0.0 112.381 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.447 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 14.2 m -55.43 135.69 50.19 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.345 -0.389 . . . . 0.0 110.891 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.3 mm100 -102.2 32.52 3.47 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.192 -179.472 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.9 m-20 -146.43 14.14 1.24 Allowed 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 111.795 0.294 . . . . 0.0 111.795 -179.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.1 t0 68.53 43.85 1.32 Allowed 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 121.199 0.524 . . . . 0.0 110.218 -179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.452 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -89.95 178.82 6.11 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.411 -179.503 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 99.0 m -99.25 145.51 27.19 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.808 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 50.3 t -106.67 137.6 44.39 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.712 179.818 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.444 ' HB2' HD11 ' A' ' 26' ' ' ILE . 0.2 OUTLIER -133.18 118.53 18.75 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.196 -0.457 . . . . 0.0 110.976 -179.945 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 17.7 p30 -69.7 122.87 20.0 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.89 179.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -95.89 -76.57 0.5 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.943 -179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 23.9 mt -145.28 -46.55 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.092 -0.504 . . . . 0.0 111.167 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -144.64 -38.16 0.06 OUTLIER Glycine 0 CA--C 1.518 0.235 0 C-N-CA 120.751 -0.738 . . . . 0.0 112.844 -179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -89.79 178.63 6.19 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.916 0.388 . . . . 0.0 111.004 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 47.7 p90 -100.17 153.84 18.93 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.121 -0.49 . . . . 0.0 111.053 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.7 tt0 -132.36 112.66 12.38 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.795 179.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -90.01 109.94 20.95 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.005 -179.792 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.452 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 31.0 mt -99.44 90.88 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.827 179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 p -97.32 -176.37 3.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.128 -0.487 . . . . 0.0 111.068 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.439 ' HB3' ' CE1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -51.38 168.51 0.26 Allowed Pre-proline 0 C--N 1.33 -0.249 0 CA-C-N 116.095 -0.502 . . . . 0.0 111.105 -179.891 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.407 ' HD2' ' CG ' ' A' ' 28' ' ' MET . 86.9 Cg_endo -82.07 138.73 10.35 Favored 'Trans proline' 0 C--N 1.346 0.409 0 C-N-CA 122.697 2.264 . . . . 0.0 112.448 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 78.82 24.06 62.97 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.708 -0.758 . . . . 0.0 112.714 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.439 ' CE1' ' HB3' ' A' ' 28' ' ' MET . 2.6 m-85 -90.38 -176.37 4.77 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.77 0.319 . . . . 0.0 110.726 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -150.09 -178.47 6.51 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.255 -0.43 . . . . 0.0 111.124 -179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 100.12 176.0 30.42 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.82 -0.705 . . . . 0.0 112.522 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 23.2 t -89.88 -48.1 14.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-O 120.882 0.372 . . . . 0.0 110.996 179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -100.38 28.91 4.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.799 179.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 1.2 m 58.85 51.95 6.99 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.875 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -113.86 -33.43 5.78 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.823 179.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.59 ' O ' HG22 ' A' ' 38' ' ' ILE . 28.7 mm . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.263 -0.426 . . . . 0.0 111.06 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.795 0.331 . . . . 0.0 110.923 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.484 HG23 ' OE2' ' A' ' 4' ' ' GLU . 9.5 m -95.38 147.37 5.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.227 -0.442 . . . . 0.0 111.182 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 20.7 m-20 -76.8 133.31 39.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.87 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . 0.484 ' OE2' HG23 ' A' ' 2' ' ' VAL . 1.0 OUTLIER -126.38 -79.67 0.6 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.255 -0.43 . . . . 0.0 110.946 -179.948 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.439 ' C ' HD12 ' A' ' 6' ' ' ILE . 12.6 t -100.11 83.28 2.66 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.237 -0.438 . . . . 0.0 111.053 -179.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.626 ' N ' HD12 ' A' ' 6' ' ' ILE . 1.7 mp -102.09 -75.72 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.808 179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 3.2 t -107.97 55.91 0.64 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.046 -0.524 . . . . 0.0 110.809 179.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 53.8 t-20 59.15 90.26 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.902 179.943 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -53.31 -38.31 81.93 Favored 'Trans proline' 0 C--N 1.344 0.328 0 C-N-CA 122.581 2.187 . . . . 0.0 112.313 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.738 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 4.6 m -57.13 168.21 0.74 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.823 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.435 ' HB2' ' HB3' ' A' ' 37' ' ' GLU . 1.6 mm-40 -127.99 27.26 5.71 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.285 -179.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 29.1 m-20 -146.13 17.19 1.38 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.496 -0.32 . . . . 0.0 111.518 -179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 69.71 52.65 0.42 Allowed 'General case' 0 C--N 1.332 -0.156 0 CA-C-O 121.305 0.574 . . . . 0.0 110.195 -179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.738 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -97.53 176.55 5.82 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.553 -0.748 . . . . 0.0 111.256 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 72.0 m -90.03 149.85 22.35 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.816 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 53.0 t -125.89 139.15 53.7 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.875 179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.47 HD22 ' HA ' ' A' ' 17' ' ' LEU . 0.2 OUTLIER -126.34 126.16 43.45 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.924 -179.871 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -65.02 137.54 57.78 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.911 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . 0.464 ' OE1' HD12 ' A' ' 20' ' ' ILE . 0.1 OUTLIER -149.48 163.54 37.51 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.991 -179.955 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.464 HD12 ' OE1' ' A' ' 19' ' ' GLN . 2.6 mp -90.36 90.21 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.235 -0.439 . . . . 0.0 111.176 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 141.41 -82.19 0.23 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.669 -0.777 . . . . 0.0 112.518 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -113.31 178.02 4.43 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.855 0.359 . . . . 0.0 110.85 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.472 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 54.8 p90 -89.96 142.33 27.8 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.999 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 28.7 tt0 -109.39 96.77 6.51 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.887 -179.985 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -106.29 119.16 38.51 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.888 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.667 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 29.8 mt -90.06 116.57 31.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.099 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 14.4 m -73.56 178.48 4.65 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.045 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.449 ' CB ' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -75.66 170.79 14.12 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.814 179.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -75.45 72.6 4.86 Favored 'Trans proline' 0 C--N 1.344 0.323 0 C-N-CA 122.526 2.151 . . . . 0.0 112.475 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 125.37 38.78 0.47 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.777 -0.725 . . . . 0.0 112.621 179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.449 ' CD1' ' CB ' ' A' ' 28' ' ' MET . 4.9 m-85 -112.16 -175.95 2.81 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.86 0.362 . . . . 0.0 110.772 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -150.04 179.23 8.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.871 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 99.8 -177.7 29.33 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.691 -0.766 . . . . 0.0 112.501 -179.999 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.6 t -90.03 -50.54 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.837 0.351 . . . . 0.0 111.035 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.472 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 6.3 m-85 -98.21 28.69 3.9 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.862 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 6.2 m 54.12 30.73 12.56 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.968 0.413 . . . . 0.0 110.753 -179.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.435 ' HB3' ' HB2' ' A' ' 11' ' ' GLN . 15.1 pt-20 -100.56 -23.66 14.64 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.983 -0.553 . . . . 0.0 111.212 -179.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.5 mm . . . . . 0 C--N 1.329 -0.284 0 CA-C-N 116.37 -0.377 . . . . 0.0 111.08 -179.942 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 18.8 p-10 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.868 0.366 . . . . 0.0 110.909 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 25.8 t -78.57 88.87 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.146 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -122.32 146.22 47.52 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.777 179.973 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.1 mt-10 -115.9 -9.41 11.81 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.435 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . . . . . . . . . 53.3 m -89.91 73.84 7.4 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.918 0.39 . . . . 0.0 110.872 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 23.3 mm -101.59 -67.7 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.226 -179.886 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -106.64 53.57 0.7 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.016 -179.803 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 59.3 t-20 49.44 91.72 0.06 OUTLIER Pre-proline 0 C--N 1.328 -0.332 0 CA-C-N 116.074 -0.512 . . . . 0.0 111.29 179.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -62.96 -39.36 41.05 Favored 'Trans proline' 0 C--N 1.345 0.369 0 C-N-CA 122.519 2.146 . . . . 0.0 112.221 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.739 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 1.9 m -49.5 151.37 1.61 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.261 -0.427 . . . . 0.0 111.107 -179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.4 ' HB2' ' HB2' ' A' ' 37' ' ' GLU . 7.3 mm-40 -114.08 32.07 6.14 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.259 -0.428 . . . . 0.0 111.31 -179.438 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 34.4 m-20 -149.6 17.83 0.91 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.764 0.283 . . . . 0.0 111.764 -179.917 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.6 t0 69.98 57.91 0.29 Allowed 'General case' 0 C--N 1.332 -0.168 0 CA-C-O 121.197 0.522 . . . . 0.0 110.482 179.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.859 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -108.1 -175.6 2.82 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.683 -0.689 . . . . 0.0 111.251 -179.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.416 HG22 ' N ' ' A' ' 16' ' ' CYS . 89.4 m -105.57 160.62 15.04 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.153 -0.476 . . . . 0.0 111.054 -179.829 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . 0.416 ' N ' HG22 ' A' ' 15' ' ' THR . 0.1 OUTLIER -122.01 148.41 44.85 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.781 179.918 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.414 HD23 ' H ' ' A' ' 18' ' ' ASP . 0.3 OUTLIER -142.98 159.68 41.78 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.93 -179.975 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.414 ' H ' HD23 ' A' ' 17' ' ' LEU . 1.4 t70 -113.29 158.66 20.25 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.926 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.86 -77.03 0.33 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.929 -179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 3.6 mt -123.93 -67.43 0.93 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.409 0 CA-C-N 116.088 -0.505 . . . . 0.0 111.089 179.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -148.32 26.96 1.39 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.821 -0.704 . . . . 0.0 112.399 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.33 -178.98 5.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.76 0.314 . . . . 0.0 110.968 179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 44.6 p90 -106.53 137.26 44.85 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.036 -179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 2.9 tt0 -124.93 94.95 4.33 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.644 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 1.8 t -89.94 130.54 36.14 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.846 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.859 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 29.1 mt -89.91 122.87 41.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.987 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.3 m -84.36 -176.1 6.09 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.048 -179.806 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.425 ' CB ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -84.75 172.1 9.65 Favored Pre-proline 0 C--N 1.328 -0.34 0 CA-C-N 115.984 -0.553 . . . . 0.0 110.611 179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.425 ' HD2' ' CB ' ' A' ' 28' ' ' MET . 72.9 Cg_endo -74.17 75.46 3.29 Favored 'Trans proline' 0 C--N 1.345 0.343 0 C-N-CA 122.403 2.069 . . . . 0.0 112.356 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 122.98 38.57 0.56 Allowed Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.557 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -112.95 -176.21 2.84 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.774 0.321 . . . . 0.0 110.945 179.996 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.2 pt-20 -150.1 -177.26 5.82 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.877 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.36 174.03 41.84 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.491 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 28.9 t -89.96 -53.4 9.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-O 120.82 0.343 . . . . 0.0 110.954 179.898 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -97.81 25.62 5.77 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.157 -0.474 . . . . 0.0 110.815 179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER 52.17 100.24 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.934 0.397 . . . . 0.0 111.068 -179.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . 0.4 ' HB2' ' HB2' ' A' ' 11' ' ' GLN . 3.9 tp10 -173.84 -33.14 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.011 -0.54 . . . . 0.0 110.976 -179.818 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 13.1 mm . . . . . 0 C--N 1.332 -0.192 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.979 -179.941 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 11.9 t70 . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.761 0.315 . . . . 0.0 110.932 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.438 ' O ' HG23 ' A' ' 2' ' ' VAL . 5.8 m -64.62 93.18 0.11 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.245 -0.434 . . . . 0.0 111.077 -179.949 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -121.7 82.96 2.02 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.872 179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -140.38 -79.42 0.29 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.997 -179.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.51 ' C ' HD12 ' A' ' 6' ' ' ILE . 1.2 m -106.72 90.24 3.26 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.833 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.629 ' N ' HD12 ' A' ' 6' ' ' ILE . 1.6 mp -106.14 -77.82 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.941 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -102.9 53.97 0.77 Allowed 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.91 -179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 56.5 t-20 53.4 86.3 0.17 Allowed Pre-proline 0 C--N 1.327 -0.371 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.169 179.775 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . 0.467 ' HB2' ' CE1' ' A' ' 35' ' ' TYR . 17.4 Cg_endo -58.9 -37.39 93.88 Favored 'Trans proline' 0 C--N 1.346 0.415 0 C-N-CA 122.529 2.152 . . . . 0.0 112.249 179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 1.3 m -56.97 177.37 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.925 -179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 mm-40 -134.95 28.14 3.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.251 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 30.3 m-20 -146.36 15.75 1.3 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.568 -0.287 . . . . 0.0 111.716 -179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.5 t0 70.23 49.68 0.45 Allowed 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.085 0.469 . . . . 0.0 110.209 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.814 ' HB1' ' O ' ' A' ' 26' ' ' ILE . . . -89.97 175.1 7.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.617 -0.72 . . . . 0.0 111.203 -179.523 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 98.7 m -90.04 154.22 19.98 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.906 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 1.2 m -112.9 131.07 55.88 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.743 179.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -143.34 112.58 6.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.89 179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -80.57 151.05 29.3 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.851 179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 36.1 mt-30 -118.75 -80.37 0.61 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.93 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 5.0 mt -129.2 -68.31 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.111 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -123.28 -37.45 0.6 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.825 -0.703 . . . . 0.0 112.546 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.1 mt-10 -89.87 172.48 8.85 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.809 0.338 . . . . 0.0 110.938 -179.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 50.2 p90 -97.64 162.87 13.08 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.014 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -147.74 96.46 2.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.817 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 3.8 t -90.08 131.06 36.15 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.201 -0.454 . . . . 0.0 111.028 -179.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.814 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 28.9 mt -91.88 118.52 37.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.001 179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 6.9 t -100.2 161.39 13.64 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.976 -179.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.406 ' HB3' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -60.67 171.69 0.99 Allowed Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 116.061 -0.518 . . . . 0.0 110.835 179.949 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . . . . . . . . . 97.6 Cg_endo -78.73 127.22 7.79 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.656 2.237 . . . . 0.0 112.424 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 79.96 31.24 39.99 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.664 -0.779 . . . . 0.0 112.51 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.406 ' CD1' ' HB3' ' A' ' 28' ' ' MET . 5.2 m-85 -106.68 -174.88 2.64 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.816 0.341 . . . . 0.0 110.885 -179.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 mt-10 -147.09 -176.98 5.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.844 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 92.59 164.92 38.32 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.726 -0.75 . . . . 0.0 112.456 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 30.1 t -89.94 -30.19 5.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-O 120.799 0.333 . . . . 0.0 111.042 -179.999 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.467 ' CE1' ' HB2' ' A' ' 9' ' ' PRO . 1.7 m-85 -118.12 35.98 4.52 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.892 179.927 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 8.3 t 49.84 84.81 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -157.31 -42.62 0.07 Allowed 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.864 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 38' ' ' ILE . 1.6 mp . . . . . 0 C--N 1.329 -0.285 0 CA-C-O 120.891 0.377 . . . . 0.0 110.681 179.993 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.868 0.366 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.487 HG12 ' N ' ' A' ' 3' ' ' ASN . 20.4 t 64.47 159.3 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.118 179.962 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . 0.487 ' N ' HG12 ' A' ' 2' ' ' VAL . 1.3 m-20 62.56 101.36 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.24 -0.436 . . . . 0.0 110.786 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -107.1 -73.12 0.7 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.916 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.403 ' C ' HD12 ' A' ' 6' ' ' ILE . 0.5 OUTLIER -150.12 71.11 1.06 Allowed 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.239 -0.437 . . . . 0.0 110.843 179.879 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.627 ' N ' HD12 ' A' ' 6' ' ' ILE . 1.7 mp -99.67 -77.74 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.046 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 1.4 t -93.37 55.49 2.27 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.076 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.6 t-20 53.06 92.93 0.05 OUTLIER Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.999 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -63.67 -46.17 9.62 Favored 'Trans proline' 0 C--N 1.346 0.397 0 C-N-CA 122.504 2.136 . . . . 0.0 112.243 179.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.796 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 9.6 m -59.88 161.45 6.49 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.621 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.87 28.96 4.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.354 -0.384 . . . . 0.0 111.188 -179.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.9 m-20 -149.18 18.34 0.96 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.536 -0.302 . . . . 0.0 111.511 -179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 6.8 t70 71.83 50.43 0.25 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.17 0.509 . . . . 0.0 110.465 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.796 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -90.17 171.62 9.39 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.691 -0.686 . . . . 0.0 111.174 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.497 ' HB ' HD12 ' A' ' 26' ' ' ILE . 96.9 m -94.93 136.65 34.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.821 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 51.8 t -113.46 118.81 35.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.893 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.95 132.84 53.79 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.925 179.903 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . . . . . . . . . 28.2 t0 -60.56 122.28 14.27 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.901 -179.952 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.79 -165.81 1.08 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.822 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.2 pt -94.23 23.81 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 CA-C-N 116.339 -0.391 . . . . 0.0 111.633 -179.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . 150.93 -37.78 0.87 Allowed Glycine 0 C--N 1.331 0.266 0 C-N-CA 120.563 -0.827 . . . . 0.0 112.675 179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.3 pt-20 -100.06 177.33 5.12 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.793 0.33 . . . . 0.0 110.894 -179.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.492 ' CZ ' ' CE1' ' A' ' 35' ' ' TYR . 44.3 p90 -102.14 146.63 27.68 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.02 179.999 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 -116.76 92.01 3.75 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.002 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . . . . . . . . . 41.9 t -90.96 113.53 25.79 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.813 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.58 ' O ' ' HB1' ' A' ' 14' ' ' ALA . 18.0 mt -89.92 119.11 36.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.989 -179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -91.7 172.8 8.24 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.048 -179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.44 ' HB2' ' CD1' ' A' ' 31' ' ' TYR . 0.0 OUTLIER -72.51 172.36 7.77 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.791 179.943 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.411 ' HD2' ' CG ' ' A' ' 28' ' ' MET . 71.7 Cg_endo -76.47 62.56 7.05 Favored 'Trans proline' 0 C--N 1.345 0.358 0 C-N-CA 122.499 2.133 . . . . 0.0 112.254 -179.969 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 136.57 43.11 0.1 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.753 -0.737 . . . . 0.0 112.467 -179.944 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.44 ' CD1' ' HB2' ' A' ' 28' ' ' MET . 2.6 m-85 -109.93 -175.37 2.72 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.806 0.336 . . . . 0.0 110.873 -179.845 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -144.37 175.71 9.9 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.92 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 93.55 166.25 37.7 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.792 -0.718 . . . . 0.0 112.52 179.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.4 t -90.16 -33.82 6.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.759 0.314 . . . . 0.0 111.159 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.492 ' CE1' ' CZ ' ' A' ' 23' ' ' PHE . 17.4 m-85 -113.54 33.29 5.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.929 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 63.8 m 49.82 88.0 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.0 179.938 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 54.9 tt0 -162.62 -43.19 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.937 -179.865 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 26.9 mm . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.071 179.999 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.449 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.23 0.07 0 CA-C-O 120.837 0.351 . . . . 0.0 110.985 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.2 p -143.27 142.37 25.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.122 179.915 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ASN . . . . . . . . . . . . . 32.4 p-10 -152.98 149.39 28.15 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.919 179.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -139.0 -59.87 0.59 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.872 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' CYS . . . . . 0.67 ' C ' HD12 ' A' ' 6' ' ' ILE . 21.1 t -143.81 80.17 1.65 Allowed 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.904 179.969 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . 0.67 HD12 ' C ' ' A' ' 5' ' ' CYS . 1.6 mp -114.81 -76.51 0.47 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.908 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.69 55.34 1.06 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.943 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 55.2 t-20 53.44 90.05 0.09 OUTLIER Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 116.172 -0.467 . . . . 0.0 111.066 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_exo -59.6 -37.52 87.79 Favored 'Trans proline' 0 C--N 1.345 0.361 0 C-N-CA 122.674 2.25 . . . . 0.0 112.323 -179.934 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' CYS . . . . . 0.849 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 20.1 m -59.45 169.6 1.21 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.905 -179.843 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.3 mm-40 -131.26 26.75 4.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.179 -179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -149.88 18.65 0.89 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.516 -0.311 . . . . 0.0 111.563 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t0 70.61 48.95 0.42 Allowed 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 121.126 0.488 . . . . 0.0 110.275 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.849 ' HB3' ' SG ' ' A' ' 10' ' ' CYS . . . -89.92 168.7 11.84 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.238 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.543 ' HB ' HD12 ' A' ' 26' ' ' ILE . 97.2 m -89.89 133.93 34.49 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.809 179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' CYS . . . . . . . . . . . . . 11.6 t -104.15 143.33 33.06 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.267 -0.424 . . . . 0.0 110.908 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.518 HD13 ' N ' ' A' ' 18' ' ' ASP . 0.2 OUTLIER -142.45 132.98 25.16 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.915 -179.965 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ASP . . . . . 0.518 ' N ' HD13 ' A' ' 17' ' ' LEU . 29.5 t0 -126.81 129.87 49.15 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.857 -179.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLN . . . . . . . . . . . . . 45.8 mt-30 -124.88 -62.15 1.26 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.891 179.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.6 mt -93.87 -67.73 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.422 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.108 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLY . . . . . . . . . . . . . . . -172.12 33.29 0.13 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.874 -0.679 . . . . 0.0 112.494 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -135.1 158.01 45.45 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.764 0.316 . . . . 0.0 110.886 179.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.494 ' CE2' ' CE1' ' A' ' 35' ' ' TYR . 51.1 p90 -95.05 123.23 38.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.124 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLN . . . . . . . . . . . . . 46.2 mt-30 -105.21 102.6 12.08 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.784 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' CYS . . . . . 0.433 ' SG ' ' HB3' ' A' ' 14' ' ' ALA . 42.6 t -90.03 128.39 36.27 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.069 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . 0.543 HD12 ' HB ' ' A' ' 15' ' ' THR . 21.2 mt -106.87 106.7 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.077 -0.511 . . . . 0.0 110.808 179.726 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' CYS . . . . . . . . . . . . . 1.8 t -87.07 161.24 18.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.301 -0.408 . . . . 0.0 111.113 -179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.412 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -58.67 172.78 0.48 Allowed Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.012 -0.54 . . . . 0.0 110.941 -179.927 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.412 ' HD2' ' CG ' ' A' ' 28' ' ' MET . 87.1 Cg_endo -78.05 119.32 4.64 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.536 2.157 . . . . 0.0 112.306 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 92.12 20.59 35.5 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.778 -0.725 . . . . 0.0 112.441 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 4.2 m-85 -100.56 -177.04 3.37 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.831 0.348 . . . . 0.0 110.734 179.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -150.07 -177.02 5.68 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.86 179.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' GLY . . . . . . . . . . . . . . . 98.4 169.16 31.59 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.649 -0.786 . . . . 0.0 112.38 -179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 21.7 t -93.06 -36.05 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.837 0.351 . . . . 0.0 111.145 179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' TYR . . . . . 0.494 ' CE1' ' CE2' ' A' ' 23' ' ' PHE . 3.8 m-85 -111.1 26.27 10.87 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.988 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' CYS . . . . . . . . . . . . . 37.8 t 51.66 92.38 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.866 -179.896 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -162.29 -37.37 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.158 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 12.8 mm . . . . . 0 C--N 1.329 -0.308 0 CA-C-N 116.445 -0.343 . . . . 0.0 110.998 -179.837 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' FUC . . . . . 0.455 ' H61' HG22 ' A' ' 26' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' NAG . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_